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The final diagnosis of most types of cancers is performed by an expert clinician
in anatomical pathology who examines suspicious tissue or cell samples extracted
from the patient. Currently, this assessment largely relies on the experience of the
clinician and is accomplished in a qualitative manner by means of traditional imaging
techniques, such as optical microscopy. This tedious task is subject to high degrees
of subjectivity and gives rise to suboptimal levels of discordance between different
pathologists, especially in early stages of cancer development.
Fourier Transform infrared (FTIR) spectroscopy is a technology widely used in
industry that has recently shown an increasing capability to improve the diagnosis
of different types of cancer. This technique takes advantage of the ability of mid-
infrared light to excite the vibrational modes of the chemical bonds that form the
biological samples. The main generated signal consists of an absorption spectrum
that informs of the chemical composition of the illuminated specimen. Modern FTIR
microspectrometers, composed of complex optical components and high-sensitive
array detectors, allow the acquisition of high-quality hyperspectral images with
spatially-resolved chemical information in a common research laboratory. FTIR
images are information-rich data structures that can be analysed alone or together
with other imaging modalities to provide objective pathological diagnoses. Hence,
this emerging imaging technique presents a high potential to improve the detection
and risk stratification in cancer screening and surveillance.
VII
VIII Abstract
This thesis studies and implements different methodologies and algorithms
from the related fields of image processing, computer vision, machine learning,
pattern recognition, multivariate analysis and chemometrics for the processing
and analysis of FTIR hyperspectral images. Those images were acquired with a
modern benchtop FTIR microspectrometer from tissue and cell samples affected
by colorectal and skin cancer, which were prepared by following protocols close to
the current clinical practise. The most relevant concepts of FTIR spectroscopy are
thoroughly investigated, which ought to be understood and considered to perform
a correct interpretation and treatment of its special signals. In particular, different
physicochemical factors are reviewed and analysed, which influence the spectroscopic
measurements for the particular case of biological samples and can critically affect
their later analysis.
All these knowledge and preliminary studies come into play in two main
applications. The first application tackles the problem of registration or alignment of
FTIR hyperspectral images with colour images acquired with traditional microscopes.
The aim is to fuse the spatial information of distinct tissue samples measured by
those two imaging modalities and focus the discrimination on regions selected by
the pathologists, which are meant to be the most relevant areas for the diagnosis of
colorectal cancer. In the second application, FTIR spectroscopy is pushed to their
limits of detection for the study of the smallest biomedical entities. The aim is
to assess the capabilities of FTIR signals to reliably discriminate different types of
skin cells containing malignant phenotypes. The developed studies contribute to the
improvement of objective decision methods to support the pathologist in the final
diagnosis of cancer. In addition, they reveal the limitations of current protocols and
intrinsic problems of modern FTIR technology, which should be tackled in order to
enable its transference to anatomical pathology laboratories in the future.
Resumen
El diagnóstico final de la mayoŕıa de tipos de cáncer lo realiza un médico experto en
anatomı́a patológica que examina muestras tisulares o celulares sospechosas extráıdas
del paciente. Actualmente, esta evaluación depende en gran medida de la experiencia
del médico y se lleva a cabo de forma cualitativa mediante técnicas de imagen
tradicionales como la microscoṕıa óptica. Esta tarea tediosa está sujeta a altos grados
de subjetividad y da lugar a niveles de discordancia inadecuados entre diferentes
patólogos, especialmente en las primeras etapas de desarrollo del cáncer.
La espectroscoṕıa infrarroja por Transformada de Fourier (siglas FTIR en inglés)
es una tecnoloǵıa ampliamente utilizada en la industria que recientemente ha
demostrado una capacidad creciente para mejorar el diagnóstico de diferentes tipos
de cáncer. Esta técnica aprovecha las propiedades del infrarrojo medio para excitar
los modos vibratorios de los enlaces qúımicos que forman las muestras biológicas.
La principal señal generada consiste en un espectro de absorción que informa sobre
la composición qúımica de la muestra iluminada. Los microespectrómetros FTIR
modernos, compuestos por complejos componentes ópticos y detectores matriciales
de alta sensibilidad, permiten capturar en un laboratorio de investigación común
imágenes hiperespectrales de alta calidad que aúnan información qúımica y espacial.
Las imágenes FTIR son estructuras de datos ricas en información que se pueden
analizar individualmente o junto con otras modalidades de imagen para realizar
diagnósticos patológicos objetivos. Por lo tanto, esta técnica de imagen emergente
alberga un alto potencial para mejorar la detección y la evaluación del riesgo del
paciente en el cribado y vigilancia de cáncer.
IX
X Resumen
Esta tesis estudia e implementa diferentes metodoloǵıas y algoritmos de los campos
interrelacionados de procesamiento de imagen, visión por ordenador, aprendizaje
automático, reconocimiento de patrones, análisis multivariante y quimiometŕıa para
el procesamiento y análisis de imágenes hiperespectrales FTIR. Estas imágenes se
capturaron con un moderno microscopio FTIR de laboratorio a partir de muestras de
tejidos y células afectadas por cáncer colorrectal y de piel, las cuales se prepararon
siguiendo protocolos alineados con la práctica cĺınica actual. Los conceptos más
relevantes de la espectroscoṕıa FTIR se investigan profundamente, ya que deben ser
comprendidos y tenidos en cuenta para llevar a cabo una correcta interpretación y
tratamiento de sus señales especiales. En particular, se revisan y analizan diferentes
factores fisicoqúımicos que influyen en las mediciones espectroscópicas en el caso
particular de muestras biológicas y pueden afectar cŕıticamente su análisis posterior.
Todos estos conceptos y estudios preliminares entran en juego en dos aplicaciones
principales. La primera aplicación aborda el problema del registro o alineación de
imágenes hiperespectrales FTIR con imágenes en color adquiridas con microscopios
tradicionales. El objetivo es fusionar la información espacial de distintas muestras
de tejido medidas con esas dos modalidades de imagen y centrar la discriminación en
las regiones seleccionadas por los patólogos, las cuales se consideran más relevantes
para el diagnóstico de cáncer colorrectal. En la segunda aplicación, la espectroscoṕıa
FTIR se lleva a sus ĺımites de detección para el estudio de las entidades biomédicas
más pequeñas. El objetivo es evaluar las capacidades de las señales FTIR para
discriminar de manera fiable diferentes tipos de células de piel que contienen fenotipos
malignos. Los estudios desarrollados contribuyen a la mejora de métodos de decisión
objetivos que ayuden al patólogo en el diagnóstico final del cáncer. Además,
revelan las limitaciones de los protocolos actuales y los problemas intŕınsecos de la
tecnoloǵıa FTIR moderna, que debeŕıan abordarse para permitir su transferencia a
los laboratorios de anatomı́a patológica en el futuro.
Resum
El diagnòstic final de la majoria de tipus de càncer ho realitza un metge expert en
anatomia patològica que examina mostres tissulars o cel·lulars sospitoses extretes del
pacient. Actualment, aquesta avaluació depèn en gran part de l’experiència del metge
i es porta a terme de forma qualitativa mitjançant tècniques d’imatge tradicionals com
la microscòpia òptica. Aquesta tasca tediosa està subjecta a alts graus de subjectivitat
i dóna lloc a nivells de discordança inadequats entre diferents patòlegs, especialment
en les primeres etapes de desenvolupament del càncer.
L’espectroscòpia infraroja per Transformada de Fourier (sigles FTIR en anglès)
és una tecnologia àmpliament utilitzada en la indústria que recentment ha demostrat
una capacitat creixent per millorar el diagnòstic de diferents tipus de càncer. Aquesta
tècnica aprofita les propietats de l’infraroig mitjà per excitar els modes vibratoris
dels enllaços qúımics que formen les mostres biològiques. El principal senyal generat
consisteix en un espectre d’absorció que informa sobre la composició qúımica de
la mostra il·luminada. Els microespectrómetres FTIR moderns, compostos per
complexos components òptics i detectors matricials d’alta sensibilitat, permeten
capturar en un laboratori d’investigació comú imatges hiperespectrals d’alta qualitat
que uneixen informació qúımica i espacial. Les imatges FTIR són estructures de dades
riques en informació que es poden analitzar individualment o juntament amb altres
modalitats d’imatge per a realitzar diagnòstics patològics objectius. Per tant, aquesta
tècnica d’imatge emergent té un alt potencial per a millorar la detecció i la avaluació
del risc del pacient en el cribratge i vigilància de càncer.
XI
XII Resum
Aquesta tesi estudia i implementa diferents metodologies i algoritmes dels
camps interrelacionats de processament d’imatge, visió per ordinador, aprenentatge
automàtic, reconeixement de patrons, anàlisi multivariant i quimiometria per al
processament i anàlisi d’imatges hiperespectrals FTIR. Aquestes imatges es van
capturar amb un modern microscopi FTIR de laboratori a partir de mostres de teixits
i cèl·lules afectades per càncer colorectal i de pell, les quals es van preparar seguint
protocols alineats amb la pràctica cĺınica actual. Els conceptes més rellevants de
l’espectroscòpia FTIR s’investiguen profundament, ja que han de ser compresos i
tinguts en compte per dur a terme una correcta interpretació i tractament dels seus
senyals especials. En particular, es revisen i analitzen diferents factors fisicoqúımics
que influeixen en els mesuraments espectroscòpiques en el cas particular de mostres
biològiques i poden afectar cŕıticament la seua anàlisi posterior.
Tots aquests conceptes i estudis preliminars entren en joc en dues aplicacions
principals. La primera aplicació aborda el problema del registre o alineació d’imatges
hiperespectrals FTIR amb imatges en color adquirides amb microscopis tradicionals.
L’objectiu és fusionar la informació espacial de diferents mostres de teixit mesurades
amb aquestes dues modalitats d’imatge i centrar la discriminació en les regions
seleccionades pels patòlegs, les quals es consideren més rellevants per al diagnòstic
de càncer colorectal. En la segona aplicació, l’espectroscòpia FTIR es porta als seus
ĺımits de detecció per a l’estudi de les entitats biomèdiques més xicotetes. L’objectiu
és avaluar les capacitats dels senyals FTIR per discriminar de manera fiable diferents
tipus de cèl·lules de pell que contenen fenotips malignes. Els estudis desenvolupats
contribueixen a la millora de mètodes de decisió objectius que ajuden al patòleg en
el diagnòstic final del càncer. A més, revelen les limitacions dels protocols actuals i
els problemes intŕınsecs de la tecnologia FTIR moderna, que haurien d’abordar per
permetre la seva transferència als laboratoris d’anatomia patològica en el futur.
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ñ(ν̃) Complex refractive index
n∞ Average real refractive index
NA Numerical aperture
N Set of natural numbers
nKK Output of the first Kramers-Kronig transform
Np Number of pixels
Nw Number of wavenumbers
P Cauchy principal value of improper integrals
XXX Symbols
P Matrix of loadings or autovectors (PCA)
Pi Probability of intensity level i in R
pi Loadings or autovectors of principal components
Pij Joint probability of intensity levels i in R and j in T
Pj Probability of intensity level j in T
Q Matrix of Qext(ν̃) curves
q Loadings vector of the response vector (PLS)
Qext(ν̃) Extinction cross section (Mie scattering)
R Restriction point in cell cycle; Reference image in registration
r Radius of the scattering sphere (RMieS-EMSC); Number of
orientations of descriptor (SIFT)
R2 Coefficient of determination
R Red component of RGB color space
R Set of real numbers
rms Root-mean-square level
rod Ratio of distances closest/next closest (SIFT)
S Syntesis phase in cell cycle
s Number of scale samples per octave (SIFT)
S Covariance matrix




T (ν̃) Transmittance spectrum
T1 Original target image
T2 Intermediate target image transformed by rigid transformation
T3 Final target image transformed by non-rigid transformation
T Matrix of scores (PCA)
Ti Deformed intermediate states of target image





T Rigid spatial transformation
{T (xi)} Generic set of transformed points
{TFB(xi)} Set of points transformed by the feature-based registration step
{TPA(xi)} Set of points transformed by Procrustes analysis
tx Translation in horizontal direction
ty Translation in vertical direction
u Non-rigid displacement field
w Weight vector (PLS)
X Data or measurements matrix, independent variables
x Horizontal spatial dimension or horizontal pixel position
X̂ Data or measurements matrix of new samples to predict
x Pixel or spatial point position (vector)
{xi} Set of selected points in T1
y Vertical spatial dimension or vertical pixel position
Y Luma component of Y IQ color space
y Response or labels vector, dependent variable
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1.1 Cancer
According to the World Health Organization (WHO), cancer is a generic term which
includes a large group of pathologies that may affect any part of the body [1]. Cancer
is a genetic disease caused by mistakes or mutations during Deoxyribonucleic Acid
(DNA) replication. The likelihood of suffering these remaining mutations is mainly
determined by environmental factors and lifestyle (around 90-95% of all cancer cases)
and in a lower degree by inherited genetic defects (only 5-10% of all cancer cases) [2].
The key characteristic of cancer is the rapid growth of abnormal cells capable of
dividing out of control and spreading beyond their natural boundaries. This invasion
of other tissues is called metastasis and it is the first cause of death in cancer patients.
Tumour is the common word to refer to neoplasms, that is, abnormal growths of
tissue with an increase in volume [3]. Tumours can be generally classified in two major
types: benign and malignant. Benign tumours only grow in a local and restricted
region without invading nearby tissues, meanwhile malignant tumours can spread to
adjacent and distant tissues (metastasis). Despite these differences, the word tumour
is commonly used with implicit malignant connotations. Most primary tumours in
humans are benign and do not cause any harm, unless their expansion presses a vital
organ and affects its correct operation. The majority of deaths connected with cancer
are caused by malignant tumours in the more advanced metastatic state.
Tumours are created by malfunctioning cells, which are incapable of building
tissues with normal morphology and functioning, disobeying the rules that control
the correct construction and maintenance. Cancer cells only have one target: making
more copies of themselves [4]. They can achieve this purpose by acquiring new
capabilities (Sec. 1.1.2) as a result of accumulated genetic mutations, which are
transferred to their descendants [5].
Some of these unsuitable alterations are the deactivation of apoptosis and the
invisibility to immune system. Apoptosis is the programmed mechanism of cellular
suicide by which all normal cells destroy themselves when they perform an incorrect
biological functioning. When this mechanism fails the immune system is responsible
for killing the defective cells. However, cancerous cells are able to hide from
immune system through different processes or remain unaffected by their defence
mechanisms [6].
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1.1.1 Development of cancer
The development of a malignant tumour is a slow process comprising different steps
where proper mutations get accumulated. In most cases the progression of a tumour
requires several years, in the order of decades. That is why cancer is considered as a
chronic disease more associated with old people.
The typical steps of cancer can be illustrated with the evolution of carcinoma.
Carcinoma is a cancerous lesion that begins in the epithelial tissue and is the most
common malignant tumour. Epithelial tissue is a sheet of cells that forms the inner
and outer surfaces of the body, such as the external layers of the bowel or the skin.
As illustrated in Fig. 1.1, the main stages in the development of carcinoma are [4, 7]:
1. Genetically altered cell : the tumour development starts when a normal cell
undergoes a genetic change that increases its predisposition to proliferate.
2. Hyperplasia: is the result of an unconstrained division of one altered cell into
a high number of cells in a limited region of tissue. The structure in these
cells is not altered and they look normal although their size may be larger.
Hyperplasia is a reversible process and is normally produced as a response to
an irritant stimulus. After years in this stage, one cell in a million suffers an
additional mutation that makes it grow more uncontrollably.
3. Dysplasia: literally means disordered growth and is the result of an excessive
proliferation of cells in hyperplasia, which lose their normal structure and get
disorganised due to additional genetic changes. In this stage, cells keep growing
in an abnormal way. Just as hyperplasia, cells in dysplasia can recover their
normal state but sometimes, after a time, a rare mutation occurs that changes
the cell behaviour. Therefore, tissues in dysplasia must be specially controlled
and, in some cases, receive treatment.
4. In situ cancer : this stage is reached when cells do not recover their normal state
and accumulate more and more alterations. The tumour presents an irregular
structure. In this state, the cells are not able to invade other tissues and remain
confined in the primary location, maybe indefinitely. However, in situ cancers
must be promptly resected or treated before they acquire invasive properties
because of further mutations.
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5. Invasive cancer : is the final stage of tumour formation. Cells become malignant
and invade adjacent tissue and even spread to distant sites through the
blood vessels or the lymphatic system. The spread cells can get attached to
different tissues and create new tumours, producing metastasis. This stage
normally becomes lethal because spread cells, which typically cannot be totally







Fig. 1.1: Illustration of the development of a cancerous lesion in the epithelial tissue.
Reproduced from [7] with permission by courtesy of Scientific American, Inc.
1.1.2 The characteristics of cancer
The cell cycle
Before explaining the main properties that distinguish cancer at the cellular level,
it is interesting to describe the cell cycle. All living cells reproduce by dividing
in two daughter cells following a coordinated cell cycle that tries to guarantee the
conservation of the genome. As depicted in Fig. 1.2, in most human cells this cycle is
composed of four main stages [8]:
1. G1 phase (Gap 1): the cell grows in volume by synthesising proteins and making
copies of its subcellular components called organelles, but excluding the nucleus,
which contains DNA.
2. S phase (Synthesis): the chromosomes, the macromolecules of DNA that
encodes the genetic information, are replicated into two identical entities called
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sister chromatids that remain attached. This is the longest stage of the cycle.
Once entered this phase of replication, cells must finish the complete cycle.
3. G2 phase (Gap 2): the cell growth continues by making more proteins and
organelles. The cellular content is also reorganised in preparation for the next
step. In particular, the chromatids of chromosomes become more compact.
4. M phase (Mitosis): the replicated chromosomes and the cytoplasm (the non-


























Fig. 1.2: Stages of the cell cycle. Reproduced from [7] with permission by courtesy of
Scientific American, Inc.
The whole cycle is strictly regulated by specific signals both coming from outside
and inside the cell, which ensure a correct cell division. For instance, at the end of
G1 phase there is a specific period called restriction point (R) [9] where cells must
receive from the outside the so-called growth factors to trigger the DNA replication.
In normal tissues, these growth factors are not supplied if, for example, a nutritional
deficiency exists in the region. From this point, cells do not depend on extracellular
stimuli to finish the cell cycle. If growth factors are not supplied, cells enter in a
quiescent or still stage called G0, in which they have an active metabolism but they
do not keep on growing and synthesising more proteins. In addition, each phase of
the cell cycle has specific checkpoints [10], which prevent entering into the next phase
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if the preceding phase is not correctly completed. In particular, multiple checkpoints
try to guarantee that incomplete or damaged chromosomes are not replicated. As
detailed below, cancer cells can break the strict rules governing the cell cycle by
complex and interrelated pathways that benefit their sustained proliferation [11–15].
The hallmarks of cancer
In the past, tumours were considered as accumulations of relatively homogeneous
cancer cells whose biology only depended on autonomous properties. However, now
it is widely recognised that tumours are not just isolated masses of proliferating
cancer cells but heterogeneous mixtures of different cell types interacting with one
another and constructing a tumour microenvironment of high complexity, as depicted
in Fig. 1.3a.
As commented, cancer is a very complex and diverse disease but research
discoveries in the last decades have revealed that this diversity may be reduced to
a small number of principles. Hanahan and Weinberg [16, 17] suggested a series of
hallmarks or distinctive characteristics (illustrated in Fig. 1.3b) that allow cells to
survive, proliferate and disseminate and which differentiate cancer cells and their
microenvironment from normal cells and tissues. In 2000 [17], they initially proposed
six complementary hallmarks or functional capabilities:
 Sustaining proliferative signaling : cancer cells can develop different mechanisms
to maintain a supply of growth factors, which allow them to circumvent the
restriction point (Fig. 1.2) and favour their chronic proliferation. In some
cases, they can produce these substances themselves or they can stimulate other
normal cells to provide the growth factors to them.
 Evading growth suppressors: cancer cells can elude regulatory circuits of cellular
proliferation from extracellular and intracellular sources. For instance, they
abolish the signals generated by cell-to-cell contacts that prevent excessive
propagation in dense populations of normal cells.
 Resisting cell death: cancer cells do not follow apoptosis, the programmed
cell death induced by physiologic stresses and DNA damage associated with
hyperproliferation. The most common way is inactivating the production of the
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(a)
(b)
Fig. 1.3: The characteristics of cancer. (a) Illustration of a tumour microenvironment,
which is composed by a complex mixture of different cell types. (b) Illustration of
the hallmarks and enabling characteristics that distinguish cancer cells and their tumour
microenvironment. Reproduced from [16] with permission by courtesy of Elsevier.
protein p53, nicknamed the guardian of genome [18], which triggers apoptosis
when irreparable damage to the genome or other crucial subcellular subsystems
are detected in the different stages of the cell cycle [19]. Autophagy is another
mechanism that cancer cells develop to survive in the highly-stressed and
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nutrient-limited environments of tumours by which they can break down their
cellular components and recycle the obtained metabolites. Finally, a surprising
characteristic is that cancer cells seem to be able to conveniently induce cell
death by necrosis. Whereas apoptosis is an organised process which breaks cells
into compact pieces that are consumed by neighbours, necrotic cells explode
and release all their content into the local microenvironment. This release of
cellular debris attracts immune inflammatory cells (Fig. 1.3a), which generate
stimulating signals that promote the growth and invasiveness of the remaining
cancer cells (see below). Therefore, some tumours may tolerate some degree of
necrotic cell death in order to favour the surviving cells.
 Enabling replicative immortality : chromosomes have protective ends called
telomeres, which give them structural stability. In most adult normal cells,
telomeres shorten during successive replications as a programmed ageing until
reaching a non-proliferative state called senescence or suffering apoptosis.
However, cancer cells can produce enzymes that regenerate telomeres and get
an unlimited number of replications, becoming immortal.
 Inducing angiogenesis: cancer cells can stimulate endothelial cells (Fig. 1.3a) to
construct new blood vessels around the tumour region even in the early stages
of development. With this ability they guarantee the supply of nutrients and
oxygen and the evacuation of metabolic waste and carbon dioxide, which is
essential for the tumour expansion.
 Activating invasion and metastasis: this is the most dangerous and lethal
characteristic of cancer cells. They develop alterations that modify their
attachment to other cells and to the extracellular matrix. However, the
mechanisms that empower cancer cells to colonise other tissues and travel to
other distant parts of the body remain quite unknown. The development of
a secondary malignant tumour requires a permissive microenvironment in the
new colonised zone.
Experimental advances during the first decade of this century confirmed and
further clarified the described traits and allowed to add two emerging hallmarks in
2011, whose workings are not well understood yet [16]:
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 Reprogramming energy metabolism: cancer cells can reprogram their glucose
metabolism, and thus their energy production, in order to fuel cell growth and
replication. The uptake of glucose is highly increased in many tumours and the
modifications in its utilization seem to be key in the hypoxic conditions existing
in the tumour microenvironment.
 Evading immune destruction: immune system constantly monitors all the body
components and quickly recognise and eliminate the majority of altered cells
that may become cancer cells. By still-unresolved mechanisms, cancer cells
seem to manage to hide from immune system or limit its killing response.
In addition, two enabling characteristics that make possible the acquisition of the
described hallmarks were identified:
 Genome instability and mutation: cancer cells often accelerate their rates of
random mutations by showing an increased sensitivity to mutagenic agents.
This instability is translated into a high heterogeneity between different tumour
types and an extreme adaptability to new conditions.
 Tumor-promoting inflammation: tumour microenvironment is rich in inflam-
matory cells belonging to the immune system, which try to eradicate tumours.
Unfortunately, inflammatory cells not only attack cancer cells without success
but also produce growth factors that favour proliferation and promote angio-
genesis, invasion and metastasis.
Understanding these hallmark principles and their underlying mechanisms is
playing and will play a crucial role in identifying therapeutic targets that effectively
stop and eradicate malignant tumours without hurting normal tissues excessively [20].
1.1.3 Colorectal cancer
Colorectal cancer is a very common human malignancy that starts in the walls of
the large intestine. Before summarising some facts of this type of cancer, it is worth
describing some concepts of the anatomy and physiology of the large intestine.
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Fig. 1.4: Structures of the human large intestine, rectum, and anus. Reproduced from [22]
with permission by courtesy of Encyclopaedia Britannica, Inc., copyright 2003.
Anatomy and physiology of the large intestine
The large intestine is the last part of the alimentary tract. It is about 1.5 meters long
and, as shown in Fig. 1.4, can be divided into several regions namely cecum, colon
(ascending, transverse, descending and sigmoid), rectum, anal canal and appendix.
As a part of the digestive system, the main functions of the large intestine are the
absorption of electrolytes, fluids and gases, and the conversion of undigested materials
and dead bacteria into faeces [21].
As can be appreciated in the detail view of Fig. 1.4, the walls of most regions of
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the large intestine (excluding the anal canal and the appendix) are composed of four
main layers of tissue [23]:
1. Mucosa: is the inner part of the wall and constitutes the lining of the intestine.
Mucosa consists of three sub-layers of tissue:
(a) Epithelium: is the external layer, which is composed of different types
of cells in a simple columnar configuration. The epithelium together with
the lamina propria build invaginations in the form of simple tubular glands
or crypts. The rectum contains fewer and deeper crypts than the colon.
Between the cells composing the epithelium, goblet cells have an important
role because they secret mucus into the central hole of the crypts, called
lumen. Mucus lubricates the lining of the intestine and facilitates the
movement and evacuation of faeces.
(b) Lamina propria: is composed of loose connective tissue whose main
function is to give structural and nutritional support to the epithelium.
(c) Muscularis mucosae: is a thin outer layer of smooth (involuntary) muscle
cells, which gently contract to promote the evacuation of the crypts’
content.
2. Submucosa: is composed of fibroelastic connective tissue and contains blood,
lymphatic vessels and nerves. It gives support to the rest of tissue layers.
3. Muscle layer : consists of two layers of smooth muscle, the inner one is circular
and the outer one is longitudinal. The involuntary contraction and relaxation
of these layers generate a movement called peristalsis that pushes the content
of the intestine onwards.
4. External layer : is formed by connective tissue and is called adventitia in the
ascending and descending portions of the colon, where it has a structural
function. In the cecum and remainder colon, it is called serosa and is composed
of a layer of connective tissue and another one of epithelium, which secretes
lubricating fluid to reduce the friction with the muscle layer.
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Main facts of colorectal cancer
Colorectal cancer [24], also referred to as bowel cancer [25] or sometimes differenced
as cancer of the colon [26] and the rectum [27], originates in the epithelial cells of
the mucosa that form the glands or crypts. This type of malignant tumour is called
adenocarcinoma (adeno- is the Greek term for gland) and accounts for more than
90% of cancer cases whose primary site is the wall of the large intestine [28]. Another
precursors of cancer in other layers of tissue are muscle cells (produce sarcomas), cells
of the lymphatic system (give rise to lymphomas) or specialized hormone-making cells
(produce carcinoid tumours), but these subtypes are normally included in categories
different from colorectal cancer.
As was described in Fig. 1.1, several mutations are accumulated in the epithelial
cells that develop a tumour. When these tumours appear in the lining of the colon
or the rectum, they are called polyps. Polyps can be divided in two main types :
 Hyperplastic polyps: present, in general, little potential to become an invasive
cancer. They are relatively common and are normally considered as benign.
 Adenomatous polyps or adenomas: are known as the main precursors of cancer
lesions and constitute a premalignant condition. Adenomas have characteristics
associated with cancer development (Sec. 1.1.1), such as epithelial overgrowth,
dysplasia and abnormal differentiation. Nevertheless, few adenomas progress to
invasive cancer and the process can take over one to three decades.
Several genetic pathways are already known to be responsible for the change from
premalignant polyps to invasive lesions. In fact, the family history of colorectal cancer
and other hereditary syndromes have relevant influence in this change. Apart from
the inherited predisposition, the main risk factors associated with colorectal cancer
are: obesity and sedentary life, smoking, alcohol, high-caloric diet, high red meat
consumption, overcooked red meat and high-saturated fats. On the contrary, high
level of physical activity and diets high in fibre, low in red and processed meat, and
rich in fresh fruit and vegetables, seem to decrease the risk of colorectal cancer.
Different tests are applied in screening programs in order to detect colorectal
cancer in undiagnosed individuals. The three most common tests are fecal occult
blood tests and two endoscopy alternatives: sigmoidoscopy (endoscopy of the left side
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of the colon) and colonoscopy (endoscopy of the entire colon). Endoscopy is also used
to extract small biopsies from small portions of tissue or even remove whole polyps.
It also gives valuable complementary information to perform a final diagnosis, which
is accomplished by histological examination (Sec. 1.1.6).
The clinical management of colorectal cancer differs depending on the location
of the tumour and its spread [25]. If tumours are localized in the colon, the
involved bowel segments including the local lymphatic drainage area are normally
removed by laparoscopic surgery, with high curative potential (Sec. 1.1.5). Cancers
in the rectum, especially in carcinomas below the mid-sigmoid region, may also be
treated with radiation therapy apart from surgical resection. In advanced stages of
spread, complementary adjuvant treatments, such as chemotherapy or other systemic
therapies, can also be applied to prevent the formation of new tumours in the primary
or secondary sites.
1.1.4 Skin cancer
Melanoma is the most aggressive subtype of skin cancer. As in colorectal cancer, some
concepts of the anatomy and physiology of the skin and its relevant constituents must
be explained prior to describe some general facts of skin cancer and melanoma.
Anatomy and physiology of the skin
The skin is the outer covering and the largest organ of human body. Its functions
are: to protect the body against injury, desiccation and infection; to regulate body
temperature; to absorb Ultraviolet (UV) radiation; and to contain receptors for touch,
temperature and pain stimuli from the external environment [23]. The skin is divided
into two main layers: the epidermis (upper or outer layer) and the dermis (lower
or inner layer) (Fig. 1.5). These two tissue layers are separated by the basement
membrane.
The epidermis is composed of stratified keratinised squamous epithelium, whose
predominant cell type is the keratinocyte [21]. Keratinocytes are arranged in five
layers or strata, where they acquire different characteristics. In the deepest layer of
epidermis, keratinocytes are also called basal cells and are mitotically active, that
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Fig. 1.5: Illustration of the anatomy of healthy skin. Reproduced from [29] with permission
by courtesy of Terese Winslow (Illustrator).
is, they are in continuous cell division to regenerate the upper layers. In the rest
of epidermis layers, keratinocytes are called squamous cells and they evolve towards
the surface until becoming flattened dead cells filled with impermeable keratin in the
most superficial layer.
Melanocytes are cells also present in the deepest layer of the epidermis. The
mission of melanocytes is to synthesise a dark brown pigment called melanin and to
transfer it into nearby keratinocytes (see detail view of Fig. 1.5). Melanin protects
against tissue damage caused by UV radiation and its synthesis is promoted by
continuous exposure to sunlight.
The dermis is formed by connective tissue that supports different structures, such
as blood and lymph vessels, nerves, sweat and oil glands, and hair follicles. Connective
tissue plays an important role in immune and inflammatory responses, tissue repair
after injury, as well as delivering nutrients to the avascular epidermis through the
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basement membrane [30]. Fibroblasts are the resident cells of connective tissue, whose
mission is to elaborate fibres, such as collagen and elastin, and other components of
the extracellular matrix.
Main facts of skin cancer
Skin cancer can be divided into two main groups: non-melanoma skin cancer and
melanoma skin cancer. Among non-melanoma skin cancer, two subtypes are more
common [31]:
 Basal cell carcinoma: is a slow-growing neoplasm that originates from
keratinocytes in the basal cell layer of the epidermis. This carcinoma rarely
produces metastasis but its local recurrence and invasiveness result in significant
tissue destruction. As depicted in Fig. 1.6a, basal cell carcinoma normally
remains confined in the epidermis and does not expand to other tissues. It
typically develops on sun-exposed regions of people with lighter skin.
 Squamous cell carcinoma: is a neoplasm that has malignant characteristics, such
as local invasion and metastatic potential. It originates from kerotynocytes of
epidermis in squamous cell configuration and can invade nearby tissues like
the dermis, as illustrated in Fig. 1.6a. Most lesions of this cancer type do not
cause pain and remain undetected, growing slowly until they become invasive
carcinomas.
Melanoma is a neoplastic disorder that starts with the transformation of normal
melanocytes [35–37]. Although melanocytes are also present in other body locations
(e.g., meninges, upper oesophagus or eyes), their malignant transformations are more
common in the skin. Melanoma is the most aggressive type of skin cancer, that is why
it is normally considered as an individual category. In fact, it is one of the most violent
and therapy-resistant human cancers, mainly due to its high mutation capability and
heterogeneity. Compared with other skin cancers, melanoma is characterised by its
superior ability to grow and spread both radially and vertically, finally invading inner
tissues in a very aggressive way (Fig. 1.6a).
Melanoma occurs mainly in white people with fair skin. Although not necessary
occurring in all cases, some melanomas start from common accumulations of
1.1. Cancer 17
(a) (b) (c)
Fig. 1.6: Skin cancer. (a) Illustration of the most common types of skin cancer. Reproduced
from [32] with permission by courtesy of Mayo Foundation for Medical Education and
Research. All rights reserved. (b) Photographs of five common benign moles. Reproduced
from [33]. (c) Photograph of a malignant melanoma. Reproduced from [34].
melanocytes called nevi or moles (Fig. 1.6b). Individuals with a high number of
melanocytic nevi (more than 50) have higher odds of developing melanoma [38]. A
famous rule to distinguish the features of a malignant melanoma (Fig. 1.6c) is the
mnemonic ABCD method [39,40]: Asymmetry, Border irregularity, Colour variation,
Diameter >6mm.
The common major risk factor in skin cancers is sun overexposure with inadequate
protection even in the absence of sunburn, especially in childhood and adolescence,
or other cumulative exposures to UV radiation as artificial tanning lamps and beds.
Other risk factors include inherited genetic susceptibility, immunosuppression and
viral infections. The clinical management of skin cancers depends on the tumour
aggressiveness and stage, and also on the current status and medical record of
the patient. The common treatments expand from traditional surgical excision to
destructive modalities that include cautery or electrodesiccation, cryosurgery, laser
surgery, radiation therapy and chemotherapy. In the excisional surgery, the borders
of the extracted mass of tissue can be studied to assess the completeness of the tumour
ablation. However, the destructive techniques do not provide any information to know
if the cancer has been completely removed.
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1.1.5 Cancer statistics
Cancer burden
GLOBOCAN project, elaborated by the International Agency for Research on Cancer
(IARC), the specialized cancer agency of WHO, provides the most updated and
reliable estimates of the global cancer burden, which can be retrieved from [41, 42].
These statistics correspond to 2012 and are given in terms of estimated incidence,
mortality and prevalence [43,44]. In this case, these terms are defined as follows [45]:
 Incidence: is the number of new cases arising in a specified population within a
given period of time. Here it is expressed as the absolute number of new cases
per year (2012).
 Mortality : is the number of deaths occurring in a specified population within a
given period of time. Here it is also expressed as the absolute number of deaths
per year (2012).
 Prevalence: is a function of both incidence and survival. It is defined as the
number of individuals within a specified population who have been diagnosed
with a specific cancer and who are still alive at a given point in time (i.e. the
survivors). In this case, it is presented as partial prevalence, which limits the
number of patients to those diagnosed during a fixed time in the past, 5 years
in particular. In most types of cancers, patients still alive at 5 years after
diagnosis are usually considered cured because the death rates of such patients
are similar to those expected in the general population [46]. Therefore, the 5-
year prevalence is an estimate of the cure rate of a specific cancer. Here it is
presented the number of estimated cases diagnosed since 2004 who were still
alive at the end of 2008 [44].
Fig. 1.7 graphically summarises the described measures for the corresponding top
10 cancer sites worldwide and in Europe, for both sexes. Roughly more than 14
million new cases of all cancers were diagnosed in the world in 2012 and 3.4 million
of them were registered in Europe. WHO foresees a rise of 70% in this value over
the next 2 decades due to population increase and ageing [47], which will result in






































































































































Fig. 1.7: Estimated incidence (first row), mortality (second row) and 5-year prevalence
(third row) of the corresponding top 10 cancer sites worldwide (first column) and in Europe
(second column), for both sexes in 2012. The relative values for each cancer site with respect
to the corresponding total number of cases are shown in parentheses. The relevant cancer
sites for this PhD thesis (colorectum and melanoma of skin) are highlighted with bold letters.
Adapted with the graphs produced from [42].
20 Chapter 1. Introduction
cancer sites for this PhD thesis, colorectal cancer was the 3rd most diagnosed cancer
worldwide in 2012 (9.7% of all new cases) and melanoma of skin occupied the 19th
position (1.7%). The relative incidence in Europe for these types of cancer is higher,
with colorectal cancer in the 2nd place (13%) and specially melanoma in the 9th
position (2.9%). Some factors that may explain these local differences could be the
characteristics of population (e.g., people with white skin for melanoma), their habits
or the screening programs which are mainly applied in more developed countries.
Cancer is the second leading cause of mortality, just after cardiovascular diseases,
both worlwide with around 8.2 million deaths and in Europe with more than 1.7
million deaths in 2012. Lung cancer deserves special mention since it is clearly the
most lethal type of cancer, causing around 20% of all cancer deaths. These data
are even more shocking when they are compared with the corresponding incidence.
Colorectal cancer is also a very lethal cancer, ranking the 4th worlwide (6.4%) and the
2nd in Europe (12%). For its part, melanoma is in the 22nd place worlwide (0.7%)
and in the 19th position in Europe (1.3%).
The estimated 5-year prevalence of all cancers rises to almost 32.5 million patients
worlwide and more than 9 millions in Europe. By comparing the values for each cancer
type with the respective incidence, an idea of the survival rate can be extrapolated.
Again the lethality of the lung cancer can be confirmed by this way, especially in
Europe. Colorectal cancer is the third most prevalent cancer both worlwide (11%)
and in Europe (13%), meanwhile melanoma ranks the 11th worlwide (2.7%) and the
6th in Europe (4.3%).
According to the described figures, cancer constitutes a major public health
problem. In particular, colorectal cancer and melanoma can be considered as very
serious diseases with a high general impact on the population. Further details and
analyses of the cancer statistics from GLOBOCAN can be found in [48].
Cancer survival by stage of diagnosis
As commented, the 5-year prevalence compared with the incidence can be used as a
rough estimate of the survival rate for a specific cancer. However, knowing the exact
survival rate, especially by the stage at which cancer was diagnosed, is very valuable
to develop appropriate screening programs and surveillance guidelines.
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These values are not easy to get because not many countries have enough resources
to record high-quality national data with such richness. Despite that, some national
agencies have aggregated data where diagnosed cancers are broadly classified in few
categories depending on the spread of the lesion. Two main staging systems are
commonly used for all types of cancer:
 TNM Staging System: was developed and is revised jointly by the American
Joint Committee on Cancer (AJCC) [49] and the Union for International Cancer
Control (UICC) [50]. It specifies five stages in Roman numerals (0 -IV ).
 SEER Summary Staging : is promoted by the Surveillance, Epidemiology, and
End Results (SEER) Program of the National Cancer Institute of the United
States (US) [51]. It specifies four categories: in situ, localized, regional and
distant.
An additional stage or category called unknown is also considered in both staging
systems to catalogue those cases without enough evidence to be assigned to the other
stages. Although each cancer type may have its own variants, the overall stages are
common and can be illustrated for the particular case of colorectal cancer (Fig. 1.8).
In the case of melanoma, the transition from the first abnormal melanocytes to
metastatic melanoma can be divided into the same stages or categories, which are
mainly characterised by the vertical growth of the tumour. The stages of the TNM
Staging System, related to the categories from the SEER Summary Staging, are:
 Stage 0 : abnormal cells appear in the first tissue site, but they have not
spread to other tissues. In the case of colorectal cancer, these cells appear
in the epithelium of the mucosa layer without penetration of the basement
membrane (Fig. 1.8). This stage is equivalent to the in situ category of the
SEER Summary Staging.
 Stage I : cancer acquires invasive properties and spreads to nearby tissue
layers. In colorectal cancer, the malignant cells spread from the mucosa to
the submucosa and muscle layer (Fig. 1.8). In this stage, the cancer is still in
the localized category of the SEER Summary Staging because it is limited to
the organ where it started.
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 Stage II : cancer manages to spread through all the layers of organ (all the
intestine wall, including the external layers, in the case of colorectal cancer,
Fig. 1.8), and even invades nearby organs. According to the SEER Summary
Staging, this is an intermediate stage where the lesion may be defined as localized
or regional depending on whether the lesion does or does not remain confined
to the organ of origin, respectively.
 Stage III : this stage is more complicated and have a variety of different sub-
stages. In them, the cancer may or may not have locally spread from the original
organ, but it manages to access the lymphatic vessels and spread to nearby
lymph nodes. In the SEER Summary Staging, the cancer clearly reaches the
regional level but is still limited to a specific area of the body.
 Stage IV : cancer finally produces metastasis and spreads to other parts of the
body through the lymphatic or circulatory systems, giving rise to secondary
tumours. This phase corresponds to the distant category in the SEER Summary
Staging.
Fig. 1.8: Stages of colorectal cancer. Stages from the TNM Staging System are specified
in black fonts and the corresponding categories from the SEER Summary Staging in white
fonts. Adapted from [52] with permission from Terese Winslow (Illustrator).
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To the author’s knowledge, only two sources provide survival statistics specified by
stage of diagnosis for the two cancer types of interest here (colorectal or bowel cancer
and melanoma). The first source is Cancer Research UK [53], which summarises
the records of the adult cancer patients (aged 15-99 years), separated by sex, from
the Former Anglia Cancer Network in the period 2002-2006. The staging of this
source uses the TNM Staging System. The second source is the SEER Program [54],
which uses the SEER Summary Staging to distinguish the data obtained from the US
population in the period 2007-2013. The most relevant data from these sources are
graphically presented in Fig. 1.9.
The survival statistics in both sources are given in terms of 5-year relative survival.
It compares the survival during five years or more after diagnosis of a cohort of cancer
patients with the survival of another cohort of people from the general population with
similar characteristics (same age, race, and sex) but not diagnosed with cancer. If
this relationship is greater than 100%, it indicates that cancer patients in a specific
group have a better chance of surviving five years after diagnosis compared with the
studied general population.
As can be seen in Fig. 1.9.a and Fig. 1.9.c (top graph), colorectal or bowel cancer
has good expectancies of 5-year survival when it is detected at early Stage I or is still
localized (90-100% relative survival). The survival gradually decreases in intermediate
stages of spread (∼85% in Stage II, ∼63% in Stage III and ∼71% in regional stage).
But there is an abrupt drop in survival when the cancer produces metastasis (roughly
10% or less in Stage IV and distant stage). The data from US population (Fig. 1.9.c,
bottom graph) also inform about the percent of patients diagnosed at each stage.
According to them, colorectal cancer does not have good records of early diagnosis
with 39% of cases detected in the localized stage and 35% with regional spread. Sadly,
more than 20% of cases were diagnosed in the distant stage, with the worst prognosis.
Only 4% of cases could not be classified in a specific stage.
Similar survival trends can be observed in melanoma (Fig. 1.9.b and Fig. 1.9.d,
top graph). Cases diagnosed during first stages of localized primary tumours have
a high cure rate with almost and even more than a 100% 5-year relative survival.
The survival also gradually decreases in stages with intermediate spread (∼80% in
Stage II, ∼50% in Stage III and ∼63% in regional stage). However, patients whose
cancers have advanced up to metastatic stages only reach a 5-year relative survival



























































































































Fig. 1.9: Survival by stage of diagnosis. First row: 5-year survival rate by stage in the period
2002-2006 of the adult cancer patients (aged 15-99 years), separated by sex, from the Former
Anglia Cancer Network who were diagnosed with (a) bowel cancer and (b) melanoma (Data
retrieved from [53] using the TNM Staging System; no significant differences were found
between men and women at any stage or type of cancer). Second and third row: 5-year
survival rate by stage (second row) and percent of cases per stage (third row) in the period
2007-2013 of the US population diagnosed with (c) colorectal cancer and (d) melanoma (Data
retrieved from [54] using the SEER Summary Staging).
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from around 10 to 20%. Again, the percent of patients diagnosed at each stage in
the US population is shown for melanoma (Fig. 1.9.d, bottom graph). The early
diagnosis in melanoma seems to be much more effective than in colorectal cancer in
this population: 84% of cases detected in the localized stage, 9% with regional spread
and just 4% with distant metastasis. In this case, just 3% of cases were not properly
catalogued.
As main conclusion of these figures, early diagnosis is the key factor to reduce
mortality. Current diagnosis protocols seem to have a low rate of early diagnosis
for colorectal cancer but a high rate for melanoma. Finally, it must be noticed that
these statistics correspond to two leading countries in screening programs and cancer
treatments.
1.1.6 Cancer diagnosis and research
Although some cancer lesions show different observable signs that allow its detection
in vivo (directly in the patient), ultimate diagnosis and staging is currently established
ex vivo by analysing biological samples extracted from the patient. Histopathology and
cytopathology are the main medical disciplines that analyse the ex-vivo specimens with
diagnostic purposes. On the other hand, in-vitro techniques, such as cell culture, play
a crucial role in cancer research and in the development of new diagnostic technologies.
Histopathology
Histopathology is the branch of anatomical pathology that uses histology (the science
that studies tissues) to diagnose diseases. Histopathology is considered the gold
standard or reference test to perform a final diagnosis of cancer. That is, although
different techniques such as endoscopy, radiology or blood test are used to detect the
lesion or even obtain complementary diagnostic information, the final evaluation and
staging depend on the histological findings.
In histopathology, small portions of tissue extracted from suspicious regions of
the patient are examined under a microscope to assess different properties, especially
their morphology. The pathologist must follow a series of steps in order to prepare
the sample for examination under a microscope. The main steps of a typical tissue
preparation are detailed below [55] and some of them are illustrated in Fig. 1.10:
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(a) (b) (c) (d)
(e) (f) (g) (h)
Fig. 1.10: Tissue processing for histopathology. (a) Fresh biopsy extracted from a patient.
(b) Fixation of the tissue. (c) Chemically processed tissue is placed into a metal mould
and embedded in molten paraffin. (d) Solidified block of paraffin with the embedded tissue.
(e) Cut of thin serial sections with a microtome. (f) Paraffinated sections are placed in
a warm bath to flatten them and then they are mounted on a microscope slide. (g) The
mounted tissue sections are stained, typically with Hematoxylin and Eosin (H&E). (h) The
final stained and mounted slides are ready to be examined with a microscope by an expert
pathologist. Images (a), (b), (e), (f) reproduced from [56]. Images (c), (d), (g), (h)
reproduced from [57].
 Biopsy extraction: a piece of tissue called biopsy is extracted from a patient;
for example, during surgery or endoscopy (Fig. 1.10a). The fresh biopsy must
be processed quickly to avoid its breakdown.
 Fixation: the fresh tissue is treated in order to harden it and preserve its
morphological structure with the time (Fig. 1.10b). Although fixation can be
accomplished by physical methods (e.g., heating, microwaving, or freeze-drying),
liquid chemical fixatives are commonly used. In particular, the most typical
fixative used in diagnostic pathology is formaldehyde in aqueous solution, which
is normally called formalin.
 Dehydration: water and aqueous fixatives are removed from tissue components
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by hydrophilic substances, such as ethanol. Immersion of specimens into
dehydrating reagents is performed through a series of baths of increasing
concentration in order to prevent cell distortion.
 Clearing : this is a necessary intermediate step because dehydration reagents are
not miscible with infiltrating solutions. The clearing substance must be miscible
with both the dehydration and infiltrating solutions. They normally have a
refractive index similar to protein and they produce a translucent appearance
in the tissue: hence the term clearing agent. One of the most used clearing
substance is xylene.
 Infiltrating and embedding : the clearing agent is replaced by an infiltrating
substance, typically molten paraffin wax. The specimen is placed in a metal
mould with a proper orientation and embedded in molten paraffin (Fig. 1.10c).
When the paraffin solidifies, the block with the embedded tissue gains rigidity,
which prevents distortion of its structure during microtomy (Fig. 1.10d).
 Cutting : the block of paraffin is cut with a microtome into very thin sections of
around 5 µm thickness (Fig. 1.10e). The cut sections are put into a warm water
bath in order to flatten them and then recovered with a microscope slide where
they get attached (Fig. 1.10f).
 Staining : the mounted slices of tissue are treated with chemicals to remove the
paraffin and then immersed in different stains (Fig. 1.10g). The excessive stains
are removed with water and the final slides get ready for observation with a
microscope (Fig. 1.10h).
Tissue processing is a complex procedure which employs chemical and physical
processes that can potentially alter and distort the characteristics of the tissue. For
diagnostic pathology, it is important to guarantee that induced undesired artifacts
are at least consistent. Therefore, a strict and repeatable protocol should be followed
during the whole tissue processing.
As described, the last step of the tissue processing is the staining. Processed tissues
are transparent in the visible light and they must be coloured with stains. Stains or
dyes are substances that have affinities with particular components of the tissue,
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(a) (b) (c) (d)
Fig. 1.11: Histopathological images of colorectal biopsies with different pathological
conditions and stained with H&E. Green scale bars represent 200 µm. (a) Normal sample.
(b) Hyperplastic polyp (benign). (c) Adenoma (precancerous). (d) Adenocarcinoma
(cancer).
promoted by specific chemical interactions. They have also absorptive properties to
electromagnetic radiation, typically in the visible light range, which give them colour.
Hematoxylin and Eosin (H&E) stain is by far the most used dye in anatomical
pathology and is actually considered the gold standard technique to diagnose tissue
diseases. Its popularity is based on its relative simplicity and its ability to reveal a
high number of different tissue structures. H&E is a combination of two chemical
substances with complementary properties. Hematoxylin is a basic dye that binds
to acidic (or basophilic) structures, such as cell nuclei, and colours them in dark
blue or violet. By contrast, eosin is a dye with varying shades and intensities of
pink, orange and red, which has an acidic nature and, therefore, it binds to basic
(or acidophilic) substances, such as proteins in the cytoplasm of cells or fibres of the
extracellular matrix. With these two dyes, the main tissue structures are revealed
and, by interpreting their morphological arrangement, the pathologist can assess the
underlying condition of the tissue and establish a diagnosis.
As an example, Fig. 1.11 shows four H&E histopathological images of colorectal
biopsies from lesions with different pathological conditions. These kinds of
histopathological samples will be employed in Ch. 4. Some typical characteristics
of each condition [28,58] can be identified in these images:
(a) Normal sample: nuclei of epithelial cells in the mucosa layer, stained with
hematoxylin in dark shades of violet, are aligned in the outer border of glands
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or crypts. As can be seen in Fig. 1.11a, glands have approximately round or
elliptical shapes, depending on their orientation with respect to the microtome’s
cutting plane. Cytoplasms of epithelial cells, coloured in a light purple, are
placed inward the glands enclosing the lumen, which mainly has white tones.
This spatial orientation is called polarity and facilitates the secretion of mucus
and other fluids into the lumen. Outside the glands, nuclei from different types
of cells of the rest of layers are surrounded by their cytoplasm and extracellular
matrix stained with pink eosin. Some breaks in the tissue can also be observed
in white.
(b) Hyperplastic polyp (benign): as in the normal state, epithelial nuclei are small,
regular and round. However, hyperplastic tissue presents increased cellularity
and mitotic activity, which can be mixed up with adenoma. In fact, they have
some mutations in common that make them adopt similar features. Hyperplastic
polyps have also simple tubular architecture with elongated and straight crypts,
which cannot be properly visualised in Fig.1.11b due to the cutting orientation.
Nonetheless, this view allows to identify the serrated (saw-tooth or star-
shaped) morphology of the glands, which characterises this abnormal and benign
condition.
(c) Adenoma (precancerous): this precursor lesion is defined by the presence
of intraepithelial neoplasia, which is characterized by hypercellularity with
enlarged, hyperchromatic nuclei, varying degrees of nuclear stratification, and
loss of polarity [28]. In some types of adenoma, glands also present a serrated
configuration if they are observed with a low magnification microscope, but the
epithelial cells are dysplastic unlike in hyperplastic polyps. Dysplastic cells lack
morphological uniformity, lose their architectural orientation and often contain
large hyperchromatic nuclei with a high nuclear-to-cytoplasmic ratio [3]. In
adenoma, dysplastic glandular structures normally occupy a great portion of
the luminal surface, as can be observed in the bottom-left region of Fig. 1.11c.
(d) Adenocarcinoma (cancer): its defining feature is invasion through the mucosa
into the submucosa, where it has higher risk of metastasis. The grade of
adenocarcinoma is mainly determined by the extent and appearance of the
glands, which become more heterogeneous and distorted. Depending on whether
the glands can be identified, the lesions can be divided into well, moderately and
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poorly differentiated adenocarcinoma. Fig. 1.11d is an example of a moderately
differentiated adenocarcinoma, where the epithelial cells are large and tall, and
the gland lumina have almost disappeared or contain cellular debris.
Tumours present a great histological diversity, showing different regions with
various degrees of differentiation, proliferation, vascularity, inflammation and/or
invasiveness [16]. Histopathological comparison of normal tissue and tumours,
although reveals morphological differences, also confirms common features in their
microarchitecture. The pathologist must be able to identify these (sometimes subtle)
differences in order to define the grade of cancer and then choose the best clinical
management. This assessment is even harder in intermediate phases of development,
when lesions are localised in small regions of the sample and may not show clearly
distinctive characteristics.
Cytopathology
In a similar way to histopathology, cytopathology studies and diagnoses diseases at
the cellular level [59–61]. In certain types of cancer, individual cells are examined
as a complementary test to histopathology or even as the main diagnostic tool. The
most typical examples are leukaemia, cervical cancer and bladder cancer, where cells
can be collected in a relatively simple way. However, a significant amount of cells
can be extracted from less accessible regions, for example, by fine needle aspiration
as in lymph nodes. Cytopathology gives valuable information about molecular and
morphological changes that helps in the diagnosis of precancerous and malignant
lesions.
Cytopathology, as well as a science, is considered an art even more challenging
than histopathology because changes in cells can be subtler or more hidden than
in tissue samples [59]. The quality of the preparation of cytological samples is
crucial to perform an accurate interpretation. As done with tissues, cell specimens
collected from suspicious sites by exfoliative procedures, fine needle aspiration or
even endoscopy, must be processed in different steps that typically include [62]:
cytocentrifugation, to separate cells; fixation, to maintain morphology; and staining,
to facilitate cell visibility, detection and interpretation with classical light microscopes.
A famous dye in cytopathology is the Papanicolau stain, which is a mixture of five
dyes including hematoxylin and eosin.
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Cell culture
In parallel with traditional cytopathology, where ex-vivo cells collected from
humans are directly studied for diagnostic purposes, cell culture consists of creating
cytological samples under controlled laboratory conditions (in vitro). Cell culture is
becoming more important in both academic research and industry to develop new
diagnostic technologies, to generate and use test or model systems, or to produce
biopharmaceuticals or other oncological products [63]. The main advantage of cell
cultures is the homogeneity of replicated samples, which normally belong to a specific
cell line. This is specially useful in the development of screening systems for diagnosis
and drug testing because the pathological conditions of the cell lines are known and
the obtained results can be potentially consistent and reproducible [64]. As main
limitations, culture techniques require high levels of expertise and relatively expensive
equipments in order to guarantee the quality of the cell culture. In addition, not only
for quality but also for safety reasons, people working with cultured cells must follow
standard protocols and specific practical guidelines [65–67].
As commented, cell cultures normally employ catalogued cell lines with known
properties that were originally extracted from human or other animal tissues. Fig.1.12
illustrates the evolution with the time, in terms of cumulative number of cells, of a
hypothetical cell line. After tissue removal or explantation, cells are isolated and
placed into a suitable culture environment to create the primary culture. These
original cells grow and proliferate until reaching confluence, that is, cells occupy all the
available substrate and make close contact with one another. At this point, cells are
detached from the substrate with enzymes and moved to a new substrate to produce
the first subculture or passage and give rise to the cell line. The process is repeated in
a series of passages where the most proliferative cell lineages gradually predominate
and the cell line becomes more stable.
Cell lines created from normal tissue, unlike malignant cells (Sec. 1.1.2), have a
limited number of replications due to the shortening of telomeres and finally undergo
senescence (non-proliferative state). The population of these finite cell lines reaches
a maximum and then decreases when the non-proliferative existing cells gradually
die (Fig. 1.12). However, some cultured cells experiment genetic transformations and
originate a continuous cell line capable of replicating infinitely. This transformation
or immortalisation may occur spontaneously or be chemically or virally induced. Not
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Fig. 1.12: Evolution of a cell line. The vertical axis represents total cell growth (assuming
no reduction at passage) for a hypothetical cell culture. Total cell number (cell yield) is
represented on this axis in a logarithmic scale, and the time in culture is shown on the
horizontal axis on a linear scale. Although a continuous cell line is depicted as arising at 14
weeks, with different cells it could arise at any time. Likewise senescence may occur at any
time. Reproduced from [64] with permission by courtesy of John Wiley & Sons Inc.
all types of cells have been successfully immortalised. The most famous case is normal
human fibroblasts, which never give rise to continuous cell lines [64].
Established cell lines can be cryopreserved and stored with liquid nitrogen,
perpetuating their characteristics indefinitely. A great diversity of cell lines are
available from recognised cell banks, which guarantee their authenticity and freedom
from microbial contamination [67]. Specialised laboratories, which must have trained
personnel and appropriate equipment (e.g., microbial safety cabinets, incubators,
autoclaves, water filtration units, etc.), can acquire batches of catalogued cell lines
from recognised cell banks or distributors and create their own cell cultures for
research purposes.
When culturing animal cells, it is essential to consider that they only survive
under relatively constant physiological conditions, which must simulate blood plasma
or interstitial fluids and avoid contamination with external microorganisms. They also
require a strict control of the physicochemical microenvironments in order to develop
their specific phenotype (distinguishable characteristics or traits). In particular, some
factors that determine the correct development of cultured cells are: the incubation
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temperature; the concentration of nutrients and growth factors in the supplied media;
the nature of the substrate, especially for cell adhesion; and the interaction and
contact between cells.
Cell proliferation is governed by the cell cycle (Fig. 1.2), which is regulated
by growth factors that must be artificially supplied and other signals from the
microenvironment. For instance, normal cells stop proliferating in highly dense
cultures due to cell contact inhibitions, whilst cancerous and other transformed cell
lines may keep dividing (Sec. 1.1.2). Each cell line, mainly specialised cells such as
epidermal keratinocytes, needs specific culture conditions and handling in order to
proliferate and keep differentiated.
Four different skin cell lines will be analysed in this thesis (Ch. 5): two of them
(HaCaT and NIH-3T3) derived from normal or healthy skin (Sec.1.1.4) and the other
two (A-375 and SK-MEL-28) from different melanoma lesions. Fig.1.13 shows images
from specific regions of cultures of each cell line, which were acquired with a phase
contrast microscope. Some characteristics of these skin cell lines can be described in
alphabetical order:
(a) A-375 : is a cell line derived from a 54-year-old female of unknown ethnicity
with malignant melanoma, which was established in 1973 [68]. When inoculated
subcutaneously in immunosuppressed mice in vivo, these cells rapidly develop
tumours resembling amelanotic melanomas.
(b) HaCaT : is an immortal cell line that was spontaneously transformed in vitro
from normal keratinocytes extracted form a 62-year-old Caucasian male in
1988 [69]. It presents unlimited growth potential but remains nontumorigenic
and is capable of reproducing the orderly structure of normal epithelial
tissue. Therefore, HaCaT cells tend to join together and form densely packed
monolayers in cultivations in vitro.
(c) NIH-3T3 : is an immortal non-pathological cell line created from NIH Swiss
mouse embryo fibroblasts in 1969 [70]. It is considered a standard fibroblast cell
line and has been used in numerous cytological studies as a substitute of human
fibroblasts, which have not been successfully immortalised and present critical
problems of instability in vitro [64].
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(a) (b) (c) (d)
Fig. 1.13: Phase contrast microscopic images (with corrected background) from cell cultures
of four different skin cell lines, including melanoma. Green scale bars represent 100 µm.
(a) A-375 (Malignant melanoma). (b) HaCaT (Non-tumoral keratinocytes). (c) NIH-3T3
(Non-tumoral mouse fibroblasts). (d) SK-MEL-28 (Malignant melanoma).
(d) SK-MEL-28 : is a malignant melanoma cell line that was established from an
axillary lymph node of a 51-year-old male of unknown ethnicity in 1976 [71].
SK-MEL-28 cells cultivated in vitro tend to grow as a monolayer and normally
present a polygonal morphology.
As can be observed in Fig. 1.13, each cell line has different morphological and
growing properties. HaCaT cells form the most organised and connected monolayer,
whereas NIH-3T3 fibroblasts and specially melanoma cells grow in a more disorganised
way with frequent areas of overlapping cells. In addition, individual melanoma
cells present more compact and rounded shapes, as a sign of their enhanced mitotic
activity (Sec. 1.1.2).
Finally, as in traditional cytopathology, cell cultures can be processed after growing
to be visualised with specific imaging methods and allow their storage for posterior
studies. In particular, they can be chemically treated with fixatives to keep their
morphology with the time. However, these treatments may alter the chemical
characteristics of the cells.
1.2 Motivation
As was described and supported with official statistics in Sec.1.1.5, cancer in general,
and colorectal cancer and melanoma in particular, are major health problems with
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high incidence and mortality. Besides, the survival of cancer patients dramatically
decreases when the lesion is not diagnosed at early stages of development. As also
commented before, histopathological (and in some cases cytopathological) analysis
remains the gold standard for the diagnosis of most types of cancer.
Nowadays, the final assessment of suspicious biopsies is still performed by an
expert pathologist, who visually inspects the prepared samples with a traditional
optical microscope and gives a qualitative judgement. This lengthy and tedious
methodology possesses a high degree of subjectivity and heavily relies on the
experience and skills of the clinician. Several studies, involving pathologists with
many years of experience, have revealed a suboptimal inter-observer variability in
the differentiation and reporting of both colorectal polyps [72–75] and melanocytic
neoplasms [76–79]. This diagnostic discordance is normally higher (even surpassing
30% of studied cases [78]) in early stages when abnormal tumours do not show clearly
discriminant signs yet. This circumstance leads to changes in clinical management
and gives rise to situations where a region of benign tissue is removed (overdiagnosis)
or, even worse, a malignant lesion is not properly treated (underdiagnosis). The
controversy in the diagnosis mostly disappears in advanced stages, but the lesion
is already lethal in most of those cases. Most reported studies conclude that more
objective criteria should be applied for risk stratification in screening and surveillance
guidelines.
1.2.1 Infrared spectroscopy and cancer diagnosis
One of the main targets in cancer research is the discovery and validation of new
biological markers (biomarkers), which are representative of the pathology. A cancer
biomarker is any functional entity that can be objectively measured, such as genes,
proteins, metabolites, morphological, cytogenetic or cytokinetic parameters, as well
as any other physical feature or detectable change in body fluids or tissues that can
be significantly related to a specific cancerous disease [80]. Infrared (IR) spectroscopy
(Ch.2) takes advantage of the ability of IR light to excite the vibrational modes of the
chemical bonds that form the biological matter. Its main generated signal provides
rich and concise information about the biochemical composition and the omics of the
illuminated specimen, fitting all the characteristics to become a useful biomarker of
cancer in clinical practice [81].
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Unlike other imaging techniques well-established in medical practice, such as
Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) [82, 83], IR
spectroscopy is still an emerging technology in the biomedical field. IR spectroscopic
techniques have been successfully used since the last century in chemical and
pharmaceutical industry, e.g., in the characterisation of polymers and drugs [84, 85].
Some attempts were made since the 1950’s to investigate biological specimens,
although they are far more complex than industrial material. But it has been
mainly in the current century when new advances in instrumentation, data acquisition
and data analysis have shown the potential of IR spectroscopy for biomedical
applications [86].
Many proof-of-concept studies have demonstrated the diagnostic capabilities of
IR spectroscopy in different types of cancer over the past decades [81, 87–89].
This incipient technology potentially offers objective and automated analyses of
biological specimens, which could even be adapted to routine screening. Therefore,
IR spectroscopy can play a significant role at different levels of cancer diagnosis
and research, from in-vitro applications such as analysis of cell cultures, ex-vivo
diagnosis such as histopathology and cytopathology, and even in-vivo screening
such as non-invasive early detection of skin cancer [90]. Nevertheless, translation
to clinical practice still must be justified with statistically relevant studies of
increasing complexity that gradually incorporate the current existing variability in the
instrumentation, sample preparation, measurement protocol and data processing [91].
1.2.2 MINERVA project
MINERVA is a project funded by the European Commission through its Seventh
Framework Programme (FP7) that brings together thirteen partners from across
Europe with the common objective of developing mid-IR technology to improve the
diagnosis and research of cancer [92,93]. MINERVA pursues several targets in parallel,
from developing new IR instrumentation, such as fibre lasers, Acousto-Optic (AO)
modulators, supercontinuum sources and detectors in the mid-IR range, to explore
the performance and limitations of current IR spectroscopic technology in cancer
identification.
The spectral region studied in MINERVA covers the so-called fingerprint region
(Sec. 2.4.1), which includes the most distinctive absorption peaks of biomolecules.
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By studying the pattern of IR spectroscopic signals it is possible to deduce
valuable information for disease diagnosis. But this process is not straightforward
because the useful molecular information is buried in the interrelated distribution
of biological species, which only differ in subtle biochemical changes. In addition,
IR spectroscopic signals are affected by different kinds of spectral artifacts, which
may arise from the preparation of the sample, the acquisition procedure or other
undesirable physicochemical effects. Therefore, advanced mathematical techniques,
such as multivariate analysis and machine learning, are required to extract the
relevant information from the large amount of spectral data in order to identify and
differentiate cancer.
This thesis has been developed within the framework of MINERVA project.
Universitat Politècnica de València (UPV), as a partner of MINERVA, has
collaborated in the acquisition, processing and analysis of IR spectra from biomedical
samples. In particular, two applications related to cancer diagnosis have been explored
in MINERVA:
 Histopathology : the main aim is to evaluate the capabilities of IR spectra to
discriminate colon cancer in tissue biopsy samples. In this task, UPV has
collaborated with University of Exeter (UoE) and Gloucestershire Hospitals
NHS Foundation Trust (GHFT), both from the United Kingdom (UK). A
significant number of tissue samples, extracted from patients with colon cancer
in different pathological conditions, was provided by GHFT. Hyperspectral
Fourier Transform Infrared (FTIR) images from all these samples were acquired
at UoE by using a state-of-the-art benchtop FTIR microspectroscope. Expert
spectroscopists from UoE and GHFT have been in charge of the acquisition
and analysis of this relevant dataset of hyperspectral FTIR images. UPV has
mainly played a supporting role in this application, by adapting and developing
algorithms from the fields of image processing and computer vision in order to
fuse the information of hyperspectral FTIR images and conventional microscopic
images (Ch. 4).
 Cytopathology : the aim is to assess the potential and limitations of IR
spectroscopy to distinguish different types of catalogued skin cell lines including
melanoma. To accomplish this task, UPV has collaborated with Westfälische
Wilhelms-Universität (WWU), from Münster (Germany). WWU provided the
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biomedical support by preparing the cell cultures of skin cell lines. UPV has
played a more significant role in this application by acquiring most of the
hyperspectral FTIR images from the cell cultures at UoE, as well as processing
and analysing them (Ch. 5). During this process, UPV counted on the valuable
help and supervision of experts from UoE and GHFT.
1.3 Objectives
This thesis aims at contributing to the improvement of the final diagnosis of cancer,
a real and relevant problem in the biomedical field, by means of new optical
technologies and analytical methodologies. In particular, the main aim is to contribute
to the development and assessment of objective decision support systems based
on images captured from tissue and cell samples with modern benchtop FTIR
microspectrometers. In order to fulfil this global and generic task, several specific
objectives are derived:
 Reviewing and synthesising the most relevant concepts from the biomedical field
which are essential to correctly deal with pathological samples.
 Reviewing and synthesising the most updated knowledge concerning the technol-
ogy of IR spectroscopy, including its instrumentation and the physicochemical
phenomena involved in the creation of FTIR spectral signals for the special case
of biological samples. These concepts are needed to collaborate in the correct
acquisition of FTIR hyperspectral images and to perform a sounder processing
of the spectral data.
 Reviewing and identifying the most relevant methods and algorithms currently
employed for the processing and analysis of the recorded hyperspectral FTIR
images. These methods belong to different interconnected areas, such as image
processing, computer vision, machine learning, pattern recognition, multivariate
analysis, chemometrics, as well as specific techniques from the spectroscopic
field.
 Applying all the concepts and methodologies together with preliminary studies
to real diagnostic problems based on histopathological and cytopathological
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samples. Special emphasis will be given to the correct assessment of the
obtained results and the possible limitations of the employed technologies and
methodologies.
1.4 Outline
In this chapter the most relevant notions from the biomedical field related to cancer
and its final diagnosis have been reviewed. This background helps to understand the
necessity for the studied technology. In addition, its knowledge is essential to perform
a correct treatment, measurement and analysis of the involved biological samples.
The rest of chapters focus on the technological concepts and their applications.
Ch. 2 will present the most relevant theoretical an practical aspects concerning
Infrared spectroscopy, which must be considered and understood to proceed correctly
in the later applications.
Ch. 3 will describe several techniques connected with the preprocessing of FTIR
spectra acquired from biological samples as well as the methods commonly used to
extract the most relevant information in these high-dimensional datasets.
Ch. 4 will thoroughly detail the first of the two main applications of this thesis,
which aims at helping to improve the diagnosis of histopathological samples. This
application consists of the development of a methodology that automatically aligns
different histological sections measured by two imaging modalities in order to combine
the spatial information extracted from those two techniques. To that end, the
theoretical background of FTIR spectroscopy described in previous chapters will be
fused with modern methodologies from the fields of image processing and computer
vision.
Ch.5 will present the second main application of this thesis, this time with the goal
of improving the diagnosis of cytopathological samples. Its main objective is to assess
the generalisation capabilities of FTIR signals to reliably discriminate different types
of skin cells containing malignant phenotypes. The followed methodology, which fuses
techniques described in previous chapters with new methods from the areas of machine
learning and pattern recognition, will be detailed together with the main reasoning
behind each applied step. In addition, the final results will be quantitatively assessed
and thoroughly discussed.
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Finally, Ch. 6 will summarise the most relevant conclusions derived from
the previous chapters with special attention to the most important findings and
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2.1 Introduction
In this chapter, the fundamental concepts of Infrared spectroscopy, its practical
instrumentation, and the key ideas related to the signal and image formation will
be described. Special emphasis will be made in the practical aspects that will affect
the later applications. In particular, the main sources of artifacts and errors that may
hamper the posterior analysis of the measured signals will be detailed.
2.2 Infrared spectroscopy
Infrared spectroscopy together with Raman spectroscopy constitute the field
of analytical chemistry called vibrational spectroscopy. This field has many
diverse applications in biomedicine, biochemistry, forensic sciences or food and
pharmaceutical industry [94].
IR band covers the wavelengths (λ) of the electromagnetic spectrum which are
immediately superior to the visible spectrum (λ ∼380-780 nm). The division of the
IR band is not precise and can vary depending on the field of application or the
related publication. Considering the definitions of spectral bands specified by the
International Organization for Standardization (ISO) [95], IR band can be divided
into three main regions of increasing wavelength: near-IR (λ ∼780 nm-3 µm), mid-IR
(λ ∼3-50 µm) and far-IR (λ ∼50 µm-1 mm). Fig. 2.1 illustrates the most useful
bands of the electromagnetic spectrum with an enlarged view of the visible and
IR spectrum (wavelength axis is not scaled). In this figure, schematic drawings of
objects with different sizes have been added at the position of the approximate scale
of wavelength. It must be pointed out that the typical size of a human cell is around
tens of microns, which lies in the mid-IR region.
The most common spectral metric in spectroscopy is the wavenumber (ν̃), which





ν̃ represents the number of wave cycles per unit length and its usual unit is
cm−1. Therefore, the mid-IR region defined by ISO [95] extends from 200 cm−1
to around 3300 cm−1. It must be remarked that bibliographic references in the field
of spectroscopy (e.g., [84, 98–101]) usually delimit the mid-IR region between 400-
4000 cm−1 (λ ∼2.5-25 µm).
















Fig. 2.1: Illustration of the electromagnetic spectrum. Adapted from [96] and [97].
The energy E of a photon is defined by the Planck-Einstein relation:




where h is the Planck’s constant, f is the frequency of the radiation and c is the speed
of light in the vacuum. The energy of mid-IR photons extends from 0.025 to 0.4 eV
(according to ISO [95]) and covers the quantum values which are able to excite most
vibrational modes of matter [98].
Each kind of molecular bond has characteristic modes of vibration whose states of
energy are quantised. In a traditional absorption process, a resonance interaction
is produced when a photon of the incident light possesses the exact energy of a
specific molecular energy level. In that case, that molecule is promoted into a state
of higher excitation and the photon is absorbed [101]. Hence, if a sample of matter is
placed into the path of a mid-IR beam, its molecules will absorb those photons whose
frequencies match their resonant frequencies of vibration. This is the main principle
of IR spectroscopy. The fundamental vibrational modes which can be detected in
mid-IR spectroscopy are stretching (changes of bond lengths), both symmetric and
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asymmetric, and bending (changes of bond angles) modes [81]. These fundamental
vibrational modes are sketched in the case of a non-linear triatomic molecule, e.g.,
water, in Fig. 2.2.
symmetric stretching asymmetric stretching bending
Fig. 2.2: Diagram of the fundamental modes of molecular vibration detectable by mid-IR
spectroscopy in the case of a non-linear triatomic molecule, e.g., water.
2.3 FTIR spectrometers
Nowadays, FTIR spectrometers are the most widely used devices to perform IR
spectroscopy. A conventional FTIR spectrometer is composed of three main elements:
the source, the interferometer and the detector. Although there are many different
designs and combinations of these components, their main and most common
characteristics will be summarised in the following sections.
2.3.1 Source
The IR light in commercial spectroscopes is commonly generated by blackbody sources













where Bλ is the blackbody spectral radiance, as a function of λ and the absolute
temperature of the source Tk, and kB is the Boltzmann’s constant. In the
International System of Units (SI), Bλ is expressed in
W
sr·m3 . By means of Eq.2.3, the
blackbody spectral radiance emitted by the source can be estimated for some specific
values of its absolute temperature, resulting in the curves shown in Fig. 2.3.










Fig. 2.3: Blackbody spectral radiance at different absolute temperatures.
As can be observed in Fig. 2.3, the overall radiated energy increases with the
source’s temperature and the maximum peak of the curve moves toward shorter
wavelengths (Wien’s displacement law). Therefore, although higher spectral radiance
is obtained in the IR region at higher temperatures, the proportion of IR radiation
compared to the total energy emitted is lower. As a compromise solution, thermal
sources operating in the range of 1400 to 2000 K are usually employed [101]. These
sources, normally heated by an electric current, consist of a filament or rod made of
materials that are relatively inert to atmospheric oxygen at the operating temperature.
Globar is a patented material of silicon carbide disposed in a diamond lattice, which
is widely used as blackbody IR source in FTIR spectrometers. Globar is relatively
stable at ∼1300 K (its typical operating temperature [98]) and does not need a special
inert atmosphere.
2.3.2 Interferometer
The interferometer is the key element of FTIR spectrometers. Its role is to separate
the contributions of the polychromatic spectrum provided by the blackbody source.
Commercial FTIR spectrometers typically use Michelson interferometers, whose
schematic is shown in Fig. 2.4. The light emitted by the IR source is collimated
to get a parallel beam that is directed towards a beam splitter. Half of the radiation
is reflected and the other half is transmitted by the beam splitter. The reflected
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split beam is reflected again by a fixed mirror, meanwhile the portion of transmitted
beam is reflected by a mirror that is continuously moving with a specific frequency
and amplitude. Both beams are directed back to the beam splitter where they are
recombined. Again, due to the construction of the interferometer, the beam splitter
conducts half of the recombined beam towards the source (this part of the light is lost
for the final measurement and it is not drawn in Fig. 2.4 for clarity) and the other














Fig. 2.4: Schematic diagram of a Michelson interferometer configured for FTIR
spectroscopy. Adapted from [104].
The split beams travel along paths with different lengths due to the movement of
one mirror, making changes in the phases of the beams. Constructive or destructive
interference patterns are produced when the beams are recombined, depending on
their path difference or phase shift. The final intensity pattern of the recombined
beams measured by the detector is called interferogram J(ξ), which is a function of
the moving mirror displacement ξ. When a broadband source emitting light in a
continuous way at all wavenumbers (or wavelengths) is used to illuminate the sample,





where I(ν̃) is the spectral intensity passing through the sample and reaching the
detector at a specific wavenumber ν̃. Eq. 2.4 arises when the interference pattern of
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the recombined waves is studied [98, 101]. The integral of Eq. 2.4 has the form of a
Fourier cosine transform, which is the real part of a full complex Fourier Transform
(FT). I(ν̃) can be computed through the inverse FT, resulting in the integral (apart





Thanks to the duality between different domains granted by the FT, the
spectrum I(ν̃), which is an intensity distribution in the wavenumber domain ν̃, can
be obtained from the interferogram J(ξ), which is the intensity distribution actually
recorded by the detector and which depends on the moving mirror position ξ. This
is the main property of FTIR spectrometers.
Fig.2.5 presents an example of interferogram and its associated intensity spectrum
measured without any sample placed in the beam path between the interferometer
and the detector. Only the values and units of ν̃ in the intensity spectrum I(ν̃) have
been specified to identify some relevant absorption bands. As the plots correspond to
a measurement with no sample, these absorption bands are mostly produced by the
water vapour and CO2 which the IR beam encounters on the air along its travel from
the source to the detector (Sec. 2.6.2).


















Fig. 2.5: Example of a recorded interferogram (left) and its associated intensity spectrum
computed by applying the Fourier transform (right). These graphics correspond to a
measurement with no sample. Some relevant absorption bands have been identified in the
intensity spectrum. Adapted from [106].
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2.3.3 Detector
Detectors for IR region are different from those designed for the visible spectrum
or other higher frequency regions because the energy of IR photons is lower. The
detectors used in FTIR spectroscopy can be classified in two classical categories [107]:
thermal detectors and quantum detectors.
Thermal detectors measure the heating effect produced in a material when it
absorbs IR radiation. Depending on the effect of the temperature change, thermal
detectors can also be divided into distinct subcategories: thermocouples, which
measure an electromotive force or voltage in a junction of different metals; bolometers
and thermistors, which respectively detect changes in the resistance of a conductor or
a semiconductor; pneumatic detectors, which measure the increase of pressure in an
enclosed gas; and pyroelectric detectors, which monitor metals behaving as a capacitor
whose charge on the surface changes with the temperature. All kinds of thermal
detectors have been used for mid-IR spectroscopy in the past. However, the main
drawback of thermal detectors is their response time (around several milliseconds),
which is too long for the high frequencies of modern FTIR spectrometers [98].
Nowadays, the only thermal detectors that have a practical use are made of a
pyroelectric material called Deuterated Triglycine Sulfate (DTGS). DTGS detectors
are equipped in low-cost, medium-performance devices and can be operated at room
temperature.
Quantum detectors respond to the direct interaction of IR photons with the
electrons of the detector material, which can be excited to a higher energy state.
This excitation only takes place if the energy of IR photons is higher than a
certain threshold Emin determined by the material properties. As the photon
energy is directly proportional to the wavenumber (Eq. 2.2), the lower the radiation
wavenumber, the higher the number of IR travelling photons for a given amount
of total energy. Because more electrons are excited by IR photons, the sensitivity
of quantum detectors increases when the wavenumber decreases. However, there is
a limit ν̃min related to Emin from which the response drops off abruptly. Quantum
detectors can be generally subdivided into photoemissive detectors and semiconductor
detectors.
Photoemissive detectors directly measure the number of electrons released from
an illuminated surface. This kind of detectors, which include phototubes and
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photomultipliers, cannot be used with IR radiation because they need higher energies
to release electrons from the photoemissive surfaces.
Semiconductor detectors are composed of materials with two bands of different
energy, namely valence band and conduction band, which are separated by a band gap.
If the energy of an incident photon is greater than the band gap, an electron will jump
from the valence band into the conduction band and the resistance of the detector will
diminish. These devices commonly work as photodiodes and the change in resistance
is measured as a variation in the current across the detector. Normally, materials with
band gaps between 400 and 800 cm−1 are used in FTIR spectroscopy [101]. Mercury
Cadmium Telluride (MCT), a mixture of HgTe and CdTe, is the material used in
the most common semiconductor mid-IR detectors. MCT has high sensitivity, fast
response times (∼ µs) and covers a spectral range from about 700 to over 5000 cm−1.
These types of detectors are normally cooled to 77 K with liquid nitrogen because the
thermal energy at room temperature (around 208 cm−1) produces unwanted electron
promotions to the conduction band, which increase the noise in the measurement.
2.4 FTIR spectra
There are different ways of measuring the interaction of IR light with the
sample. Three main sampling strategies or modes are normally applied in the
analysis of biological materials by FTIR spectroscopy: transmission, transflection
and Attenuated Total Reflection (ATR). Each mode has distinct advantages and
disadvantages [108], and its choice depends on the type of study and the available
resources. In this thesis, all the described and analysed FTIR measurements were
acquired in transmission mode.
In transmission measurements, the detector mainly receives the light which
passes through the sample, as was sketched in Fig. 2.4. Transmission is the most
straightforward and traditionally used sampling technique. It does not require
additional equipment to perform the measurements and allows quicker acquisitions.
Moreover, it is exempt from additional artifacts directly caused by reflection but does
not avoid scattering effects associated with transmission. Its main drawbacks are the
need for thin sections of samples, the complexity of the sample preparation and the
cost of the required auxiliary materials.
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The biological sample, such as fixed tissues or cells, must be specifically prepared
for transmission measurements and laid on a transparent substrate. In particular, the
substrate used in transmission commonly consists of windows made of CaF2 (calcium
fluoride). CaF2 is practically transparent from 1000 to 77000 cm
−1 and its refractive
index is relatively low and similar to biological substances (1.4 at 2000 cm−1) [109],
which reduces the light loss at the window-sample interface. Moreover, CaF2 is
suitable for direct use in preparations of biological samples, such as cell cultures,
because it is chemically inert and water insoluble [84]. The principal inconvenience
of CaF2 is its cost, which can range from around 10 to more than 100 e for each
window [110], depending on its size and quality.
The final shape of the intensity spectrum computed from the recorded interfero-
gram is determined by the convolution of the source emission profile, the detector
sensitivity profile and the response of any optical component in the beam path [101].
Transmittance (T (ν̃)) is the metric used to extract the attenuations caused by the
molecules of the sample in the IR beam and (ideally) cancel out the rest of contribu-





where I(ν̃) is the transmitted intensity spectrum passing through the sample
(including the substrate) and reaching the detector, and I0(ν̃) is the transmitted
intensity spectrum reaching the detector in the absence of sample. I0(ν̃) is known as
the reference background spectrum and is commonly measured before I(ν̃) by selecting













Fig. 2.6: Schematic of the acquisition of the reference background spectrum I0(ν̃) and the
intensity sample spectrum I(ν̃) in transmission measurements.
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2.4.1 Absorption spectrum and Beer-Lambert law
The higher the amount of radiation absorbed by the sample, the lower the intensity
I(ν̃) reaching the detector and, as can be checked in Eq.2.6, the lower T (ν̃). In order to
operate with a direct relationship of the absorption level, the metric called absorbance












Both T (ν̃) and A(ν̃) are dimensionless, as they are a ratio and the logarithm of
a ratio between intensities. The curve of absorbance values for a range of measured
wavenumbers is called absorption spectrum. As an example, Fig.2.7 shows I0(ν̃), I(ν̃)
and A(ν̃) spectra acquired from a region of a fixed skin cell as was sketched in Fig.2.6.
These spectra are presented both in the whole range of measured wavenumbers (1000-
3800 cm−1) and cropped to the fingerprint region (see below).
Absorbance is an experimental quantity that can be ideally related to the
theoretical physicochemical properties of the sample by the Beer-Lambert-Bouguer
law or commonly called the Beer-Lambert law [112,113]:
A(ν̃) = ` · C · ε(ν̃) (2.8)
where ` is the effective optical path length (length which the light beam travels
through the sample), C is the concentration of the sample and ε(ν̃) is the molar
attenuation coefficient or absorptivity. When the sample is a mixture of J chemical
components or constituents, which can absorb at the same ν̃ and have constant
absorptivity along the sample thickness, the total absorbance is given by the equation:
A(ν̃) = ` ·
J∑
j=1
Cj · εj(ν̃) (2.9)
where the subscript j identifies each chemical component or constituent. In the
previous equations, some complex optical phenomena have been neglected, such
as scattering due to inhomogeneous samples, reflections at the substrate-sample
interface, chemical changes due to intermolecular interactions and other additional
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Fig. 2.7: FTIR spectra from a region of a fixed skin cell. Top plots: reference background
spectrum I0(ν̃) (blue) and intensity sample spectrum I(ν̃) (red) for (a) the whole range
of recorded wavenumbers and (b) the fingerprint region. Bottom plots: corresponding
absorption spectrum A(ν̃) for (c) the whole range of recorded wavenumbers and (d) the
fingerprint region.
effects which may take place in the interaction of the light beam with the sample [113].
However, it highlights that the recorded absorbance is mainly determined by the
morphology of the sample (through `), the chemical abundance of its components
(through C) and their molecular transitions (through ε(ν̃)). Note that both ` and
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C do not depend on ν̃ and produce multiplicative effects in the global shape of the
absorption spectrum, whose main peaks are determined by ε(ν̃).
Biological materials are made of organic macromolecules, which can be classified
as proteins, lipids, carbohydrates and nucleic acids. These macromolecules are
composed of different chemical bonds that create structures more complex than non-
biological compounds like industrial polymers. Thus, the final absorption spectrum
of a biological specimen reflects the overall attenuations of this big mixture of
biomolecules, which have strongly overlapping characteristics. Despite this chemical
complexity, some relevant peaks can be related to some vibrational modes in a typical
biological absorption spectrum, as shown in Fig. 2.8.
Huge efforts have been made in traditional FTIR spectroscopy to identify the most
characteristic peak frequencies in biological studies [100,114]. Most of these relevant
peaks are located within the so-called fingerprint region [81], which approximately
extends from 1000 to 1800 cm−1. This range also contains the strongest peak of a
typical biological spectrum, the Amide I peak (∼1640-1680 cm−1), which is associated
with the carbonyl stretching of the peptide bond in proteins (Fig. 2.8).
2.4.2 Limitations to the Beer-Lambert law
There are several factors that may cause deviations from the ideal linear relationships
with the measured absorbance proposed by the Beer-Lambert law (Eqs. 2.8 and 2.9).
Although not exhaustive, a list of some of these factors is presented below [112,113]:
 Real limitations: the Beer-Lambert law was designed to describe the behaviour
only of dilute solutions. Therefore, other kinds of samples, such as solid
mixtures, may not follow this law.
 Chemical deviations: the Beer-Lambert law supposes that the chemical
absorbers (molecules, ions, etc.) act independently of each other. On
the contrary, intermolecular interactions between chemical species may cause
changes in the absorptivity that lead to deviations from the Beer-Lambert
law. These effects are likely to occur in biological samples, which have complex
chemical compositions and structures.
 Instrumental and measurement deviations: several sources of deviations and
limitations due to measurement causes can be distinguished:















































































Fig. 2.8: Typical FTIR absorption spectrum of a biological sample in the range
800-3000 cm−1. Some relevant peaks have been identified, which are associated with
vibrational modes (νs = symmetric stretching, νas = asymmetric stretching, δs =
symmetric bending) of different organic macromolecules (see respective colours). Adapted
from [108] with permission by courtesy of Macmillan Publishers Ltd.
– Polychromatic radiation: strictly speaking, the Beer-Lambert law only
applies when the incident light is monochromatic. In the case of using
polychromatic radiation, as the one that blackbody sources provide,
departures from the Beer-Lambert law will be higher when the differences
of absorptivity between wavenumbers increase.
– Stray light : it comprehends all the radiation measured by the sensor that
was not intended in the original design. This radiation does not pass
through the sample and often results from scattering and reflection off the
surfaces of the experimental components or the surrounding environment.
In this case, the measured absorbance is called apparent absorbance
(Aapp(ν̃)) and is lower than the true absorbance of the sample, which limits
the dynamic range of the system. These deviations are more significant at
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higher absorbance values. In the presence of stray light of intensity Is(ν̃),
Aapp(ν̃) for a specific wavenumber is defined as follows:






– Inhomogeneous or scattering medium: this is one of the most important
factors to disobey the Beer-Lambert law. Uneven optical properties or
thickness both in the analysed sample or the substrate, as well as the
presence of scattering centres, significantly modify the effective path length
and induce severe deviations from the Beer-Lambert law.
– Non-linearity of the detector : the non-linearity of the response is more
important in MCT detectors. The effect in the recorded spectrum is
very similar to that of stray light and the accuracy of the quantitative
measurement also decreases with higher absorbance values.
Although the restrictive conditions of the Beer-Lambert law are hardly fulfilled
in many situations, the linear relationships with the optical path length and the
concentration are used as a guide to develop some preprocessing and analysis
methods (Ch. 3).
As last remark, it is worth clarifying the subtle difference between absorption
spectrum and absorbance spectrum, which are sometimes mixed up. The absorption
spectrum normally only refers to the physicochemical process that occurs when the
molecules of the sample absorb the incident light, which actually would follow the
Beer-Lambert law. The absorbance spectrum, on the other hand, includes absorption
and others phenomena that attenuate the incident light, such as reflection, scattering,
and other physical processes that cause deviations from the Beer-Lambert law.
Despite of this difference, both terms are symbolised by A(ν̃) because the absorbance
spectrum is the one actually measured in real situations, whereas the ideal absorption
spectrum is commonly unknown.
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2.5 Micro-FTIR spectroscopic imaging
FTIR microspectroscopy arises when coupling a spectrometer with a microscope
whose optical components are adapted to the mid-IR region [101,115]. Fig. 2.9a illus-
trates the configuration of the main elements present in a common microspectrometer













Fig. 2.9: (a) Schematic of main components in a common microspectrometer (spectrometer
placed at left and microscope at right). Reproduced from [116] with permission by courtesy
of SAGE publications Inc. (b) Photograph of a modern commercial microspectrometer (in
this case, spectrometer placed at right and microscope at left). Reproduced from [117].
Basically, the microscope is an additional arrangement of optical components
located between the interferometer and the detector whose main task is to redirect
the IR light leaving the interferometer just into small regions of the sample. The core
elements to accomplish this task are a pair of optical components called objective
and condenser. Almost all FTIR microscopes are equipped with a Schwarzchild
objective and condenser [118], which are a special type of Cassegrain objectives.
Schwarzchild objective and condenser are composed of a convex and a concave mirror
which are concentric. This concentricity grants excellent imaging characteristics over
a surprisingly wide Field of View (FOV) [85].
As outlined in Fig. 2.10a, the condenser focuses the IR beam, coming from the
interferometer and properly reflected by several mirrors, into a small region of the
sample. The sample is mounted on a motorised stage which has a hole to let the IR
light pass through freely and whose position can be modified in three directions. The
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direction perpendicular to the stage (z axis) can be adjusted to place the sample into
the beam focus and the other two directions in the stage plane (x and y axes) allow
to choose the specific illuminated region. The objective gathers the light transmitted
through the substrate and sample and refocuses it to continue its travel towards the
detector. A small part of this light is guided to a traditional optical viewer and a
Charge-Coupled Device (CCD) camera, which provide a visible image of the sample.
This visible image is used during the acquisition to define the region to measure and
to focus the sample correctly. Most of the light leaving the Schwarzchild objective is
reflected by a series of mirrors and passes through an adjustable aperture that can














Fig. 2.10: (a) Sketch of the functioning of a Schwarzschild objective and condenser
configured in transmission mode. (b) Sketch of the regions covered with a single-point
(up) and a Focal Plane Array detector (down) in a cellular sample.
Two main types of detectors are commonly used to perform measurements of
IR spectra with micrometric resolution, namely single-point and Focal Plane Array
(FPA) detectors (Fig. 2.9a). Single element detectors have been employed since
the beginning of FTIR microspectroscopy by the middle of the last century [119].
The adjustable aperture plays a crucial role with single-point detectors because it
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is responsible for refining the spatial localisation of the measured ROI. As sketched
in Fig. 2.10b, in single-point measurements only one interferogram is acquired from a
squared region of the sample whose side is typically around 25-50 µm.
In the past, single-point detectors were used to create hyperspectral images by
mapping the sample point-by-point. However, with the introduction of FPA detectors,
originally designed and developed for military applications, the collection time of
images drastically decreased [120]. First successful applications of FPA detectors were
reported around 20 years ago [121,122]. Since then, FTIR microscopes equipped with
multichannel detectors have been the standard to perform IR imaging [116]. Focal
Plane Array detectors, also called multichannel detectors [123], are squared grids of
multiple small sensing elements, commonly known as pixels. Each one of these pixels
is capable of capturing an interferogram from a small region of the sample during a
single acquisition (Fig. 2.10b). Both single-point and FPA detectors are made of the
materials described in Sec. 2.3.3. In particular, MCT sensors require liquid nitrogen
for cooling and hence depleting the level of noise (Fig. 2.9a).
FPA detectors can provide spatially-resolved measurements in the form of
hyperspectral images in relatively short times of acquisition. As illustrated in Fig.2.11,
these hyperspectral images have two spatial dimensions (x, y) that indicate the
position of the pixels and a spectral dimension ν̃ corresponding to the wavenumbers
of the measured absorbance spectra.
All the FTIR images analysed in this thesis were captured with an Agilent 620
FTIR microscope coupled to an Agilent 670 FTIR spectrometer with a Globarr light
source (Fig. 2.9b). This device has a FPA detector composed of 128×128 (16384)
pixels, each one covering around 5.5×5.5 µm2 in the sample (see next section) when
using 15× Cassegrain reflective condenser and objective (NA = 0.62) and jointly
covering an effective FOV of 704×704 µm2 per frame. Normally, the hyperspectral
images from contiguous areas of sample, recorded in successive FPA acquisitions, are
stitched together in order to augment the total FOV. As a result, FTIR hyperspectral
images are information-rich entities containing huge loads of data, easily accounting
for several gigabytes.
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Fig. 2.11: Example of FTIR hyperspectral image (centre), which has two spatial dimensions
(x, y) and a spectral dimension ν̃. The absorbance spectra of two selected pixels are also
presented: one corresponding to an empty region of substrate (left) and the another one
corresponding to a region of a skin cell (right).
2.5.1 Spatial resolution
An important factor in any microscopy technology is spatial resolution, and more
specifically lateral spatial resolution. Several definitions of this concept exist
depending on the specific research community [124]. Roughly speaking, spatial
resolution is normally defined as the minimum distance at which two close points
of the same intensity can be clearly distinguished as two different points in the image.
Mathematically, this minimum distance d is commonly defined by the Rayleigh’s








where NA is the numerical aperture of the optical setup, normally the objective,
which is determined by its optical properties. Following this equation, several curves
of d as a function of the wavenumber ν̃ and the wavelength λ for different values
of NA have been represented in Fig. 2.12. These NA values correspond to different
objectives that can be chosen for the microspectroscope used for the measurements
in this thesis [117]. In particular, all the samples that will be analysed were measured
with an objective with NA = 0.62.
As can be observed in Fig. 2.12, better resolution (lower d) can be achieved
with higher NA and higher wavenumbers (lower wavelengths). This theoretical
behaviour is normally followed in practice, although the final practical resolution
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Fig. 2.12: Rayleigh lateral spatial resolution d as a function of the wavenumber and
wavelength for several values of numerical aperture NA.
is not only determined by the used objective, but by the total optical system (e.g.,
internal optical elements). Therefore, the actual resolution of a specific system can
only be experimentally measured. A common methodology is using a USAF 1951
resolution target, which has geometrical patterns (e.g. vertical and horizontal bars)
at different scales and separated by calibrated distances [117,124–126]. This target is
normally composed of a glass substrate at which a chromium test pattern is vacuum-
deposited [124].
Resolution is normally wrongly mixed up with the concept of effective pixel size on
the sample. The effective pixel size, also called nominal pixel size or simply pixel size,
is mainly determined by the size of the individual elements in the FPA detector and
all the optical components of the system (not only the objective), which determine
the total system magnification [117, 125]. The pixel size is inversely related to the
spatial sampling rate, which is determined by the Nyquist criterion [126]. In order
to fulfil this criterion and not lose spatial information, the pixel size must be smaller
than the practical resolution. Anyway, the manufacturers of microspectroscopes and
objectives normally provide only the information of the pixel size on the sample and
favour this confusion between concepts. It must also be remarked that as the actual
resolution is not known, the pixel size has been used as a guide for different tasks
performed in this thesis. For instance, for the comparison of the spatial dimension
between different microscopy modalities (Ch.4) or for the representation of scale bars
in the microscopic images.
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2.5.2 Synchrotron light sources
Synchrotron radiation is a very bright broadband light, ranging from the X-ray to
the IR region (Fig. 2.1), which is emitted from electrons travelling at relativistic
velocities close to the speed of light. These extremely high velocities are achieved
by accelerating the electrons into circular trajectories through sequences of magnets.
Nowadays, synchrotron sources are built in large expensive facilities and their use is
mainly focused on research.
There are several synchrotron facilities around the world, but to access them a
well-defined research plan must be justified. Synchrotron radiation has been employed
in FTIR microspectroscopy for around two decades [127] and several biomedical
applications were reported shortly after [128–130].
The main advantage of synchrotron sources is their high brightness (about two
orders of magnitude) compared with common thermal sources [131]. This high flux
of photons makes possible to collect spectra with a very high Signal-to-Noise Ratio
(SNR) from regions around several microns (e.g., 3×3 µm2), achieving sub-cellular
resolution. However, its main drawback is that synchrotron beams are normally
confined into very narrow areas of around 10×10 µm2 and, typically, they are only
used in single-point measurements. Therefore, it takes much time to acquire a
hyperspectral FTIR image with a small FOV by sequentially scanning with the single-
point detector and the synchrotron beam.
Most of the pioneering work in biomedical FTIR microspectroscopy was
accomplished by using synchrotron sources. These works comprehend the reference
methodologies and theoretical background that is being extrapolated to thermal
sources. Recent advances in optical elements have made possible to develop FTIR
microspectrometers, with thermal sources and FPA detectors, capable of collecting
high-spatial resolution images with a nominal pixel size up to 1.1×1.1 µm2, similar
to that of a synchrotron [125].
Although the spectral SNR of these commercial devices is still lower than
synchrotron’s, they allow to measure larger FOV in shorter times and in a common
laboratory. In this thesis, all the analysed spectral measurements were collected with
commercial devices equipped with thermal sources, but some reference studies (which
will be properly cited) used synchrotron sources.
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2.6 Artifacts, anomalies and common errors
Artifacts, anomalies and errors are three nouns normally used to denote those spectral
features whose presence implies that the data are imperfect, that the data were derived
in an imperfect way or that the data are impure [132]. The word anomaly also implies
ignorance or lack of knowledge and normally refers to those unexpected phenomena
which cannot be explained with current existing theories [133]. In fact, historically,
IR spectroscopy has been mostly an empirical technique whose technology has been
always one or several steps ahead of its theoretical background, which has been driven
by the experimental findings.
Each new imaging technique introduces a new set of artifacts that may interfere
with clinical diagnosis [134]. The underlying mechanisms that generate such
artifacts should be identified in order to avoid incorrect interpretation or misleading
quantitative analysis of spectra. Nevertheless, the identification of a spectral feature
as an artifact is not easy and requires a deep knowledge of the spectroscopic technology
and the underlying physicochemical phenomena. In addition, the relevance of an error
or artifact will finally depend on the specific application.
The presence of some artifacts can be avoided, or at least minimised, before and
during the acquisition of the spectral data, e.g., during the design of the experimental
setup or during the preparation of samples. Nevertheless, different types of artifacts
appear in the final recorded spectra and they can only be corrected for by some kinds
of computerised processes (Sec. 3.2). Several lists of artifacts have been identified
in FTIR spectroscopy [132, 135], containing even up to 50 error sources [136]. They
range from stochastic measurement noise to various sources of systematic errors,
such as non-linear instrument responses, shift problems and interfering effects of
undesired chemical and physical variations [137]. Here, only the most relevant
artifacts and sources of error encountered during the development of this thesis
will be described, which have been grouped under several main topics: instrument,
environment, substrate, contamination, scattering and microscopy measurements.
2.6.1 Instrument
The contribution of the instrument is called the instrument response function [99].
This function is determined by the convolution of the source emission spectrum
(Fig. 2.3), the spectral sensitivity of the detector and the rest of optical components
64 Chapter 2. Fourier Transform Infrared Spectroscopy
in the spectrometer, which define the overall or broad shape of the intensity
spectra (Figs. 2.5 and 2.7). In the case of the employed spectrometer, this broad shape
increases with the wavenumber until reaching a maximum around 1200-1300 cm−1
and then decreases monotonically. This suggests that the higher signal levels are
recorded approximately in the fingerprint region (∼1000-1800 cm−1).
The source and the rest of optical elements normally have a relatively constant
spectral behaviour during time, but their variations can cause unexpected baseline
curvatures in A(ν̃) [99]. In contrast, the detector response may experiment more
significant fluctuations during time. In the case of MCT detectors, these fluctuations
are constrained as far as the volume of liquid nitrogen in the cooling deposit is enough
to maintain a constant cryogenic temperature of 77 K, although some electrons may
still jump the band gap and produce random noise (Sec. 2.3.3).
In order to soften the instrumental fluctuations, the interferograms are remeasured
in the same region several times and averaged or co-added before computing the
intensity spectra by Fourier transform. These repeated measurements are called
scans and are normally carried out in powers of 2, e.g., 32, 64, 128 or 256 scans. As
the number of scans increases, the instrument interferences (mainly present as high
frequency random noise) are more negligible in A(ν̃). In some cases, a higher number
of scans are co-added when measuring I0(ν̃) than when I(ν̃) is recorded because each
I0(ν̃) measurement is used as a reference for several regions of the same sample. For
instance, in Fig. 2.7, 256 scans were co-added to compute I0(ν̃), meanwhile 128 scans
were averaged to obtain I(ν̃).
2.6.2 Environment
Some parts of spectrometers such as the interferometer are normally isolated from the
room environment, but other parts such as the analysed sample can be in contact with
the room atmosphere. In a laboratory of biospectroscopy, this atmosphere is normally
controlled to keep a nearly constant temperature and humidity, but the air existing
in the room is regular with no special filtrations. Therefore, the IR beam encounters
different gasses whose molecules can absorb mid-IR photons and have influence in the
final measurements. In particular, the interferences caused by CO2, and especially by
water vapour, are major problems in FTIR spectroscopy.
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Some spectrometers have an isolation chamber to introduce the sample, which
is purged with dry air having a very low water content. Fig. 2.13 shows an
intensity spectrum recorded after isolating and purging the sample chamber with
dry air (blue), which lacks the peaks associated with water vapour that can be
observed in the spectrum recorded without purging (red). Fig. 2.14 also presents
an absorption spectrum from a different un-purged spectroscope cropped to the
range 1300-1800 cm−1. Minimising the presence of water vapour in the isolated
atmosphere requires much time (around one hour) and impedes the manipulation
of the sample during the isolation. Some spectrometer manufacturers get rid of the
isolation chamber and try to alleviate the problem of water vapour by directly purging
the environment surrounding the sample with dry air. This system is far from being
efficient and the water vapour peaks appear in the recorded spectra, as can be checked





















Fig. 2.13: Water vapour intensity spectrum. Intensity spectrum recorded when purging
(blue) and not purging (red) the isolated sample compartment with dry air. Adapted
from [138] with permission by courtesy of Macmillan Publishers Ltd.
Carbon dioxide (CO2) has a strong absorption band quite concentrated in the
range 2300-2400 cm−1, where no relevant biomolecular absorbers exist. On the
contrary, water vapour molecules have a more complex vibrational mechanism and
their absorption bands occupy a broad spectral range, from about 1300 to 2000 and
from 3500 to 3900 cm−1. The attenuation peaks induced by the water vapour are
weaker than those of CO2 and their pattern resembles high frequency noise. As can
be observed in Fig.2.14 and also in Figs. 2.5, Fig.2.7 and 2.13, the first range of water













Fig. 2.14: Absorption spectrum of water vapour at room temperature and ambient humidity
in the range 1300-1800 cm−1, measured through an un-purged infrared microscope with a
path length of about 1 m. Adapted from [101] with permission by courtesy of John Wiley
& Sons Inc.
vapour absorption overlaps the fingerprint spectral region and is particularly stronger
in the Amide I and Amide II peak regions (Fig. 2.8). Due to the gaseous nature
of water vapour, the interaction of its rotational and vibrational transitions create
a complex absorption spectrum that strongly depends on the local temperature and
humidity, and which is extremely difficult to model during the spectral preprocessing
of the recorded data [101].
Biological samples with low concentrations, such as cells, produce relatively low
absorption signals. Therefore, their spectra are particularly sensitive to environmental
interferences and other sources of noise. Especially in those cases, there is a critical
trade-off when selecting the number of scans. A higher number of scans reduces the
random noise mainly generated by the detector but involves a longer acquisition time,
which produces changes in the concentrations of gases surrounding the sample. As
a final consequence, the CO2 and, more importantly, the water vapour peaks appear
superimposed in the absorption spectra and distort the shape of relevant peaks in the
fingerprint region (e.g., compare the Amide II peak in Fig.2.8 and Fig.2.7). This fact
must be considered when comparing spectra acquired with different devices or even
with the same spectrometer operating at different conditions (e.g., at different times).
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2.6.3 Substrate
As was depicted in Fig. 2.6, the background spectrum I0(ν̃) is recorded in a region of
substrate containing no biological sample. Although the CaF2 substrate is normally
manufactured with high standards, it may contain some chemical impurities or
physical defects (e.g., thickness variability or scratches) that may affect the correct
ratioing of I0(ν̃) and I(ν̃). However, the most important differences between I0(ν̃)
and I(ν̃) due to the substrate can be caused by the presence of chemical contaminants
on its surface. These contaminants may come from a deficient manipulation or
preservation, but they can also be introduced during the sample preparation.
For instance, when culturing cell populations on the substrate, different chemical
compounds such as cell medium are used, which is a mixture of organic substances.
Although these compounds are normally removed by washing with water, relevant
concentrations can remain adhered to the substrate. The spectral interferences owing
to the substrate may be minimised by selecting a clean region of substrate with no
defects. Nevertheless, sometimes this task is not feasible because the contaminants
extend all over the empty surface of substrate.
Another problem associated with the substrate is the effect of reflection loss in the
sample-substrate interface [111]. This effect takes place when the refractive indices
of sample and substrate differ. Although the substrate materials are selected so that
their refractive indices are very close to those of biological samples (e.g., CaF2, see
Sec. 2.4), they can differ in some regions of the sample. Nevertheless, its influence
is normally neglected in the analysis of spectra mainly because the exact optical
properties of the biological samples are unknown or very sample-dependent and its
quantification is infeasible.
2.6.4 Contamination
The final sample can contain substances or materials different from the biological
specimens intended to measure, which create absorption bands that can be incorrectly
attributed to the studied specimens. These contaminants may come from the sample
preparation or may have been accidentally introduced at any phase of the handling.
In the first case, the substances may unintentionally remain in the sample, such as
residual chemical agents used in cell culture, or left on purpose. For instance, paraffin
may not be removed in histological samples to prevent chemical distortions (Ch. 4).
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Detecting a contaminant involves checking if its spectrum is similar to the expected
absorption profile. This task is challenging because sometimes the expected spectrum
may be totally unknown or may be too ideal for the imperfect recorded spectra, which
can contain other kinds of artifacts (Sec.3.2.1). Moreover, the undesired contaminants
may give rise to spectra very similar to the studied specimens, such as cell media,
which have a biomolecular composition similar to cells. Finally, in some cases a
contaminant may not be detected, mainly because its concentration is not high enough
and it gets masked under the specimen’s absorption, or it may be confounded with
other types of anomalies or artifacts.
Anyway, the most straightforward method to detect a contaminant is applying
heuristic rules depending on the problem in hand. For example, one solution is
removing the specific spectral regions containing the characteristic absorption peaks
of a known contaminant, such as paraffin (Sec.4.2.3). But in other cases, the features
of a reference spectrum can be used to reject contaminated spectra, e.g., the Amide I
peak is normally the maximum absorbance in a typical biological spectrum (Fig.2.8).
2.6.5 Light scattering
Light scattering may be the most distinctive problem in biomedical applications of
FTIR spectroscopy. Most problems associated with scattering are generated by the
morphological and optical properties of the analysed sample. In applications involving
artificial materials, the sample preparation and presentation for FTIR measurements
may be adapted in order to avoid or minimise scattering. However, the preparation
of biomedical samples is much more restricted and is normally determined by clinical
routine or laboratory procedures.
The general phenomenon of scattering in FTIR spectral acquisition is coarsely
illustrated in Fig. 2.15. In an ideal homogeneous flat sample (left side of Fig. 2.15),
a fraction of the collimated IR light is absorbed by the sample and practically the
rest of radiation (neglecting the reflection at interfaces) continues its travel towards
the detector without significant deviations. Nevertheless, in a real biological sample
with heterogeneous morphological and optical properties, such as a single cell (right
side of Fig. 2.15), the incident light is scattered, giving rise to significant deviations
in the photon paths. As the scattered rays may not reach the detector, the recorded
absorption spectrum may be higher than it would be in the absence of scattering. As
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a result, this virtual increment in absorption can be wrongly interpreted as chemical









Fig. 2.15: Illustration of scattering phenomena. In an ideal homogeneous flat sample (left)
the transmitted light has the same direction of the incident light. However, in a real biological
sample with heterogeneous morphological and optical properties (right) the incident light is
scattered, giving rise to significant deviations in the photon paths.
In biological samples, many scattering sources are still unknown or require
extremely complex mathematical modelling, but few of them have been identified
and (at least partially) understood. This last category comprehends the so-called Mie
scattering and resonant Mie scattering, which are mainly related to the morphology
and size of the sample.
Mie scattering
In 1908 [140], Mie formulated the theoretical bases of the scattering phenomena
produced when dielectric spheres are irradiated with a light whose wavelength is
comparable to the size of those spheres. The typical size of animal cells ranges
between 8-30 µm and the size of subcellular structures or organelles is between
1-10 µm [86]. These dimensions are comparable and even coincident with the
wavelength range commonly used in FTIR spectroscopy, approximately between 2.5-
10 µm. Therefore, biological specimens are ideal candidates to experiment the type
of scattering formulated by Mie.
Mie-type scattering was firstly identified in cytological samples by Mohlenhoff et al.
in 2005 [141], although atypical absorbance spectra related to the cell cycle had been
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reported several years before [142,143]. The main sources of Mie scattering seem to be
the nuclei of cells, especially when the chromatin is more compact and dense. These
compact states are experimented when the cell is close to the mitotic phase (Sec.1.1.2)
or when the nucleus permanently shrinks due to cell death (piknosis) [141, 144].
Nevertheless, it is still not clear if the real sources of scattering are only the nuclei, the
entire cells or their combination. The distortions caused by Mie scattering are more
pronounced in cytological samples but they can also be present in spectral histology,
particularly at the edges of the tissue [86].
The most prominent features caused by classical Mie scattering in spherical
particles are alterations in the baseline of the absorbance spectra. These baseline
artifacts are normally modelled as undulating functions with broad sinusoidal shapes,
such as the one presented in Fig. 2.16a, which are superimposed on the spectra of
biological specimens [101, 145]. Nevertheless, the undulations of the background
observed in cells have more maxima and minima than expected from single scattering
objects, such as simple spheres, maybe because the size and morphology of cells are
not uniform [141].
Resonant Mie scattering
Apart from the relatively simple broad baseline oscillations caused by classical Mie
scattering, most severe artifacts appear in real measurements of single cells. One of the
artifacts identified so far is the so-called resonant Mie scattering, which was suggested
by Bassan et al. in 2009 [146] and tries to explain the anomalies that were previously
attributed to the dispersion artifact [147,148]. These anomalies consist of significant
derivative-like distortions of band shapes, which highly modify the intensity and the
positions of the maxima of relevant absorption peaks. As an example, Fig. 2.16b
shows an absorbance spectrum contaminated by resonant Mie scattering, which can be
compared with the corresponding pure absorption spectrum of the same protein sphere
(Fig. 2.16c.). The most prominent distortion can be observed in the Amide I peak,
whose relative intensity drastically decreases when it is compared with other peaks
such as the Amide II and whose maximum is shifted towards lower wavenumbers.
As commented, Bassan et al. [146] was the first in describing that the underlying
phenomenon of this type of artifacts is also related to Mie scattering interactions. In
classical Mie scattering, the dielectric non-absorbing spherical particles are assumed












Fig. 2.16: Illustration of Mie and resonant Mie scattering. (a) Example of a classical Mie
scattering curve of a spherical particle. (b) Example of absorbance spectrum contaminated
with resonant Mie scattering. (c) Pure absorption spectrum of a protein sphere. Adapted
from [101] with permission by courtesy of John Wiley & Sons Inc.
to have constant values of the real refractive index, independently of the wavenumber.
Nevertheless, in absorbing materials with phenomena of absorption resonance (i.e.,
the chemical molecules absorb the photons at the illuminated wavenumber), the
real refractive index rapidly changes across the wavenumbers of the resonant
absorption bands, causing sudden variations in the measured absorbance spectra.
In that publication, Bassan et al. [146] experimentally demonstrated its theoretical
supposition with the absorbance spectra from polymeric microspheres of Poly(methyl
methacrylate) (PMMA) measured with synchrotron FTIR microspectroscopy and
suggested the potential application to biological samples, especially single cells.
Further details of the scattering phenomena will be described in Sec. 3.2.1.
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2.6.6 Micro-FTIR imaging measurements
The use of optical objectives and FPA detectors introduces spatial variability in
the recorded spectra. The objectives are not ideal and they introduce a series of
aberrations in the final image, especially in the borders of the image. In addition, the
elements composing the array of pixels are not exactly equal and do not operate at
the same conditions. This is reflected in a difference in the sensitivity and, therefore,
the registered intensity may vary between pixels even with homogeneous illumination.
As an example, Fig. 2.17 shows a pseudocolour image constructed with the values
extracted from the hyperspectral image of the intensity reference spectrum I0(ν̃) at
a specific wavenumber (ν̃ = 1300 cm−1, approximately the maximum of intensity).
This image also shows the I0(ν̃) spectra of four selected pixels in the pseudocolour
image.
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Fig. 2.17: Intensity refererence spectra I0(ν̃) of a FPA detector. Left: Pseudocolour image
with its colourbar of the intensity values corresponding to a wavenumber ν̃ = 1300 cm−1.
Right: Intensity reference spectra I0(ν̃) of the pixels selected in the pseudocolour image.
In this case, the region of illuminated substrate is pretty homogeneous and the
spatial variability is mainly determined by the sensitivity of the pixels. Nevertheless,
the possible spatial inhomogeneity in the substrate is another source of artifacts that
introduces undesirable variations in the final measured spectra. This unevenness is
tangled with other spatial inhomogeneities, for instance, coming from the sensor, the
illumination source and the optical components.
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As can be observed in the pseudocolour image of Fig.2.17, the registered intensity
values are higher in the lower part of the image, meanwhile there is a small region close
to the upper-right corner (pixel 4) where the sensitivity of the sensor is significantly
lower. This spatial variability can be confirmed in the spectra of the selected pixels,
where the pixel 4 shows lower intensity at lower wavenumbers, but higher sensitivity
than the rest of selected pixels at higher wavenumbers.
These spatial differences, although are supposed to be compensated when
computing the transmittance and absorbance, introduce variations in the SNR of
the measured spectra. In particular, the pixels with lower sensitivity will have a
poorer detection limit [101] and will be more prone to different sources of noise. In
addition, the sensor can present specific pixels working at saturated levels (hot pixels)
or not registering any current (dead pixels), which normally will provide anomalous
measurements that can be identified as outliers.
The spatial variability introduced by FTIR microspectrometers can increase the
presence of the artifacts described in previous sections and complicate their removal.
For instance, some methods exist to reduce the influence of water vapour in the
spectrum, which are mainly based on modelling the contributions of a pre-recorded
reference spectrum of water vapour [149]. However, that methodology requires to
record a battery of reference spectra at different temperatures and concentrations
of water vapour in order to model the possible variability. Therefore, if the spatial
variability is added to that problem, the model complexity and the risk to introduce
additional artifacts highly increase.
Finally, as was commented in Sec. 2.5.1, the use of microscopy instruments is
always linked with spatial resolution. Resolution, theoretically determined by the
optical power of the instrument and the wavelength of the used light (Fig. 2.12),
defines the concept of diffraction limit [150], i.e., maximum resolution from which
diffraction phenomena occur. Although the advances in optical instrumentation have
made progress in the spatial resolution, the diffraction limit will be always present
mainly due to the restriction of the wavelength. In addition, practical resolution also
depends on the analysed sample.
The main consequence of the diffraction limit is the uncertainty of knowing
the spectral purity of a pixel [132]. That is, knowing if the recorded spectrum
from one pixel only contains contributions from the material within the physical
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region covered by that pixel or if there are intrusions from nearby regions due
to diffraction phenomena. These undesirable interactions are more critical for
lower wavenumbers (Fig. 2.12), which contain more useful biological information
(Fig. 2.8). This problem can seriously hamper the analysis of spectral signals,
especially in highly heterogeneous samples. Some empirical methods have been
proposed to computationally improve the spatial resolution and try to deconvolve
the contributions of pixels’ spectra [124]. Nevertheless, although these methods
can perform an aesthetic improvement in images, their real accuracy and practical
improvement for spectral analysis have not been proved.
The theoretical bases of the physicochemical phenomena occurring in modern
FTIR microspectroscopes have started to be understood and formulated very recently,
both for homogeneous [151] and heterogeneous samples [152]. As stated in [152], the
scattering phenomena, sampling geometry, sample morphology and spectral profile
in heterogeneous samples (such as biological specimens) are strongly coupled to
diffraction effects and jointly perturb the ideal chemical spectrum of the sample.
However, these phenomena are not well-understood yet and most practical methods of
processing and analysis consider the spectra as obtained with classical spectroscopes.
This is the line that will be followed in this thesis, but the advances in the theory of
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3.1. Introduction 77
3.1 Introduction
FTIR spectra are high-dimensional data structures that contain huge loads of
information, part of which can be very useful or, on the contrary, irrelevant and
spurious, depending on the specific study or application. This chapter describes
several techniques, which can be categorised as spectral preprocessing and feature
extraction, that specifically try to get better versions of the FTIR spectra and try to
separate the most relevant information in order to improve the performance of later
analyses.
3.2 Spectral preprocessing
As was described in Sec. 2.6, FTIR measurements are affected by a number of
unwanted phenomena that can hamper their quantitative analysis, which ideally
should be based on the chemical information encoded within the absorbance spectra.
Although some errors or artifacts may be avoided by good sample preparation and
measurement protocols, many of the undesired phenomena remain in the measured
spectra and should be corrected for computationally by preprocessing.
Preprocessing is normally a determining step in the analysis of FTIR spectra [153–
155]. Its main objective is to remove or at least minimise the spectral variability
not related to the chemical information of interest. Correct preprocessing can
improve the graphical interpretation of the data, as well as reduce the complexity
and improve the robustness of the subsequent data modelling (e.g., less biased future
predictions) [156]. However, preprocessing of spectral data must be applied with
caution and with supporting physical or chemical bases. Incorrect data preprocessing
introduces artificial artifacts which can reduce or distort the spectral variance specific
of each chemical species and mislead the later analysis. Nevertheless, preprocessing
is still an open field with no standard solutions and deep knowledge of spectroscopy
theory is normally required to select a specific method, which mainly depends on the
final application.
Depending on the bibliographic reference or the application field, spectral
preprocessing methods are catalogued into different categories. Here, it will be
adopted the classification proposed in [157], where preprocessing methods are coarsely
divided into two main groups, namely filtering methods and model-based methods.
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Filtering methods include all those techniques that discard some kind of undesired
spectral variation and transform the data into a presumably better version. Model-
based methods try to get also a better version of the data but creating a more
explicit mathematical model, which is used both to estimate the useful and the
unwanted information. Filtering methods are simpler techniques that have been used
traditionally in FTIR spectroscopy, whereas model-based methods have attracted
increasing attention in the last few years due to their potential ability to cope with
more complex phenomena.
Below, the model-based methods relevant for this thesis will be introduced in the
first place. The reasoning and concepts explained in those methods will help to justify
the aims of some traditional filtering methods that will be used in later applications.
3.2.1 Model-based methods
Currently, the most advanced model-based techniques used in vibrational spec-
troscopy are adaptations of the so-called Extended Multiplicative Signal Correction
(EMSC). EMSC is a flexible preprocessing method based on linear statistical regres-
sion modelling where the influence of unwanted spectral variation is estimated and
corrected [137, 157]. The main difficulty of model-based methods in general, and
EMSC in particular, is the requirement of knowing the unwanted sources of variation
and their theoretical formulation in order to model them in a precise way. The basic
principles (which are not trivial) and the versions of EMSC used to correct the FTIR
data analysed in this thesis will be discussed in the following paragraphs.
Extended Multiplicative Signal Correction (EMSC)
EMSC allows more selective corrections for various types of unwanted effects,
such as scattering, than what is feasible with standard filtering methods. EMSC
demonstrated its utility to separate light scattering effects from chemical information
in near-IR measurements [158]. Shortly after, this method was also applied to isolate
scatter (physical information) from chemical absorbance changes in FTIR images
taken from biological samples, in particular from cryo-sections of beef loin [159]. Since
then, EMSC has been used as the main preprocessing tool in different problems of
FTIR spectroscopy involving biological samples due to its versatility [157].
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The starting point for deriving EMSC models is the Beer-Lambert law. As was
stated in Sec. 2.4.1, biological samples are complex mixtures of biomolecules whose
ideal chemical absorption spectrum would obey the Eq. 2.9. Notwithstanding, as
was also described in Secs. 2.4.2 and 2.6, different undesired phenomena mask the
ideal chemical absorption spectrum within the real measured absorbance spectrum.
The key idea of EMSC is approximating the measured absorbance spectrum A(ν̃) as
physical modifications of an idealised chemical spectrum Achem(ν̃) [137]:
A(ν̃) = b ·Achem(ν̃) +Aphys(ν̃) + e(ν̃) (3.1)
where scalar b is a multiplicative physical scaling parameter that mimics the effective
optical path length ` (Eq. 2.9), Aphys(ν̃) represents additive physical contributions to
the absorbance spectrum and e(ν̃) is the residual absorbance which denotes the sum
of all other unmodelled effects and measurement errors. This theoretical formulation
must be converted into a practical mathematical form, which is accomplished by
constructing a linear model with multiplicative and additive terms adapted to the
corresponding problem at hand.
First, it is often assumed that the FTIR absorbance spectra obtained from
biological samples are very similar [157] and the chemical contributions can be





Cj · εj(ν̃) =
J∑
j=1




In some cases, Aref (ν̃) is computed as the mean spectra of the dataset, but the
selection of this ideal reference spectrum depends on the specific problem. In most
situations the specific chemical constituents, and particularly their absorptivity values
εj(ν̃), are not known or difficult to obtain. Thus, the last term of Eq.3.2 is frequently
incorporated into the unmodelled residuals e(ν̃). In addition, considering that the
sum of constituents’ concentration sums up to 1 (
∑J
j=1 Cj = 1), Eq. 3.1 becomes:
A(ν̃) = b ·Aref (ν̃) +Aphys(ν̃) + e(ν̃) (3.3)
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The physical contributions Aphys(ν̃) are mainly related to scattering effects
involved in the measurement. Therefore, Aphys(ν̃) is maybe the most problem-
dependent term and its particular modelling has given rise to different versions of
EMSC, some of which are later discussed. In some basic versions of EMSC models
the scattering effects are represented by an offset parameter a and a polynomial
baseline of order N along the wavenumbers ν̃ with coefficients dn, that is:
A(ν̃) = b ·Aref (ν̃) + a+
N∑
n=1
dn · ν̃n + e(ν̃) (3.4)
The particular case of extending the polynomial baseline up to the quadratic term
is normally called the basic EMSC model :
A(ν̃) = b ·Aref (ν̃) + a+ d1 · ν̃ + d2 · ν̃2 + e(ν̃) (3.5)
As can be observed, the most relevant simplification of EMSC is the assumption
that only linear relationships exist in the models. Although this linear restriction
may oversimplify the physicochemical phenomena in some cases, it facilitates the
estimation of the model parameters by statistical techniques. In particular, the
unknown model parameters are normally estimated simultaneously by multiple linear
regression solved by ordinary or weighted least squares [157, 159]. In the case of
weighted least squares, specific weights can be assigned to particular regions of
wavenumbers. For example, some ranges containing excessive contaminants, such
as the CO2 region (∼2300-2400 cm−1), can be given a very low weight (e.g., 10−6) in
order to reduce their influence in the parameter estimation.
Once the EMSC parameters are estimated, the spectra can be corrected by
subtracting the unwanted modelled contributions. For instance, the corrected
absorbance spectrum Acorr(ν̃) corresponding to the EMSC model described in Eq.3.4




n=1 dn · ν̃n
b
(3.6)
Note that in this equation the division by the multiplicative scaling parameter b
implies a normalisation of the corrected spectrum.
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Mie Scattering-EMSC
In some biological samples with relatively homogeneous spatial properties, such
as tissues, the scattering effects can be modelled with relatively simple functions,
e.g., the polynomial baselines described before. However, biological samples with
more complicated optical and morphological characteristics, such as single cells,
may produce more complex scattering phenomena, which are reflected in fancier
absorbance spectra.
As was described in Sec. 2.6.5, Mie-type scattering is one of the physical artifacts
that have been identified and modelled in single cell samples [141, 145]. Mie theory
was adapted in 2008 by Kohler et al. [160] to develop a version of EMSC that tries
to correct Mie scattering artifacts. Full Mie theory [140] describes the scattering
produced by an ideal homogeneous non-absorbing sphere in terms of the extinction







(2m+ 1)< (am + bm) (3.7)
where am and bm are the scattering coefficients, which are complicated Bessel
functions in cylindrical coordinates; < symbolises the real part of those functions;
and ρ(ν̃) is the size parameter, which is defined as:
ρ(ν̃) = 4πr(n− 1)ν̃ (3.8)
where r denotes the radius of the scattering sphere and n the ratio of the real refractive
indices of the particle and the surrounding medium. In the FTIR measurements that
will be studied here, the surrounding medium is air (whose real refractive index is
essentially 1) and n simplifies to the real refractive index of the scattering particle.
The original full formulation of Qext(ν̃) expressed in Eq.3.7 is normally substituted












(1− cos ρ(ν̃)) (3.9)
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This formula approximates the original Qext(ν̃) predicted by Mie within 1%
precision in the case of spheres with a large size parameter and a refractive index close
to unity [141, 160]. Fig. 3.1 shows some examples of these curves for a specific real
refractive index n = 1.3 and a range of radii of the scattering sphere r = 2− 14µm.
This graphic reveals the undulating nature of the damped sinusoidal functions in
Eq. 3.9, which fluctuate around the asymptotic value Qext(∞) = 2.
wavenumber (cm-1)
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Fig. 3.1: Examples of Mie extinction cross section functions Qext(ν̃), according to van de
Hulst approximation (Eq. 3.9), for n = 1.3 and several values of r (see the legend).
By computing Qext(ν̃), the baseline fluctuations attributed to Mie scattering could
be estimated through the parameter f , together with an offset a and a multiplicative
effect b, in the initial version of the EMSC model proposed by Kohler et al. [160]:
A(ν̃) = b ·Aref (ν̃) + a+ f ·Qext(ν̃) + e(ν̃) (3.10)
Nevertheless, in practical situations the exact values r and n of the studied
biological specimen are unknown and the corresponding Qext(ν̃) cannot be computed.
One possible solution is to consider a set of Mie extinction functions Qext(ν̃), covering
a range of feasible values of r and n, and try to find the combination of those functions
that best fits the baseline deviations in the measured absorbance spectrum. The main
problem of this approach is the non-linear nature ofQext(ν̃) functions, which can cause
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problems of stability and speed in the correction algorithm.
In order to simplify this problem, Kohler et al. [160] proposed to apply multivariate
metamodelling [162, 163]. This technique consists of computing the set of Qext(ν̃)
curves for a range of possible values of r and n, which are placed (e.g., by rows) inside
the matrix Q, and then decomposing this matrix by non-centred Principal Component
Analysis (PCA) (Sec. 3.3.1) into the corresponding matrices of scores T and loadings
or eigenvectors P:
Q = T ·PT + E (3.11)
Thus, the original set of functions can be approximated up to a certain degree (see
Sec.3.3.1) by the subspace determined by the first eigenvectors placed by columns in P
and the errors of this approximation are gathered within the residual matrix E. As an
example, with the permutations of 10 equidistant values in the range r = [2, 8] µm and
10 equidistant values in the range n = [1.1, 1.5], a total of 100 Mie extinction curves
Qext(ν̃) can be computed to create the matrix Q. When this matrix is decomposed
by non-centred PCA according to Eq. 3.11, the first six loadings or eigenvectors pi
(first six columns of matrix P) account for nearly 100% of the explained variance. As
can be observed in Fig. 3.2, the loadings of this example have different characteristics
of frequency and damping with the wavenumbers.
By using this new compressed subspace, the Qext(ν̃) curve within the EMSC model
formulated in Eq. 3.10 is approximated by the first K loadings or eigenvectors pi(ν̃)
and the original factor f is divided into K new scalar coefficients gi. The errors due
to this approximation are accumulated in the unmodelled residual e(ν̃), resulting the
equation:
A(ν̃) = b ·Aref (ν̃) + a+
K∑
i=1
gi · pi(ν̃) + e(ν̃) (3.12)
Finally, as in any EMSC model, the coefficients can be estimated by ordinary





i=1 gi · pi(ν̃)
b
(3.13)
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Fig. 3.2: Example of the first six loadings (accumulating nearly 100% of explained variance)
of the non-centred PCA metamodel of matrix Q, which contains 100 Mie extinction curves
Qext(ν̃) covering the range of parameters r = [2, 8] and n = [1.1, 1.5]
Resonant Mie Scattering-EMSC
As was commented in Sec. 2.6.5, the phenomenon termed as resonant Mie scattering
was firstly identified by Bassan et al. in 2009 [146] as the responsible for the sudden
changes in intensity peaks and shifts in the maxima of relevant absorption bands
in the measured spectrum. Shortly after, the researchers from the same group
published a version of EMSC which tries to correct the artifacts caused by resonant
Mie scattering and which was called Resonant Mie Scattering (RMieS)-EMSC [164].
In order to understand the main novelties introduced by the RMieS-EMSC algorithm,
some concepts of optics must be described before.
Optical parameters and anomalous dispersion
The absorption of radiation and the interaction of a sample with a medium are
governed by two optical parameters, n(ν̃) and k(ν̃), which respectively constitute
the real and the imaginary parts of the complex refractive index, ñ(ν̃) [98]:
ñ(ν̃) = n(ν̃) + ik(ν̃) (3.14)
where i =
√
−1. n(ν̃) is often simply called refractive index and k(ν̃) is known as
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the absorption index. For pure materials containing a single chemical component, the
absorption index k(ν̃) is also related to the absorptivity of the material ε(ν̃) by the
following equation [98,101,165]:
k(ν̃) =
ln 10 · C · ε(ν̃)
4πν̃
(3.15)
In cases where the Beer-Lambert law applies, considering the Eq. 2.8 for a pure





This last equation suggests that (under the ideal conditions when the Beer-
Lambert law applies) the absorption index k(ν̃) essentially follows the behaviour of
the measured absorbance spectrum A(ν̃). And particularly, the function k(ν̃) will
have equivalent peaks to the absorption bands in A(ν̃).
Eq.3.14 states that the refraction and the absorption of light are coupled processes
and the absorption of light is always accompanied by changes in the refractive
index [101]. This relationship between n(ν̃) and k(ν̃) is mathematically expressed
by the Kramers-Kronig transforms, which are based on the principle of causality and
connect the real and imaginary parts of many complex quantities in physics [103,165]:

















where n∞ is the average real refractive index and P symbolises the Cauchy principal
value of the integral, which tries to resolve the singularity of the denominator at s = ν̃.
The output of the first Kramer-Kronig transform is termed as nKK for convenience
in later deductions.
As commented before (Eq. 3.16), k(ν̃) will present absorption bands at the
corresponding wavenumbers (resonant wavenumbers) where the molecules of the
sample absorb photons. Consequently, following the Eq. 3.17a, the refractive index
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n(ν̃) changes across the absorption bands in k(ν̃). As an example, Fig. 3.3 shows the
refractive index (Fig. 3.3a) and the absorption index (Fig. 3.3b) for a measurement
of the polymer Poly(methyl methacrylate) (PMMA). As can be seen, the transitions
experimented by n(ν̃) are sharper when the corresponding absorption bands in k(ν̃)
are stronger and narrower. The most representative example of this behaviour is the
absorption band in k(ν̃) associated with the carbonyl stretching bond at ∼1730 cm−1,
which creates a sharp derivarive-like transition in the refractive index n(ν̃) . As
can also be observed, outside the regions containing absorption bands, the refractive
index n(ν̃) is approximately constant. The change of n with the wavenumber is
called dispersion of the refractive index and the sudden change experimented across
an absorption band is normally known as anomalous dispersion [98, 101,165].
RMieS-EMSC algorithm
Bassan et al. [164] merged in 2010 the described phenomenon of anomalous dispersion
with classical Mie scattering theory to create an improved version of the EMSC
algorithm proposed by Kohler et al. in 2008 [160] in order to correct for resonant Mie
scattering. The rest of this section will explain the main ideas behind the RMieS-
EMSC algorithm described in [164].
As already commented, classical Mie scattering assumes a constant refractive index
to compute the broadband baseline oscillations approximated by the curves Qext(ν̃)
(Eq. 3.9) because it was originally formulated for dielectric non-absorbing spheres.
The main novelty suggested in [146] to explain resonant Mie scattering is considering
that the scattering spheres can also absorb light and, therefore, the refractive index
can vary with the wavenumber in order to compute Qext(ν̃). The main problem of this
approach is that the exact curves n(ν̃) and k(ν̃) of a sample are normally unknown
and they must be approximated.
The key step of RMieS-EMSC is computing the evolution of the refractive index
n(ν̃) by means of the first Kramers-Kronig transform. To do so, an ideal reference
spectrum Aref (ν̃), free of scattering artifacts, is used to approximate the absorption
bands within the absorption index k(ν̃), whose actual value is unknown. In fact, in
analogy with Eq. 3.16, k(ν̃) is supposed to be nearly proportional to Aref (ν̃):
k(ν̃) ∝ Aref (ν̃) (3.18)
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(a)
(b)
Fig. 3.3: Spectra of optical indices of PMMA. (a) Real refractive index spectrum n(ν̃).
(b) Absorption index or imaginary refractive index spectrum k(ν̃). Reproduced from [98]
with permission by courtesy of John Wiley & Sons, Inc.
Considering this equation and omitting the 2π factor in Eq. 3.17a, the following
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As the last proportionality is obtained after several approximations, two new
parameters, an and bn, are introduced to estimate the refractive index:
n(ν̃) = an + bn · nKK (3.20)
where an is an approximation of the average real refractive index n∞ and bn is an
amplification factor for nKK , which mainly tries to correct the approximation of k(ν̃)
by Aref (ν̃) in Eq. 3.19. With this definition of n(ν̃), Eq. 3.8 can be modified to
compute the size parameter ρ(ν̃):
ρ(ν̃) = 4πr(an + bn · nKK − 1)ν̃ (3.21)
Following the same multivariate metamodelling defined by Koler et al. [160] to
estimate the particular value of Qext(ν̃), a range of possible values for the model
parameters can be considered in order to compute a set of scattering curves Qext(ν̃)
and create the matrix Q. In this case, instead of two, a total of three parameters
must be explored: r, an and bn. The ranges of values that will be considered here
were suggested by Bassan et al. in another publication [166], where the RMieS-EMSC
algorithm was applied to a small set of synchrotron FTIR spectra taken from fixed
cultured cells of a human prostate adenocarcinoma cell line. These ranges of values,
specially for r (which is supposed to be mainly related to the radii of compact nuclei),
are compatible with the type of cells that will be analysed in this thesis. In particular,
1000 Mie extinction curves Qext(ν̃) can be computed with the permutations of 10
equidistant values in the range r = [2, 8] µm, 10 equidistant values in the range
an = [1.1, 1.5] and 10 equidistant values in the range bn = [0, an−1] (see [164,166] for
further details in the selection of these ranges). This set of 1000 Qext(ν̃) scattering
curves can be approximated (up to 99.9% of explained variance [164]) by the first 7
loadings computed via the non-centred PCA model (Eq. 3.11).
Finally, the RMieS-EMSC algorithm assumes that the measured spectrum A(ν̃) is
a linear combination of a scaled reference spectrum, an offset, a linear baseline (this
term was not considered by Koler et al. [160]), a scattering curve (defined by the PCA
metamodelling) and a spectrum of unmodelled features:
A(ν̃) = b ·Aref (ν̃) + a+ d1 · ν̃ +
7∑
i=1
gi · pi(ν̃) + e(ν̃) (3.22)
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And as in other EMSC models, the coefficients can be estimated by ordinary
or weighted least squares regression and the corrected absorbance spectrum can be
computed as:
Acorr(ν̃) =
A(ν̃)− a− d1 · ν̃ −
∑7
i=1 gi · pi(ν̃)
b
(3.23)
The weakest part of RMieS-EMSC is the selection of a correct reference spectrum
Aref (ν̃) free of scattering to perform the estimation of both n(ν̃) (and consequently
the scattering Qext(ν̃) curves) and the multiplicative parameter b in the final linear
regression model. The main problem is that the perfect reference spectrum would
be the pure absorption spectrum of the sample, which is precisely the ideal output
of the algorithm. The practical solution adopted in [164] is converting the described
method into an iterative process where an approximately correct reference spectrum
is used in the first iteration and the corrected spectrum Acorr(ν̃) for each following
iteration is considered as the reference spectrum of the next iteration.
The pipeline with the main steps of the iterative RMieS-EMSC algorithm is
presented in Fig. 3.4.
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OUTPUT:
𝑨𝒄𝒐𝒓𝒓  𝝂
𝐴  𝜈 = 𝑏 ⋅ 𝐴𝑟𝑒𝑓  𝜈 + 𝑎 + 𝑑1 ⋅  𝜈 + 
𝑖=1
7
𝑔𝑖 ⋅ 𝑝𝑖  𝜈 + 𝑒  𝜈
Resonant Mie Scattering - EMSC
𝑛𝐾𝐾  𝜈
𝑘  𝜈 ∝ 𝐴𝑟𝑒𝑓  𝜈
Next iteration: 𝐴𝑐𝑜𝑟𝑟  𝜈 → 𝐴𝑟𝑒𝑓  𝜈
First
iteration
Fig. 3.4: Pipeline of the RMieS-EMSC algorithm. Adapted from [164] with permission by
courtesy of The Royal Society of Chemistry.
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The selection of the initial reference spectrum Aref (ν̃) has been a great source of
discrepancies in the spectroscopic community [167] mainly because it can potentially
introduce serious chemical deviations from the original spectrum. It has been argued
that this selection is not critical and the corrected solution finally converges for
different reference spectra after a sufficient number of iterations [168]. Nevertheless,
this number of iterations can be very high and in the order of hundreds of
iterations [168]. A spectrum of a thin layer of Matrigel (an artificial basement
membrane consisting mainly of proteins), which does not present fluctuations due to
scattering and whose absorption peaks are similar to biological samples, is normally
used as the initial reference spectrum [164, 166]. Following this practice, Matrigel is
the initial Aref (ν̃) that has been used here in all the applications of RMieS-EMSC.
Examples of corrections by EMSC models
In order to illustrate the outputs obtained by Mie-EMSC [160] and RMieS-
EMSC [164], two spectra corresponding to two different pixels from hyperspectral
images of A-375 skin cells have been selected. As can be observed in the first row
of Fig. 3.5, the selected raw spectra present clear differences although both of them
cover approximately the same range of absorbance values.
The presence of resonant Mie scattering (compare with Fig.2.16) is less pronounced
in the first spectrum (Fig. 3.5a), which only shows a slight depression beyond
the Amide I peak (∼1650 cm−1) and whose characteristic peaks are well defined.
Nevertheless, resonant Mie scattering is much more present in the second spectrum
(Fig.3.5b), which is mainly reflected in a fancier baseline, more distorted peaks and a
stronger derivative-like depression beyond the Amide I peak. Another distinguishing
factor is the presence of random noise, which is higher in the second spectrum and
more pronounced at higher wavenumbers (possibly due to the lower sensitivity of
the detector at those wavenumbers). In addition, a range enclosing the CO2 region
(∼2250-2450 cm−1) has been discarded to avoid additional artifacts.
In the rest of subfigures of Fig. 3.5, the Matrigel reference spectrum has been
plotted for comparison. It can be observed that the Matrigel spectrum presents ideal
characteristics regarding scattering, specially evident in the null absorption region
approximately between 1900 and 2500 cm−1, and the position of its characteristic
peaks are very similar to the raw cell spectra.
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Fig. 3.5: Example of corrections by EMSC models in two different pixels’ spectra (a) and
(b) extracted from hyperspectral images of A-375 skin cells. First row: Raw spectra. Second
row: Matrigel reference spectrum and corrected spectrum by Mie-EMSC [160]. Third row:
Matrigel reference spectrum and spectra corrected by RMieS-EMSC [164] after different
iterations (specified by the subscripts in the legends).
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The results of the spectra corrected by Mie-EMSC can be seen in the second row
of Fig. 3.5. When comparing with the raw spectra, Mie-EMSC seems to decrease
the baseline artifacts in most parts of the wavenumber range. Unfortunately, the
depression beyond the Amide I peak is even accentuated, suggesting a suboptimal
correction or amplification of the resonant Mie scattering artifacts. The implicit
normalisation performed by the model can be appreciated in the change of covered
absorbance values. With respect to the random noise, Mie-EMSC seems to slightly
smooth the spectra.
The outputs for different iterations of RMieS-EMSC are shown in the last row
of Fig. 3.5. As described before, the iterative RMieS-EMSC algorithm considers
the Matrigel spectrum as the initial reference Aref (ν̃) in the first iteration and the
corrected spectrum becomes the Aref (ν̃) in subsequent iterations. This mechanism
gradually makes the corrected spectra more different from the Matrigel spectrum and
hypothetically more similar to the corresponding ideal absorption spectra. Moreover,
the random noise present in the raw spectra is also recovered in increasing iterations.
In view of the represented spectra, the corrected spectra seem to become very stable
after the 10th iteration and no differences can be appreciated between the 20th
and 30th iterations (totally overlapped in the figures). Apart from the commented
characteristics, the most relevant difference between the corrections of Mie-EMSC and
RMieS-EMSC is the better compensation for the derivative-like artifacts supposedly
created by resonant Mie scattering, clearly appreciated in the depression beyond the
Amide I peak.
The stability of the iterative RMieS-EMSC algorithm and the increasing presence
of the random noise with the number of iterations have been further studied in a
dataset of 300 skin cell spectra. Fig. 3.6a displays the 300 raw spectra extracted
from pixels of hyperspectral images of four different cell lines (A-375, HaCaT,
NIH-3T3, SK-MEL-28). All those pixels contained different regions of cellular
material and were randomly selected so that each cell line was equally represented (i.e.,
75 spectra/cell line). The heterogeneity introduced by the physical phenomena can
be clearly appreciated in the variations of offsets, baselines and ranges of absorbance
values in the raw spectra. The 300 corrected spectra after 30 iterations of RMieS-
EMSC are shown in Fig.3.6b. It can be observed that the corrected spectra are much
more similar between them and the remaining variability is supposed to be mainly
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governed by the chemical contributions and the unmodelled effects, which include the
random noise. This random noise is more evident in the spectra with lower signal
levels after the normalisation, which amplifies the absorbance values equally in the
whole range of wavenumbers.
wavelength (µm)
10 9 8 7 6 5 4 3 
wavenumber (cm-1)
















10 9 8 7 6 5 4 3 
wavenumber (cm-1)









































Fig. 3.6: Example of corrections by the RMieS-EMSC algorithm in a small dataset of 300
pixels’ spectra from hyperspectral images of four types of skin cells (A-375, HaCaT, NIH-3T3,
SK-MEL-28). (a) Raw spectra. (b) Spectra corrected by RMieS-EMSC after 30 iterations.
Error bars (mean values symbolised by a circle and standard deviation by bars) for different
iterations of RMieS-EMSC of (c) Root-Mean-Square Error (RMSE) and (d) Signal-to-Noise
Ratio (SNR).
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The stability of RMieS-EMSC has been quantified by the Root-Mean-Square Error
(RMSE), which basically accounts for the differences between the corrected spectra
at a specific iteration and at the previous iteration. That is, for a generic iteration j,










where N here indicates the total number of discrete wavenumbers measured in the
absorbance spectra. The values of RMSE were computed for all the iterations of the
300 spectra of the selected dataset. The obtained results are summarised in terms of
the mean and the standard deviation with the error bars depicted in Fig.3.6c. As can
be seen, the mean value of RMSE gradually decreases with the number of iterations,
being lower than 10−3 from the 8th iteration. In addition, the standard deviation
also diminishes with the number of iterations, denoting a stabilisation even for the
most problematic spectra from around 20 iterations.
The level of random noise can be assessed in the corrected spectra after each
iteration by computing the Signal-to-Noise Ratio (SNR) with the methodology
explained in section Sec. 3.2.2. Similarly to RMSE, the values of SNR for the
300 selected spectra are summarised in terms of mean and standard deviation in
Fig. 3.6d. As was already observed in the individual spectra of Fig. 3.5, the presence
of random noise is lower after the first iteration giving the highest SNR. In this
case, the mean and standard deviation values of SNR become approximately steady
after around 4 iterations, suggesting that the random noise is quickly recovered. It
must be highlighted the high dispersion existing in the SNR values, mainly caused
by the relevant differences in the signal measured at different regions of the cell. In
particular, pixels containing only cytoplasm generate lower absorbance values than
pixels containing nuclear regions and have lower values of SNR. Finally, it can be seen
that the SNR is slightly higher in the corrected spectra than in the raw spectra.
Comments and limitations of RMieS-EMSC
Some comments should be made regarding the RMieS-EMSC algorithm:
 The selection of the number of iterations is not a trivial task. On the one
hand, the more iterations, the closer the corrected spectrum should be to the
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ideal absorption spectrum. On the other hand, the computational cost can be
prohibitive for real practical solutions, specially with FTIR images containing
thousands of spectra. As a reference, the current implementation of the RMieS-
EMSC algorithm takes around 1-2 seconds per iteration and per spectra in
an average up-to-date computer. It has been argued that few iterations (<10)
could be enough for classification purposes, at least for histological images [168],
although a reliable interpretation of the biochemical information would require
more iterations. As has been shown here in a small dataset of 300 skin cell
spectra, most corrected spectra seem to converge from the 10th iteration, but
more stable solutions are obtained with 20 iterations.
 The noise in the measurements can be amplified in the corrected spectra with
poorer SNR due to the intermediate computations of the method, specially in
the Kramer-Kronig transform [166]. For example, when the corrected spectrum
is used as a reference in the second and successive iterations, the water vapour
peaks and the random noise of the detector can mislead the estimation of the
scattering curves, which are supposed to be affected only by the absorbance
of the sample. These problems may be minimised in practice in synchrotron
measurements, where ideal measurement conditions are highly controlled. In
fact, all the algorithms described so far to correct scattering in FTIR spectra
were mainly supported by measurements performed in synchrotron facilities.
Nevertheless, in a common laboratory of biospectroscopy, the measurement
conditions may experiment fluctuations that may be more critical for some final
applications, such as the analysis of single cells.
 Its effectiveness has mainly been demonstrated in polymeric (PMMA)
spheres [146]; in simulated spectra of cells with resonant Mie scattering ar-
tifacts, which were artificially introduced [164]; and reduced dataset of cells,
mostly measured with synchrotron microspectroscopes [166]. In addition, this
effectiveness has only been supported by qualitative or visual graphics, such as
representations of the corrected spectra and PCA score plots.
 Despite the relatively complex formulations considered by RMieS-EMSC, it
still assumes severe simplifications, e.g., in the Mie scattering theory or
in the computation of the real refractive index. In the last years, more
advanced theoretical background has been formulated to cope with the physical
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phenomena in FTIR microspectroscopy [169, 170]. Even very recently a
revised and faster version of RMieS-EMSC, which seems to incorporate
some improvements (still to demonstrate), has been described [171, 172].
Unfortunately, no practical implementations of these improved methodologies
were available during the development of this thesis.
Despite all these limitations, the RMieS-EMSC algorithm described here is the
most advanced practical implementation currently available and has been used as the
reference preprocessing method in the applications involving single cells.
3.2.2 Filtering methods
As previously commented, filtering methods are simpler techniques than model-
based methods which transform the spectra with the aim of discarding the unwanted
information and retaining or enhancing the useful information. The main filtering
techniques that were used in this thesis are: smoothing or denoising, baseline
correction, differentiation and normalisation.
Smoothing/Denoising
Smoothing filters basically try to reduce the presence of random noise in the spectrum.
The main challenge is to remove this noise without degrading the underlying
information within the signal. By far, the most used smoothing filter in spectroscopy
is the Savitzky-Golay (SG) filter [173]. This filter works by moving a sliding window
which is sequentially centred in each point of the spectrum and spans a specified
number of points. The absorbance values of those points are used to fit a polynomial
by least squares (computed with convolution functions previously calculated) and the
absorbance value of the central point is substituted by its corresponding value in the
polynomial.
Two parameters must be defined in Savitzky-Golay (SG) filters: the order of the
fitting polynomial and the points that define the size of the sliding window. The least
squares fitting is normally performed with a 2nd or 3rd order polynomial to avoid
excessive distortions. The number of points must be odd and has a major impact in
the final solution. Fig. 3.7a illustrates the influence of the points used in the sliding
window when using a SG filter with 2nd order fitting polynomial to smooth a skin
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cell spectrum. As can be observed, the higher the number of points, the more high
frequency random noise is removed. However, the characteristic peaks also lose more
details and become more distorted. This smoothing procedure was applied to the
small dataset of 300 raw spectra that were plotted in Fig.3.6a and their corresponding
SNRs were computed. Fig. 3.7b summarises the variations of SNR with the number
of points of the sliding window in terms of the mean and standard deviation. As
expected, the SNR gradually increases with the number of fitting points, but this
increment is not homogeneous as demonstrated by the simultaneous growth of the
standard deviation.
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Fig. 3.7: Example of smoothing by Savitzky-Golay filtering with a 2nd order fitting
polynomial and different window sizes (points). (a) Raw and smoothed spectra of a single
pixel from a skin cell. Artificial offsets have been added for clarity. (b) Error bars (mean
values symbolised by a circle and standard deviation by bars) of the Signal-to-Noise Ratio
(SNR) of the raw and smoothed spectra of Fig. 3.6a.
Smoothing must be applied with extreme caution. Moderate smoothing does not
have a relevant influence but excessive smoothing can introduce critical artifacts. In
general, smoothing provides only an aesthetic improvement in the visualization of
spectra although it is sometimes used to reduce noise in the generation of 2D images
from the hyperspectral data cube (e.g., Sec. 4.2.3). As an alternative, in quantitative
analysis the huge information contained in the multidimensional spectra can be used
to discard the influence of random noise by means of multivariate techniques, e.g.,
PCA (Sec. 3.3.1).
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Signal-to-noise ratio
Signal-to-Noise Ratio (SNR) is the variable commonly used to assess the quality of






Nevertheless, there is not a general consensus about the specific features of the
spectrum which must be considered as Signal and Noise, giving rise to different
practical implementations of the SNR in spectroscopy [99,174–176]. Fig. 3.8 sketches
the elements used in this thesis to compute the SNR of individual spectra:
 Signal : following the general trend, it is chosen as the amplitude of the strongest
peak in the spectrum, that is the Amide I peak. This amplitude is computed
with respect to the absorbance minimum inside a range of wavenumbers
enclosing the Amide I peak (1480-1780 cm−1).
 Noise: this is the greatest source of discrepancies. As a rule, it must be
computed in a region without absorption bands so that only random noise
should be present. Here, the noise is computed as the root-mean-square
level (rms) in the region 1950-2150 cm−1, where no absorption peaks should
exist. However, as shown in Fig. 3.8, the presence of other types of artifacts
that generate complex baselines, such as Mie scattering, can mislead the
contributions of noise. Therefore, a broad baseline (computed with an aggressive
SG smoothing filter of 51 points) is removed from that spectral region before
calculating the rms.
Baseline correction
As was described in Sec. 3.2.1, spectral baselines can be distorted due to different
physical contributions, such as scattering, changes in measurement conditions or other
instrumental factors. The complexity of the baseline distortions can be high, such
as in cell samples affected by strong Mie scattering. In those cases, model-based
techniques may be the proper solution to remove baseline artifacts. Nevertheless, in
applications where those baseline distortions are not critical, simpler techniques may





















Fig. 3.8: Sketch of the elements used to compute the Signal-to-Noise Ratio (SNR).
provide acceptable results. Different baseline correction methods can be applied in
FTIR spectra [153], but two methods have been mainly applied in this thesis are:
 Offset correction: it is the simplest baseline correction method. It consists
in subtracting a constant value of absorbance (i.e., an horizontal line) to the
whole spectrum. The subtracted value is normally the minimum or the mean
absorbance value of the spectrum. This method is equivalent to estimate and
subtract the parameter a in EMSC models (Sec. 3.2.1).
 Rubberband baseline correction: it consists in automatically finding a convex
polygonal line which does not intersect the spectrum and whose edges are
relative minima within the spectrum [177]. Although being automatic is the
main advantage of this method, it can introduce severe artifacts specially in
spectra with complex baselines, such as cell spectra.
Fig. 3.9 illustrates the offset and baseline estimated by the previous methods in
a raw cell spectrum cropped to the fingerprint region and the resulting corrected
spectra after their removal. As can be observed, the relative heights of characteristic
peaks slightly change with the rubberband method, but these distortions may be
higher in cases with more complex baselines. Finally, as was sketched in Fig. 3.8, SG
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smoothing filter with a high number of fitting points can also be used to estimate a
broad baseline, but its use is merely restricted to regions without broad absorption
peaks that can interfere with the baseline estimation.
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Fig. 3.9: Example of baseline correction methods.
Differentiation
Derivative filters are widely used in spectroscopy to enhance spectral features and
identify overlapping absorption bands in complex spectral profiles [153, 177–179]. In
addition, derivative filters reduce baseline artifacts: first differentiation removes an
additive offset, meanwhile second differentiation also removes a linear baseline.
The main drawback of differentiation is the simultaneous enhancement of noise
and the consequent degradation of the SNR. Not only random noise can be enhanced,
uncompensated absorption bands from water vapour will also be enhanced by the
derivative filters [138]. In order to slightly alleviate this problem, a version of
Savitzky-Golay filters exists to compute the derivatives by least squares fitting of
a polynomial [173]. In fact, SG differentiation is normally the default technique to
compute derivatives in spectroscopy.
As an example, Fig. 3.10 shows the outputs after applying the 1st (DiffSG1) and
2nd (DiffSG2) order differentiation by SG filters with different window sizes (points)
to a raw spectrum of skin cell. The spectral information contained in the absorption
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peaks of the original spectrum augments with derivative filters, as can be seen with the
increase of the number of spectral peaks. However, noise also grows, specially at higher
wavenumbers, and almost completely hides the signal in the 2nd order differentiation.
The noise is reduced with higher numbers of fitting polynomial points, but the useful
signal is also distorted. Traditionally, 2nd order differentiation has been preferred
over 1st order derivatives, but its use may be detrimental in applications involving
low-SNR spectra.
Normalisation
According to the Beer-Lambert law (Eqs. 2.8 and 2.9), the absorption spectra depend
on the thickness (optical path length) and concentration of the sample. Depending on
the application, this information may be useful whereas it can mislead the analyses
that focus on the biochemical information. In the last cases, several normalisation
methods exist that mitigate the influence of the sample thickness and concentration,
which are individually applied to each pixel’s absorbance spectrum:
 Min-Max normalisation: it consists in firstly subtracting the minimum
absorbance value of the spectrum (similar to the simple offset correction) and
then dividing the whole spectrum by the maximum absorbance. In cases where
the spectrum is cropped to the fingerprint, this maximum value is normally
the Amide I peak. It is the simplest normalisation method but it may provide
acceptable results in situations where the scattering phenomena are not critical.
 Standard Normal Variate: the mean absorbance value is subtracted from the
whole spectrum and the resulting spectrum is divided by the standard deviation
of the whole absorbance spectrum. Originally applied in 1989 to remove
the multiplicative interferences of scatter and particle size in near-IR diffuse
reflectance spectra [180], this approach has been historically used in different
spectroscopic problems to reduce scattering effects.
 Vector normalisation: the whole absorbance spectrum is divided or scaled by its
Euclidean or L2 norm. In some cases, the mean absorbance value of the whole
spectrum is previously subtracted [153]. This type of normalisation is normally
used after differentiation [177].
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Fig. 3.10: Example of spectral differentiation. Top subfigure: raw spectrum of a skin
cell (A-375). Middle and bottom subfigure: 1st and 2nd order differentiation by Savitzky-
Golay (SG) filtering with a 2nd order fitting polynomial and different window sizes (points)
specified in the legends. Artificial offsets have been added for clarity.
The importance of normalisation can be better understood with the two raw
spectra from pixels containing structures of the same skin cell line (HaCaT) presented
in Fig. 3.11. The first impression is that each spectrum spans along different ranges
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of absorbance values and that there is an offset between them. In spite of that, both
spectra seem to have similar shape (characteristic peaks) but at different scale.
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Fig. 3.11: Example of raw spectra from pixels containing structures of the same skin cell
line (HaCaT), which are normalised in Fig. 3.12.
The coarse differences observed in the raw spectra of Fig. 3.11 are presumably
caused by variations in thickness and concentration of the biological material
within the areas covered by the pixels. Fig. 3.12 depicts the same spectra of
Fig.3.11 after applying the normalisation methods described above, together with the
resulting corrected spectra after 30 iterations of RMieS-EMSC, which also performs
a normalisation of the spectra. As can be observed, the normalised spectra are much
more similar, presenting almost the same spectral features and mainly differing in
random noise content. In spite of that, the results of the normalisation methods
differ even in this simple example without relevant distortions due to scattering and
other complex perturbations.
3.3 Feature extraction
Chemometrics [174, 181–183] is an interdisciplinary field that includes all those
methods related to the mathematical manipulation and interpretation of chemical
data [182], which are normally characterised by having multiple variables. Chemo-
metrics shares many techniques with other disciplines, such as pattern recogni-
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Fig. 3.12: Example of spectral normalisations of the raw spectra shown in Fig.3.11. (a) Min-
Max normalisation. (b) 2nd order differentiation by Savitzky-Golay (SG) filter (2nd order
polynomial and 19 fitting points) and vector normalisation. (c) Standard Normal Variate
(SNV). (d) RMieS-EMSC after 30 iterations.
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tion [184, 185], machine learning [186] or data mining [187]. Nevertheless, chemo-
metric methodologies are specially oriented toward the analysis of data with multiple
variables, normally called multivariate data.
As FTIR spectra are multivariate data structures with hundreds or even thousands
of variables (i.e., the measured absorbance values at different wavenumbers), they
have been traditionally treated by chemometric methods associated with multivariate
analysis. Among these methodologies, feature extraction techniques have special
relevance. They treat to extract the most relevant characteristics within the huge
loads of information contained in the FTIR spectra. Two of the most important
feature extraction techniques in chemometrics have been used during the development
of this thesis: Principal Component Analysis (PCA) and Partial Least Squares (PLS).
3.3.1 Principal component analysis
Principal Component Analysis (PCA) [188–190] is the most widespread technique in
multivariate analysis. Multivariate data consist of a large number of variables which
are normally highly correlated, giving rise to a huge amount of redundant information.
The main aim of PCA is to reduce the dimensionality of multivariate datasets while
retaining as much of their variation as possible.
PCA looks for a linear transformation of the initial variables so that the new
variables, called Principal Components (PCs), are aligned with the directions of
maximum variation of the data. This new set of variables has two distinguishing
characteristics: they are uncorrelated and they are ordered in terms of explained
variance. Mathematically, the original multivariate dataset, which consists of I
samples or objects (e.g., spectra) with J variables (e.g., absorbance values at
specific wavenumbers), can be used to construct the original data matrix X. The
transformation computed by PCA can be expressed as follows:
X = T ·PT + E (3.26)
where T is the matrix of scores, P is the matrix of loadings, the superscript T indicates
transpose and E is the residual matrix. The corresponding dimensions of the matrices
involved in this relationship are sketched in Fig. 3.13.







































Data Scores Loadings Residuals
Fig. 3.13: Sketch of the matrices involved in the decomposition by PCA.
Each row of the matrix T contains the scores of each sample or object of the
dataset. These scores are the coordinates of that object in the new space of K PCs.
Each column of P (note the transpose in Eq. 3.26) corresponds to the loadings or
eigenvectors of the new space of PCs. These eigenvectors form a basis of the new
vector space of PCs. The number of computed PCs, K, is a parameter that must be
selected and is limited by the minimum dimension of the original data matrix X. That
is, K ≤ {I, J}. Depending on the selected K, the original dataset is approximated
up to certain degree of intrinsic variation by the product T ·PT and the errors of this
approximation are accumulated in the residual matrix E.
In order to compute this transformation, the following steps are normally applied:
1. Translation of the origin of the initial axes to the mean point of the dataset.
This step, normally called mean-centring, is not a requirement but it is often
applied because it removes offset effects [191]. When it is not applied, the global
method is called non-centred PCA. Unless explicitly stated, mean-centring will
be applied when performing PCA.
2. Computation of the eigenvalues of the covariance matrix of the dataset. The
sum of all these eigenvalues accounts for the total variance within the dataset.
The magnitude of each eigenvalue is related to the explained variance along a
specific direction in the centred space.
3. Sorting of the computed eigenvalues in decreasing order so that the first
eigenvalues explain the highest variance in the data.
4. Calculation of the eigenvectors corresponding to each ordered eigenvalue in a
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sequential way so that they form an orthonormal basis capable of generating a
vector subspace within the original vector space.
5. Finally, the scores are computed as the projections of the variables in the original
space into the new subspace of eigenvectors.
The result of the PCA process is sketched in Fig. 3.14. In this figure, an artificial
two-dimensional dataset (blue stars) defined by the variables (x1, x2) is used to
compute the new variables or principal components (PC1,PC2), which are centred in
the mean point of the whole dataset (x1, x2). As can be observed, in the new feature
space the first axis PC1 is aligned with the direction of highest variation or dispersion









Fig. 3.14: Sketch of the Principal Component Analysis (PCA) transformation for a
hypothetical two-dimensional dataset.
The applications of PCA include the reduction of dimensionality, denoising and
the detection of outliers.
Dimensionality reduction
As described above, when the first PCs are retained and the rest are discarded, a new
feature space of lower dimensionality is obtained, which keeps the main information
(in terms of variation) of the original dataset. The level of kept information is
determined by the percentage of cumulative explained variance, which is related to
the corresponding eigenvalues of the retained components.
The benefits of dimensionality reduction include, for instance, the visualisation
of the data, the simplification of the modelling and later analysis of the dataset or
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the compression of the data. Among these applications, the visualisation of high-
dimensional data in 2D or 3D spaces has special interest to perform an exploratory
analysis of the intrinsic structure of the dataset. The information obtained with the
exploratory analysis can be very valuable as a complement or as a guide for the later
processing and analysis.
As an example, the dataset of 300 pixels’ spectra of four types of skin cells
that was presented in Fig. 3.6 has been decomposed by PCA. Fig. 3.15 shows the
main results both for the raw spectra and the spectra corrected by RMieS-EMSC
after 30 iterations. The score plots of the two first PCs (Figs. 3.15a and 3.15d)
allow to appreciate an approximation of the proximity of the spectra in the original
multidimensional space. Attending to the colours of the score plots, the spectra
belonging to the same cell type tend to form more clear groups or clusters in the
raw spectra, meanwhile there is a higher spread when they are corrected by RMieS-
EMSC. This behaviour suggests that the initial differences between cell lines in the raw
spectra may be mainly driven by physical effects, which are mostly removed during
the preprocessing by RMieS-EMSC. It must be highlighted that the information of
the cell types (labels) has only been used a posteriori to colour the points of each
spectrum but not during the processing by PCA (see Sec. 3.3.2).
The plots of the loadings or eigenvectors (Figs. 3.15b and 3.15e) give information
about the relative weights that each measured wavenumber has in the corresponding
PC. Hence, they inform of the relative importance of each absorption band in
the existing variations within the dataset. For instance, the two first PCs in the
raw spectra (Fig. 3.15b), give higher weights to the Amide I (∼1650 cm−1) and
Amide II (∼1550 cm−1) peaks. The loadings of the spectra corrected by RMieS-
EMSC (Fig.3.15e) also assign higher weights to the regions around the Amide I peak,
but the position of the maximum weight is slightly shifted depending on the PC. This
behaviour warns about suboptimal corrections of resonant Mie scattering, which is
supposed to be the main responsible for the position shifts of the strongest absorption
peaks (Sec. 3.2.1).
The evolution of the cumulative explained variance with the number of retained
PCs (Figs. 3.15c and 3.15f) also gives important information regarding the complexity
of the relationships between the spectra of the datasets. In this case, there is a clear
difference between the raw and the corrected datasets. Meanwhile in the raw spectra
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Fig. 3.15: Example of dimensionality reduction and visualisation by PCA of the dataset
of skin cell spectra that was presented in Fig. 3.6, both for raw spectra (upper row) and
spectra corrected by RMieS-EMSC after 30 iterations (bottom row). (a),(d) Score plots of
the two first PCs with the corresponding percentage of explained variance in parentheses.
Colours indicate the specific cell type corresponding to each spectrum. (b),(e) Loadings or
eigenvectors of the 4 first PCs with the corresponding percentage of explained variance in
parentheses. (c),(f) Evolution of the cumulative explained variance for the first 25 PCs.
the two first PCs accounts for more than 98% of the total variance, in the corrected
spectra the 95% of explained variance is not reached even retaining the first 25 PCs
and the two first PCs roughly explain 50% of the total variance. This difference, for
instance, has two consequences:
 Simpler models can be constructed for the raw spectra because most of the
information can be condensed by fewer PCs.
 The score plot of the raw spectra (Fig.3.15a) provides more reliable and further
information of the intrinsic structure of the multidimensional dataset than the
spectra corrected by RMieS-EMSC (Fig. 3.15d).
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Denoising
Another application or consequence of PCA is the reduction of noise when the
data are approximated by the first PCs. This is because the first PCs are mainly
associated with genuine variations within the dataset, whereas the last PCs just
measure uncorrelated noise [189,192]. Nevertheless, the number of components from
which the explained variation is essentially noise depends on the specific problem or
dataset. In a practical way, PCA is normally used as an indirect denoising method,
rather than an explicit smoothing methodology. It is important to realise that with
this methodology the amount of random noise present in an individual spectrum is
reduced by using the total information provided by all the spectra from the dataset.
In contrast, common filtering methods only use the information of individual spectra.
In order to illustrate the denoising functionality of PCA, Fig. 3.16a displays the
spectra obtained when different numbers of PCs are retained for the same spectrum,
which belongs to the dataset of 300 spectra corrected by RMieS-EMSC that was
presented in Fig.3.6b. As can be observed, the reconstructed spectra do not show the
high-frequency fluctuations present in the original spectrum even when 20 PCs are
kept. In addition, Fig. 3.16b shows the error bars of the SNR for different numbers of
retained PCs after applying PCA to the aforementioned dataset of 300 spectra. The
reduction of SNR with the number of PCs again demonstrates the increase of noise
content when more PCs are retained.
Detection of outliers
There is no clear definition of outliers. In general, outliers are samples that are
somehow anomalous or unusual. However, outliers do not necessarily mean wrong
samples, but they may belong to sub-populations that are not sufficiently represented
in the studied dataset [174, 190]. What to do with the outliers depends on the
application, but having a way to automatically detect such anomalous samples is
very useful.
The ambiguous definition of outliers is coupled with the lack of a universal method
for their detection. Here, the Mahalanobis distance is employed as a tool to assess
how far each object or spectrum is from the centre of the reduced space of PCs.
Mahalanobis distance [193,194] is a distance widely used in multivariate analysis that






























Fig. 3.16: Example of spectral smoothing or denoising by PCA. (a) Original and
reconstructed spectra of the same spectrum after retaining the number of PCs specified
in the legend. Artificial offsets have been added for clarity. (b) Error bars (mean values
symbolised by a circle and standard deviation by bars) of the Signal-to-Noise Ratio (SNR)
of the original and reconstructed spectra after applying PCA to the dataset of 300 spectra
corrected by RMieS-EMSC that was presented in Fig. 3.6b.
takes into account the intrinsic variations of the dataset by applying a normalisation
with the covariance matrix S. Formally, the Mahalanobis distance is defined as:
dMah(xi) =
√
(xi − x)S−1(xi − x)T (3.27)
where xi is the coordinate vector of the specific object (e.g., the vector of scores), x is
the vector of the mean point of the dataset (in the case of centred PCA it is the zero
vector) and S is the covariance matrix of the dataset. As the PCs are uncorrelated,
S is a diagonal matrix whose values are the eigenvalues of each PC.
Once computed the values of dMah for all spectra, the highest values will be
associated with extreme samples. Again, the number of PCs used to construct the
reduced space also has influence in the value of dMah. Fig.3.17 treats to illustrate the
procedure and results of the detection of outliers when retaining 2 and 25 PCs in the
dataset of 300 spectra corrected by RMieS-EMSC that was presented in Fig. 3.6b.
Fig. 3.17a shows the box plots of the values of the Mahalanobis distance for the
whole dataset when retaining 2 and 25 PCs. In these box plots, whiskers extend to the
most extreme data point that is no more than 1.5 times the Interquartile Range (IQR)
from the edge of the box. All the values outside the whiskers’ range are considered
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Fig. 3.17: Example of outlier detection by PCA and Mahalanobis distance in the dataset
of 300 spectra corrected by RMieS-EMSC that was presented in Fig. 3.6b. (a) Box plot
of the Mahalanobis distance when retaining 2 and 25 PCs (outliers are symbolised by red
plus signs). Score plots of the two first PCs with the outliers marked by red squares when
retaining 2 PCs(b) and 25 PCs (c). The points of each score plot are coloured according to
the corresponding colour bar of Mahalanobis distance values.
as outliers and are symbolised by red plus signs. The corresponding points designed
as outliers in the box plots can be identified (red squares) in the score plots of the
first two PCs. When 2 PCs are retained to find the outliers (Fig. 3.17b), the points
marked as outliers are approximately located outside an elliptical region centred in
the origin of the reduced space of two PCs. However, the position of the outliers is
not so evident when 25 PCs are retained to detect the outliers (Fig. 3.17c) and even
some of them are surprisingly close to the centre of the reduced space of two PCs.
In this dataset, the last option for detecting outliers when 25 PCs are retained seems
more logical as they account for a higher level of explained variance (Fig. 3.15f).
3.3.2 Partial least squares
Partial Least Squares (PLS) is another methodology very popular in the chemometric
field [174, 181, 183]. Whilst PCA is an unsupervised method of dimensionality
reduction, as it only takes into account the information contained in the data matrix
X, Partial Least Squares (PLS) can be considered as a supervised methodology. That
is because it also uses the information of the response vector y to compute a reduced
space of components, also referred to as latent variables, from the original input
variables. This is performed by defining the latent variables through the covariance
between the response and the input variables [195].
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PLS essentially tries to relate two types of variables: the measurements or
independent variables contained in the data matrix X and the response or dependent
variable y. This is performed by linearly decomposing those variables in a similar
way as in PCA:
X = T ·PT + E (3.28a)
y = T · qT + f (3.28b)
where the first equation has the same form as Eq. 3.26 (but the values obtained by
PLS are different), and q and f are respectively analogue to a vector of loadings and
a vector of residuals for the response vector y. Note that the vector of scores T is the
same in both decompositions of variables X and y. The matrices involved in Eq.3.28a
have the same structure that was sketched in Fig. 3.13, meanwhile the matrices and







































Response Scores Loadings Residuals
Fig. 3.18: Sketch of the matrices and vectors involved in the decomposition of the response
vector by PLS.
Several algorithms exist in the literature to compute the described decomposition
by PLS. Here, a variant of the algorithm called PLS1 [181,183] is applied to establish a
relationship between both types of variables (X and y). PLS1 is an iterative algorithm
where the desired number of PLS components K are computed in each iteration. Each
iteration of PLS1 consists of the following steps:
1. Compute the weight vector w of the current PLS component:
w = XT · y (3.29a)
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3. Compute the vector of loadings of data (corresponding column of the matrix P)





4. Compute the loading of the response (corresponding scalar element of the vector





5. Calculate the residuals of the data matrix Xres and the response vector yres by
subtracting the effect of the current PLS component:
Xres = X− t · pT (3.29e)
yres = y − t · q (3.29f)
6. If more PLS components are needed, X and y are respectively replaced by Xres
and yres and the process is repeated from step 1.
In the above equations, ‖·‖ symbolises the Euclidean norm of a vector. In PLS1
algorithm, the computed scores T are orthogonal (as in PCA), but the loadings P are
neither orthogonal nor normalised. Moreover, an additional matrix W of dimensions
J ×K, whose columns correspond to the weight vectors w of each iteration, is also
obtained.
Originally, the PLS method was designed for regression problems, that is, those
cases where the response vector y is a continuous variable [196]. Nevertheless,
it has been successfully adapted to classification and discrimination applications,
where it is normally called PLS-Discriminant Analysis (DA) (Sec. 5.2.8). Indeed, in
discrimination problems with high number of correlated variables (e.g., FTIR data)
where dimensionality reduction is needed, PLS normally outperforms PCA. This is
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because unsupervised PCA basically computes the new reduced space of variables
based on the gross variability of the dataset but it is not capable of distinguishing
among-groups and within-groups variability [197]. Nevertheless, PCA is an important
preliminary step of purely discriminative algorithms, which otherwise would have a
poor performance with high-dimensional multivariate data.
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4.1 Introduction
In this chapter, the first application of this thesis, aimed at improving the diagnosis of
histopathological samples, will be thoroughly described. It consists of an automated
framework to spatially align different sections of tissue measured by two distinct
imaging modalities: FTIR microspectroscopic imaging and conventional optical
microscopy. In addition, the usefulness of its development and application will be
supported by data that demonstrate the improvement in classification accuracy of
different pathological states of colorectal cancer when it is combined with other
approaches to extract information from the tissue.
As was described in Sec.1.1.6, the final diagnosis of colorectal cancer is performed
by expert pathologists, who examine histological sections extracted from suspicious
biopsies acquired during colonoscopy. These slices of tissue are commonly stained
with H&E to colour the tissue structures (nuclei in blue or purple, cytoplasm and
connective tissue in pink) and observed with an optical microscope illuminated
with visible light. However, this assessment is still done in a qualitative manner,
relying heavily on the judgement and experience of the pathologist. Indeed,
several studies [74, 75] have revealed a suboptimal inter-observer variability in the
differentiation and reporting of colorectal polyps, suggesting that more objective
criteria should be applied for risk stratification in screening and surveillance
guidelines.
FTIR images are information-rich data structures that can be analysed, alone or
together with other imaging modalities, to provide objective pathological diagnoses.
In order to develop new diagnostic algorithms, the different regions of tissue should be
correctly labelled and must spatially match between images of distinct modalities. As
commented, the H&E stained samples are the gold standard where the pathologists
can distinguish and label different anatomical and pathological structures within the
tissue. Therefore, H&E images may be the most interesting imaging modality to be
fused with FTIR images. However, the H&E stain irreversibly changes the chemical
composition of the tissue and introduces confounding artifacts in the FTIR spectra
[198]. In some cases, the tissue is measured by FTIR spectroscopy before applying
the H&E stain. Nevertheless, this option is technically challenging and it impedes
performing posterior FTIR measurements and retrospective studies. Therefore, a
common solution is to measure different slices of tissue with each imaging modality.
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4.1.1 Objective
The main objective of this application is to establish a methodology where the
two types of images (H&E and FTIR) from different tissue sections are aligned or
registered. The aim of this alignment is to compute the spatial transformation that
communicates the coordinate systems of the two images. This transformation makes
possible to translate or fuse the spatial information contained within each imaging
modality. In particular, the position and auxiliary information (e.g. pathological
labels) of different regions of interest, identified by an expert pathologist in the
H&E images, can be transferred to the FTIR coordinates with the calculated spatial
transformation. In doing so, objective diagnostic algorithms may be created in future
studies by employing the fused pixels’ information from each imaging modality.
The developed registration method must be robust against the different sources
of variability intrinsic to the problem (Sec. 4.1.2). Therefore, another important
objective is to assess the robustness and effectiveness of the proposed methodology in
a real-world dataset.
4.1.2 Problem overview
Fig. 4.1 outlines the problem faced in this application. Different histological sections
are extracted with a microtome from a colon biopsy that has been chemically treated
and fixed in a paraffin block for preservation purposes. Some sections follow the
H&E staining process and one of them is carried to an optical microscope to take
Red-Green-Blue (RGB) images in the visible spectrum range. This colour image is
composed of three channels (red, green and blue) so that a three-valued intensity
vector is associated with each pixel.
Another section is directly analysed by means of FTIR spectroscopy without any
further chemical processing. In the ideal case, this last section would be adjacent to
the one used in the optical microscope. However, this ideal case cannot be guaranteed
in clinical routine due to problems in the handling and cutting of the biopsy sample.
FTIR sensors can measure a large quantity of wavelengths in the near and mid-IR
range, providing hyperspectral images that may have hundreds or even thousands
of channels. As can be seen in Fig. 4.1, FTIR images are three-dimensional data
structures with two spatial dimensions (x,y) that define the position of each pixel and
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Fig. 4.1: Registration problem overview. Several histological sections are extracted from
a paraffin-fixed colon biopsy. One of the sections is stained with H&E and analysed with
an optical microscope to take a three-channel RGB image. A different section is directly
measured with a FTIR spectrometer to obtain a hyperspectral image, where each pixel has
an associated spectrum of hundreds or thousands of channels.
each pixel has an associated absorption spectrum that represents the overall chemical
composition of a tissue portion of several squared microns.
The variability between the images of both modalities can be divided into four
main sources:
 Intensity values: due to the distinct range of wavelengths covered by each image
detector. Finding a correct relationship between intensities of corresponding
pixels is one of the challenges of this multimodal problem.
 Pixel size: owing to the characteristics of the optics and the detectors. This can
be solved by applying a proper scaling if the exact resolutions in both images
are known or by introducing a scaling factor in the spatial transformations.
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 Coarse spatial differences: because each image device has its own spatial
reference. Therefore, large differences in spatial positions and orientation may
exist between corresponding anatomical structures.
 Local spatial differences: as a consequence of not using the same tissue
sections. These dissimilarities may be divided into anatomical differences
naturally present in the tissue and local deformations introduced by the physical
manipulation, such as cutting with the microtome. If the sections are not
adjacent, these local differences are further exaggerated.
The process of finding the alignment between images acquired with different types
of sensors and matching their spatial references is called multimodal registration.
Classical reviews of image registration can be found in [199–202] and a recent
comprehensive overview in [203, 204], where the most recent advances in this field
are described as well as the techniques applied to medical images. In the problem
addressed in this paper, the use of images from different modalities along with the
fact that they come from different sections of tissue complicate this task.
4.1.3 Related work
Many approaches exist to deal with the problem of multimodal registration, mainly
because the decisions made in each step of the process depend on the application
and on the characteristics of the involved images. To the author’s knowledge, only
two recent studies [205,206] tackle the problem of registering H&E and FTIR images.
Nevertheless, in both of them the same histological sections were firstly measured by
FTIR spectroscopy and later stained with H&E to be analysed by optical microscopy.
In [205], the images were taken from Tissue Microarrays (TMAs) of prostate cancer
and converted into binary form by trying to separate the pixels that contained tissue
from the background. As stated in [205], this binarisation bypasses the multimodal
problem because the only reliable features to establish a spatial correspondence
between these kinds of images are macroscopic sample shapes and empty spaces
(glandular lumens and breaks) inside the tissue.
A more general problem is treated in [206], where images of small regions of tissue
obtained using FTIR or other spectroscopic modalities are registered with whole-slide
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H&E images by a template matching procedure. In that study a pre-segmentation step
is performed on each image through k-means clustering, taking the FTIR spectrum
and the RGB vector as input features for each pixel. The spatial arrangement
of the segmented pixels is then matched through an exhaustive sparse search with
geometrical restrictions (only translations or little rotations up to ±30 degrees) due
to its computational complexity. However, the pre-segmentation step diminishes the
spatial local information and can also introduce severe mistakes because the natural
clusters may not reflect the same spatial structures in both images due to the different
information contained in the RGB vectors and the FTIR spectra.
A different multimodal registration problem involving microscopic images from
adjacent sections of prostatic tissue is addressed in [207]. In that study, several
adjacent sections with different grades of cancer are stained with either H&E,
immunohistochemical or fluorescence dyes. The spatial correspondence between
adjacent sections is obtained by means of a rigid registration based on the
features automatically provided by the Scale Invariant Feature Transform (SIFT)
algorithm [208, 209] and filtered using the Random Sample Consensus (RANSAC)
algorithm [210]. This approach is similar to the one used in the first step of the
registration framework proposed here (Sec. 4.2.5).
4.1.4 Proposed framework
As stated in Sec. 4.1.1, the objective of this application is to establish a complete
pipeline where the two types of images of the different sections of tissue are aligned.
After setting some parameters, this alignment is performed in an automatic way
through two registration steps which analyse different characteristics of the grayscale
images obtained from the initial images. The key step of the suggested method is to
obtain these grayscale images from the FTIR hyperspectral data cube.
The proposed framework starts by obtaining grayscale images from the two
imaging modalities, which are the inputs of the registration method. The main aim
of this preliminary step is to get images with similar local contrast where analogous
anatomical structures are easily distinguishable.
The registration process consists of two steps. The first step produces a fast coarse
alignment that offers good initial conditions for the finer registration performed in the
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second step. The first registration step is a feature-based registration that uses the
SIFT algorithm [208,209] to automatically find and match relevant keypoints in both
images. These matches are filtered with the RANSAC algorithm [210] to estimate a
coarse rigid transformation. Several combinations of SIFT parameters were considered
due to the wide spatial variability between the studied sections of tissue, which may
not be immediately adjacent. The best combination of parameters in each sample
was chosen through the maximisation of a multimodal similarity measure between
the aligned images.
The second registration step consists of an intensity-based registration that seeks
to refine the alignment and to compensate for the local spatial differences between
the tissue sections of the two imaging modalities. In this last stage, a non-rigid
transformation is iteratively estimated to maximise again the same multimodal
similarity measure. Several parameters must be adjusted in the intensity-based
algorithm, but this time a global combination of parameters was empirically fixed
to reach a reasonable fine alignment.
The obtained results for the available dataset were qualitatively and quantitatively
assessed. The rigid transformation obtained with the first registration step was
evaluated by comparison with a gold standard rigid transformation that was estimated
based on manually selected landmarks. The evaluation of the second non-rigid
registration step is more difficult because no gold standard can be practically
established for comparison. Therefore, the results were assessed by studying the
modification of a different multimodal similarity measure before and after this last
registration step.
4.2 Materials and methods
4.2.1 Dataset
The available dataset consists of 47 colon samples from different pathological groups:
16 normal (non-cancerous), 16 intermediate (comprising adenoma and hyperplastic
tissue) and 15 tumoral (cancerous). All samples were fixed and embedded in paraffin
blocks. One slice of 7 µm thickness and several contiguous slices of 3 µm were
extracted from each block with a microtome. The thicker slice was not further treated
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and was measured with the micro-FTIR imaging system that was described in Sec.2.5.
The samples were measured in transmission mode and the absorption spectra were
acquired between 1000-3900 cm−1 with a wavenumber interval of 4 cm−1. Multiple
frames were acquired and combined to allow a larger overall FOV, which varied
depending on the size of the sample and the particular ROI.
The rest of sections were chemically deparaffinated and stained with H&E. One
of these sections, ideally contiguous to the one measured by FTIR spectroscopy, was
chosen to acquire RGB images with an optical microscope. A Philip Harris DMSK211
microscope with a coupled digital camera of 1280 × 1024 pixels was used to record
sequential images that covered the full H&E sample. An objective lens of 20× was
used, giving a pixel size of 0.4× 0.4 µm2. The movement of the microscope stage was
automatised with a custom hardware based on Raspberry Pi. The tiled images were
stitched with Microsoft Image Composite Editor (ICE) in order to obtain the final
RGB image of the whole sample.
4.2.2 Registration pipeline
A block diagram with the main steps of the proposed registration pipeline is shown in
Fig. 4.2. In order to illustrate the outputs of each step, a representative image from
a specific sample is shown next to each block.
The inputs of the process are the two raw data structures of each imaging modality
(RGB and FTIR), which were described in Sec.4.1.2. The first stage of the framework
consists of obtaining representative grayscale images from the two raw inputs. This
is the key step in the pipeline and allows to apply registration methods that have
proven to be effective in other medical areas that operate with multimodal grayscale
images [203,204,211,212]. The aim is to obtain two images with similar local contrast
where analogous anatomical structures can be easily observed. These two grayscale
images, named T1 (RGB) and R (FTIR), are the inputs of the next step.
A feature-based registration with a rigid spatial transformation is performed in
the second level of the pipeline. Its main objectives are to compensate for the coarse
spatial differences between images and to provide an initial alignment based on the
correspondence of keypoints, which are automatically detected and matched in both
images using SIFT and RANSAC as described in Sec. 4.2.5. In this initial alignment,















Fig. 4.2: Block diagram of the proposed registration framework. The outputs of each step
are illustrated with a representative image from a single sample.
the representative FTIR grayscale image R acts as the reference image and the H&E
grayscale image T1 is the target image that is shifted through a rigid transformation
to produce image T2.
In the third and final step of the framework, an intensity-based registration is
applied to perform a non-rigid spatial transformation. It takes as inputs the unaltered
reference image R and the target image T2 to produce the final output image T3. The
aim of this step is twofold: on the one hand, to refine any remaining misalignment
and on the other hand, to diminish local spatial differences due to the use of different
slices of tissue.
4.2.3 Representative images
The critical step in this work is converting the data structures of each modality into
grayscale images such that registration can be performed in the grayscale domain.
The goal is to create two images with similar local contrast where corresponding
anatomical structures can be easily observed. The process to obtain these grayscale
images is different for each imaging modality.
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H&E grayscale image
Two steps were applied to construct the H&E grayscale image:
1. Resizing: A bi-cubic interpolation with an antialiasing filter was performed
to downscale the original H&E colour images to the same pixel size as FTIR
images.
2. Transformation to grayscale: The RGB values of the resized images were
converted to grayscale by computing the luma Y, which is the achromatic
component representing luminance in the Y IQ colour space [213]. In the studied
dataset, luma component demonstrated to have a high rate of convergence
to an optimal solution, especially in the first registration step, as described
in Sec. 4.3.2. In addition, it demonstrated to be more robust against different
illumination conditions (some samples had uneven spatial illumination) and
staining variability (e.g. cancerous regions stain darker than normal ones) than
other chromatic components. In a theoretical way, human visual system is
more sensitive to luminance differences rather than chromatic differences. The
luminance is closely related to the perceptual attribute called brightness, which
is the visual sensation according to which a source appears to emit more light or
less than another does [213]. On the other hand, absorbance values of the FTIR
images may be interpreted as the capability of an object to absorb more light
or less than another does. Therefore, theoretically luma component may be a
good candidate to be inversely related to a transformation that condenses the
absorbance values of the FTIR images (see next section). As commented before,
this theoretical intuition was empirically supported by the results obtained and
compared with a manual gold standard registration. The specific conversion to
obtain Y is a weighted combination of the three-valued vector (R,G,B):
Y = 0.299 · R+ 0.587 · G + 0.114 · B (4.1)
FTIR grayscale image
Before transforming the FTIR hyperspectral data into a single grayscale image, the
spectra must be preprocessed. As was extensively described in Sec. 3.2, preprocessing
is a relevant stage in FTIR data analysis and interpretation [153, 177]. It is
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essential to remove the unwanted effects involved in the spectral data acquisition
and to highlight specific information within the spectra. No universal preprocessing
method exists [108]; the specific combination of preprocessing steps depends on the
application.
In order to illustrate the applied preprocessing, the final representative FTIR
grayscale image of one sample is shown in Fig. 4.3d. In this image five pixels have
been coarsely marked with different colours and numbers. Pixels 1 and 2 exemplify two
regions without tissue (substrate), pixel 3 corresponds to a region where there is a low
amount of sample (interior of lumen), pixel 4 represents a region where the presence
of organic material is higher than in pixel 3 (outer region of lumen) and, finally, pixel
5 illustrates a region with the highest content of tissue of the selected pixels. The
same colours and numbers are used to represent the corresponding raw spectra in
Fig. 4.3a. Strong peaks due to contaminants such as CO2 (∼2300-2400 cm−1) and
paraffin (∼2800-3000 cm−1) can be easily observed in the raw spectra because they
are even present in the substrate regions (pixels 1 and 2).
The preprocessing steps applied in these images, with the reasoning behind their
use, were:
1. Spectral window selection: The raw absorption spectra were cropped to the
so-called fingerprint region (1000-1800 cm−1), which contains the vibrational
frequencies of the chemical bonds from the most relevant biomolecules [81].
Thus, attention is focused on the most informative wavenumbers and the
stronger contaminant bands are rejected (Fig. 4.3b).
2. Removal of remaining spectral contaminants: Relatively strong peaks due to
paraffin still appear in the fingerprint region (1360-1390 and 1430-1490 cm−1).
The absorbance values corresponding to those ranges of wavenumbers are
removed from the spectra to reduce the noise produced in the final images by
the interference of these contaminants and the rest of meaningful biochemical
peaks.
3. Denoising: A Savitzky-Golay filter was applied to smooth the spectra and
reduce the random noise. Its parameters were fixed to a window size of 15
points and a 2nd order fitting polynomial, which were a good trade-off between
noise attenuation and signal distortion in the studied dataset.
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Fig. 4.3: (a) Full-range raw spectra drawn in the same colour of their corresponding pixels.
(b) Raw spectra cropped to fingerprint region. (c) Preprocessed spectra after cropping to
the fingerprint region (1000-1800 cm−1), smoothing by Savitzky-Golay filtering, rejecting
the paraffin ranges (1360-1390 and 1430-1490 cm−1) and applying rubberband baseline
correction. (d) Representative FTIR grayscale image of a colon sample where five pixels
have been marked and numbered with different colours. Cyan scale bar represents 200 µm.
4. Baseline correction: It is crucial to diminish the spectral baseline effects due
to scattering, heterogeneity in external illumination, supporting substrate or
sensor’s sensitivity and other changing conditions during data collection [153].
There is a large variety of baseline correction algorithms. Here the rubberband
baseline correction method was employed [177], which subtracts a convex
polygonal line whose edges are minima within the spectrum. In particular, the
parameterless implementation of the rubberband baseline correction included in
the IRootLab toolbox [214] was used.
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The final preprocessed spectra of the selected pixels are shown in Fig. 4.3c. The
selected pixels have been numbered in increasing order of maximum absorbance values.
Absorbance is related to the concentration and thickness of the biological content
as stated by the Beer-Lambert law (Sec. 2.4.1). There are some metrics commonly
used in vibrational spectroscopy to condense the absorbance measurements, such as
peak height or peak integral [215]. In this study, different combinations of these
metrics were explored, such as finding the maximum or computing the integral of
the complete fingerprint region or only the strongest peak (Amide I peak, between
1630-1670 cm−1). However, it was found that the standard deviation (std) of each
spectrum was the most robust metric (in terms of noise, sharpness and independence
of previous preprocessing steps) to produce an image with a local contrast similar to
the corresponding H&E grayscale image. In particular, the intrinsic removal of the
mean absorbance value performed by std reduces the influence of spectral baseline
artifacts (e.g. produced by scattering) inefficiently removed in the baseline correction
preprocessing step. More specifically, if A = {A1, . . . , ANw} is the associated
absorption spectrum of a pixel with Nw wavenumbers, then the assigned value to










where A = 1Nw
∑Nw
i=1Ai is the mean absorbance value of A. The obtained std values
were linearly mapped to get a grayscale image with intensities between 0 and 255.
However, this gives the substrate low gray values, as opposed to the H&E grayscale
image where the substrate has high values and appears white. For this reason the
gray values were inverted to obtain the reference image R in the proposed registration
method.
4.2.4 Similarity measures
Images from different imaging modalities have different intensity characteristics due
to the specific properties of each sensor. Thus, multimodal registration problems
require similarity measures based on statistical relationships between the pixels of
the images rather than direct intensity relationships as in monomodal scenarios [216].
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Two similarity measures widely used in multimodal problems were employed: the
correlation ratio and the mutual information.
Correlation ratio
The correlation ratio (CR) assumes a functional relationship between the intensities
of the registered images [217, 218]. CR does not consider any specific relationship,
whereas the correlation coefficient does. The correlation coefficient assumes a
linear relationship between intensities, making it more appropriate for monomodal
registration problems. CR can take values from 0 (no functional dependence) to 1
(purely deterministic dependence) [218]. The closer CR is to 1, the more similar R
and T are and, in the extreme case (CR = 1), it would inform of a hypothetical
perfect alignment. To compute CR, the reference image R and the target image T
are viewed as random variables. Let x denote a pixel that has an intensity T (x) in
image T ; Ω the set of pixels in the overlapping region between R and T ; Np the total
number of pixels in Ω; Ωi the subset of Ω whose pixels have the same intensity level
i in R, that is, Ωi = {x ∈ Ω, R(x) = i}; Np,i the number of pixels in Ωi; then, CR is
defined as:































Mutual information (MI) is a measure from information theory that characterises
the amount of shared information between the registered images [219]. It assumes a
probabilistic relationship between the intensities of the registered images R and T .
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MI can range from 0 (statistical independence) to any positive quantity and, as in
CR, the higher MI, the more similar R and T are. However, interpretation of MI is
difficult because there is not a maximal value that can be used as a reference for a
hypothetical perfect alignment. MI is computed in terms of image entropies:
MI(R, T ) = HR +HT −HRT . (4.5)













where Pi is the probability of an intensity level i occurring in image R; Pj is the
probability of intensity level j occurring in image T ; Pij is the joint probability of
both intensity levels i in image R and j in image T occurring at the same position.
4.2.5 Feature-based registration
Scale Invariant Feature Transform (SIFT) is an algorithm to detect and describe local
features in images [208, 209]. The main characteristic of SIFT is its ability to find
distinctive keypoints that are invariant to location, scale and rotation, and robust to
affine transformations (changes in scale, rotation, shear and position) and changes in
illumination, which makes it usable for object and pattern recognition. SIFT is the
core algorithm employed for keypoint selection and feature extraction. In the SIFT
algorithm, a series of keypoints that are invariant to scale and orientation are firstly
detected by seeking extrema in a Difference-of-Gaussian (DoG) transformation. At
each candidate keypoint, a local descriptor relative to scale-invariant coordinates is
computed based on local image gradients. The feature descriptors of the candidate
keypoints in both images are matched by a nearest-neighbour strategy through
minimum Euclidean distance.
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The values of four relevant SIFT parameters have been explored to get different
rigid transformations for each sample:
 Number of orientations (r) and width of the descriptor (n): these two
parameters change the size (rn2) of the local descriptor vector, which is
computed in a n × n array of histograms of r orientations. When these values
increase, the descriptor complexity and discriminative properties grow. The
highest rates of convergence were achieved with values of r = {4, 8} and
n = {4, 6}.
 Number of scale samples per octave (s): this parameter modifies the number of
extrema detected in the DoG transformation. The higher its value, the more
candidate keypoints are detected. Although Lowe [209] experimentally found
an optimal value of 3, more robust results (higher rates of convergence) were
obtained with values of s = {6, 10} in the studied dataset.
 Ratio of distances closest/next closest (rod): each candidate keypoint is only
retained if the ratio of distances between the first and the second nearest
matched neighbour is below rod. When this threshold decreases, a higher
number of false matches is discarded although good matches can also be rejected.
The highest rates of convergence were obtained with rod = {0.8, 0.9}.
Afterwards, the Random Sample Consensus (RANSAC) algorithm [210] is used
to filter the candidate keypoints matched by means of the SIFT descriptors. In
RANSAC, a spatial transformation model between both images must be imposed in
order to estimate its parameters. In this case, a rigid transformation T is considered,

















where the original spatial coordinates x = (x, y) are converted into the new ones by
applying a global translation (tx, ty) and a rotation of angle θ.
RANSAC computes the parameters tx, ty and θ by considering a minimum
percentage of inlier matched keypoints (5% in this case) and a maximal alignment
134 Chapter 4. Multimodal registration of histopathological samples
error between the transformed keypoints and their corresponding matches. For this
work the alignment error was limited to a maximum of 15 pixels.
Due to the spatial variability between samples, a rigid transformation may not be
constructed for some combinations of parameters because no inlier correspondences
are detected. The selection of the best combination of parameters for each sample
was therefore based on the maximisation of a similarity measure (Sec. 4.2.4) between
the output target image T2 and the reference image R. In particular, the correlation
ratio (CR) was the variable to maximise.
4.2.6 Intensity-based registration
The second registration step is based on a variational approach, which has been
formulated in the frequency domain [220,221] and also implemented in the frequency
domain [222], providing a fast and efficient registration method. This method
produces a non-rigid displacement field u that compensates for the remaining
differences between the reference R and the target T2 images caused by an imperfect
alignment in the first registration step and the local spatial differences between
tissues. The obtained non-rigid displacement field u : R2 → R2 will make the
transformed target image similar to the reference image, T2(x−u(x)) ≈ R(x), where
u(x) = (ux(x), uy(x))
> and x is the spatial position x = (x, y) ∈ R2.
The non-parametric registration can be approached in terms of calculus of
variations by defining the following energy functional to be minimised:
J [u] = D [R, T2; u] + αS [u] . (4.7)
The energy term D measures the distance between the deformed target and the
reference images; S is a penalty term which acts as a regulariser and determines
the smoothness of the displacement field; and α > 0 weighs the influence of the
regularisation.
The distance measure D is chosen depending on the datasets to be registered. In
this application, since the H&E and FTIR datasets do not share the same intensity
range (multimodal problem), statistical-based measures are more appropriate. Among
the similarity measures described in Sec. 4.2.4, the correlation ratio (CR) was used in
this case because it provided more accurate alignments and had a better behaviour
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against wrong global minima during its optimisation. The regularisation term S gives
the smoothness characteristics to the displacement field [223]. In this problem, the
diffusion term was used, which is given by the energy of the first derivatives of u [220].
As described in [220], the energy functional (Eq. 4.7) can be translated into
the frequency domain by means of Parseval’s theorem. Then J [u] = J̃ [ũ],
with ũ(ω) = (ũx(ω), ũy(ω))
> being the frequency counterpart of the displacement
field, ω = (ωx, ωy) is the two-dimensional variable in the frequency domain. The
minimisation of the energy functional J̃ [ũ] leads to the translation of the Euler-
Lagrange equation into the frequency domain and provides the following iteration for
the Fourier transform of the l-th component of the displacement field:
ũ
(η)









where η ∈ N is the iteration index, l = {1, 2} in this 2D problem, H(ω) is a low-pass
filter in the frequency domain and f̃(ω) = (f̃x(ω), f̃y(ω))
> is the Fourier transform
of the external forces field. For further details, please refer to [220,221].
From Eq. 4.8, the target image is iteratively modified by u and goes through
different intermediate states Ti until the final image T3(x) = T2(x−u(x)) is obtained.
Eq. 4.8 provides a stable implementation for the computation of a numerical solution
for the displacement field in a more efficient way than existing approaches if the
two-dimensional fast Fourier transform is used [221].
The values of the most relevant parameters in this step were: a maximum number
of iterations (ηmax) equal to 400 and α = 500. The images R and T2 were preprocessed
with a 3×3 and a 5×5 median filter, respectively, before applying this last registration
step to avoid excessive local distortions that may be induced by noise artifacts.
4.2.7 Evaluation
No ground truth for alignment evaluation exists in this problem mainly for two reasons:
placing external fiducial marks in the microscopic tissue is not trivial; the deformations
produced during the processing of the different slices of tissue can be highly variable.
Even so, special care was taken to evaluate the obtained results in both registration
stages.
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The rigid registration step (Sec. 4.2.5) was assessed by a procedure similar to the
one used in [207]: an artificial rigid transformation was computed in each sample as
a gold standard for comparison. This gold standard transformation was estimated
by applying Procrustes analysis [224–226] to a set of manually selected landmarks
or control points. These sets of landmarks were manually chosen by trying to select
anatomical structures shared by both images to register (R and T1), such as distinctive
points in the glands or in the tissue border. Formally, a set of Np pixels or spatial
points {xi} were selected in the original target image T1 and their corresponding
set of points {yi} were marked in the reference image R, where i = 1, . . . , Np. For
each sample, five corresponding points (Np = 5) were selected in both images. As
an illustration, Fig. 4.4 shows the images T1 and R of one tissue sample where the
















Fig. 4.4: Illustration of the sets of manual landmarks used in the evaluation of the feature-
based registration step. Cyan scale bars represent 200 µm. (a) Target image T1 with
five manually selected points {xi} marked with diamonds. (b) Reference image R with
the corresponding set of manually selected points {yi} (diamonds), the transformed set
{TPA(xi)} (asterisks) obtained by Procrustes analysis and the transformed set {TFB(xi)}
(circles) obtained by the feature-based registration step.
The set {xi} can be mapped into the reference space of image R with a generic
rigid transformation (Eq. 4.6) to give a set of transformed points {T (xi)}. The root-
mean-square of the distances between the points of a generic transformed set {T (xi)}
and their corresponding {yi} points is the Fiducial Registration Error (FRE) [226]:
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({T (xi)} − {yi})2, (4.9)
Two FRE values can be computed for each sample by applying each rigid
transformation: one for the gold standard transformation computed with Procrustes
analysis (FREPA) and one for the transformation obtained with the proposed feature-
based registration (FREFB). These values respectively inform of the mean alignment
error in pixel units of the transformed sets {TPA(xi)} and {TFB(xi)}. Procrustes
analysis [224] computes the optimal linear transformation (rigid in this case) by least
squares minimisation of the distances between the cloud of landmarks selected in
the reference image R ({yi}) and their corresponding transformed landmarks from
the target image T1 ({T (xi)}), i.e., by minimising FRE [225, 226]. Thus, FREPA
represents the lowest possible error (in terms of minimum least squares) for the
manually selected sets of landmarks, what justifies the use of Procrustes analysis as the
gold standard rigid transformation. The difference error (∆FRE = FREFB−FREPA)
was also computed for each sample to show explicitly the disagreement between both
rigid registration methods. The transformed sets {TPA(xi)} and {TFB(xi)} for one
tissue sample have been represented in Fig.4.4b with asterisks and circles, respectively.
As can be seen, the agreement between the two rigid registrations in the chosen sample
is very high.
The evaluation of the non-rigid transformation performed in the intensity-based
registration step (Sec. 4.2.6) is not an easy task and no well-established validation
methods exist [201,216]. The comparison with a manual gold standard transformation
based on selected landmarks is not appropriate due to the local deformations produced
by the non-rigid transformation. These spatially uneven deformations may lead
to a deceptive estimation of the errors in the positioning of the manually selected
landmarks, which are actually very difficult to pick due to the use of different slices
of tissue. A usual validation method for non-rigid intensity-based approaches is the
computation of a similarity measure (Sec. 4.2.4) between the target and the reference
images before and after applying the non-rigid registration [216]. In order to avoid
false conclusions, the similarity measure used for this evaluation must be different
from the one (CR) maximised during the registration. In this case, MI was computed
for each sample and its improvement was statistically analysed by pathological group
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and over the whole dataset. In each group, the right-tailed Wilcoxon signed-rank
test [227] was applied, whose null hypothesis states that the differences before and
after applying the intensity-based registration step have zero median, meanwhile the
alternative hypothesis states that the median of these differences is positive. A p-
value was obtained for each group to assess the statistical significance of rejecting the
null hypothesis in favour of the alternative hypothesis of this non-parametric test.
Finally, careful visual assessment remains the first and most important validation
check [201,216] especially in this multimodal registration problem which involves non-
rigid deformations. The best visual results were obtained when CR was considered
as the similarity measure to maximise through the complete registration pipeline. It
must be remarked that the subjectivity in this last assessment is unavoidable due to
the high variability introduced by the non-rigid distortions.
4.2.8 Implementation
All the steps of the suggested registration framework, including its evaluation, were
implemented in MATLAB. As external programs, the IRootLab toolbox [214] was
used to perform the preprocessing of FTIR images and the implementation of SIFT
and RANSAC algorithms included in the software Fiji/ImageJ [228,229] were linked
with in-house MATLAB algorithms through the MIJ Java package [230].
The implemented code was applied to the available dataset (Sec. 4.2.1) in a
computer with a processor Intelr CoreTM i7-4790K @ 4.00GHz and 16GB of RAM
memory, running under Windows 8.1 and with the version R2016b of MATLAB
installed. Fig.4.5 shows the running times in this computer platform versus the size of
the reference image R, in terms of total number of pixels. As described in Sec. 4.2.1,
the FTIR reference image R is composed of different frames of 128 × 128 pixels
which cover the corresponding region of interest in each sample. As can be seen
in Fig. 4.5a, the computation time for the complete proposed framework varies from
around 40 to 360 seconds, with an increasing but not clear relationship with the size
of the reference image R. However, as presented in Fig. 4.5b the running time in
the intensity-based registration step does follow a linear relationship with the size of
R with an estimated slope by least-squares (coefficient of determination R2 = 0.99)
of 1.6 miliseconds/pixel. The variability in the total running time comes from the
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feature-based registration step, whose computation not only depends on the size of
the images to be registered but also on their content. Images with higher number
of relevant structures increases the detection of candidate keypoints and the time for
matching and filtering them with SIFT and RANSAC algorithms (Sec. 4.2.5).
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Fig. 4.5: Running times (in the computer platform described in the main text) vs. number
of pixels of reference image R using the samples of the available dataset for (a) the complete
proposed framework and (b) the intensity-based registration step.
Tab. 4.1 summarises the most relevant parameters of both registration steps,
including the applied values in the available dataset and the risks of using too
low or too high values. The relevance of SIFT parameters in the feature-based
registration step were described in Sec. 4.2.5. Choosing incorrect values of these
parameters would create incorrect or insufficient matches between keypoints, leading
to the computation of wrong rigid transformations or, even worse, the failure of finding
any transformation. In the intensity-based registration step, the main parameter that
can be tuned is α, which controls the smoothness of the applied deformation. The
higher α, the smoother the deformation, at the risk of not compensating sufficiently
for the local spatial differences. On the contrary, the lower α, the more unrealistic
excessive deformations may be applied. Finally, ηmax is mainly related to the chosen
α. In this case, a relatively high value of ηmax was selected to be conservative.
As last remarks, the suggested parameter values should be a good starting point
for other datasets with different sources of variability between images. In the feature-
based registration step, the indicated methodology of exploring different combinations
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of parameters and choosing the one that maximises a similarity measure between
images (CR in this case) proved to be able to handle satisfactorily different scenarios.
In the intensity-based registration step, no significant changes in the results were
observed in the range between a double and a half of the suggested values.
4.3 Results
4.3.1 Qualitative results
One sample per pathological group has been chosen to present the most relevant
images obtained in the different steps of the proposed registration framework. Fig.4.6
shows the images of the chosen intermediate sample, Fig. 4.7 the normal sample
and Fig. 4.8 the tumoral sample. In these figures, the automatically-detected inlier
keypoints of the feature-based registration step (Sec. 4.2.5) have been marked in the
original target T1 and reference R images. The output target images of the feature-
based T2 and the intensity-based T3 registrations are also shown. These output images
have been independently overlaid with the reference image R to create composite
RGB images whose gray levels denote regions with similar intensities in the two
overlaid images, whereas magenta and green regions correspond to different intensities.
Although the presence of magenta or green in some cases does not mean a bad
alignment (due to the multimodality of the overlaid images), these representations
allow a better visualisation of the alignment produced by each registration step.
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(a) T1
(b) R (c) T2 (d) T3
(e) R-T2 composite (f) R-T3 composite (g) Deformation
Fig. 4.6: Registration results for an intermediate sample. Cyan scale bars represent 200 µm.
(a) Target image T1 with automatically-detected inlier keypoints. (b) Reference image R
with automatically-detected inlier keypoints. (c) Feature-based registration output image
T2. (d) Intensity-based registration output image T3. (e) Composite RGB image of overlaid
images R and T2. (f) Composite RGB image of overlaid images R and T3. (g) Artificial grid
deformed with the non-rigid displacement field computed in the intensity-based registration.
Finally, and also for better visualisation of the applied deformation, the figures show
synthetic grids with the same dimensions as T2 and T3, which were deformed with
the non-rigid displacement fields u computed in the intensity-based registration step.
Each squared interval of the undeformed synthetic grids was chosen to occupy 16
pixels both in horizontal and vertical directions.
As can be seen in figures 4.6 to 4.8, the feature-based registration step is capable
of compensating for coarse misalignment (very relevant in the chosen intermediate
sample) and cropping the initial target image to the region of interest of the reference
image. It can be observed that the detected inlier keypoints of the tumoral sample
are placed near the edge of the tissue. In the intermediate and the normal samples,
the keypoints are also identified in the inner region of the tissue, mainly close to the
glandular regions. As the SIFT algorithm detects keypoints at different resolutions,
the ones which appear outside the tissue at this resolution belong to the border of
the tissue at a lower resolution.
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(a) T1
(b) R (c) T2 (d) T3
(e) R-T2 composite (f) R-T3 composite (g) Deformation
Fig. 4.7: Registration results for a normal sample. Cyan scale bars represent 200 µm.
(a) Target image T1 with automatically-detected inlier keypoints. (b) Reference image R
with automatically-detected inlier keypoints. (c) Feature-based registration output image
T2. (d) Intensity-based registration output image T3. (e) Composite RGB image of overlaid
images R and T2. (f) Composite RGB image of overlaid images R and T3. (g) Artificial grid
deformed with the non-rigid displacement field computed in the intensity-based registration.
It can also be seen that the intensity-based registration step refines the general
misalignment (better appreciated in the chosen normal sample) and also produces
local deformations that improve the correspondences inside the tissue. These local
modifications can be better viewed in the glands of the intermediate and normal
tissues.
4.3.2 Quantitative evaluation
Tab.4.2 summarises the quantitative evaluation of the results for the 16 Intermediate
(INT), 16 Normal (NOR) and 15 Tumoral (TUM) samples of the dataset, identified by
the code IDsample. The feature-based registration results show: the combination of
SIFT parameters that has been chosen as optimal (IDcomb; see Tab.4.3); the fiducial
registration error for the Procrustes analysis (FREPA) gold standard registration, for
the proposed feature-based registration (FREFB) and the difference between them
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(a) T1
(b) R (c) T2 (d) T3
(e) R-T2 composite (f) R-T3 composite (g) Deformation
Fig. 4.8: Registration results for a tumoral sample. Cyan scale bars represent 200 µm.
(a) Target image T1 with automatically-detected inlier keypoints. (b) Reference image R
with automatically-detected inlier keypoints. (c) Feature-based registration output image
T2. (d) Intensity-based registration output image T3. (e) Composite RGB image of overlaid
images R and T2. (f) Composite RGB image of overlaid images R and T3. (g) Artificial grid
deformed with the non-rigid displacement field computed in the intensity-based registration.
(∆FRE = FREFB − FREPA); all FRE values are expressed in pixels. The intensity-
based registration results show the mutual information between the reference and
the target images before the non-rigid registration (MIbefore), after the non-rigid
registration (MIafter) and the difference between them (∆MI = MIafter−MIbefore); all
MI values are expressed in bits. The raw results presented in Tab.4.2 will be analysed
in the next sections.
Feature-based registration
Due to the variability between tissue sections in the studied samples, 16 combinations
of the SIFT parameters (Sec. 4.2.5) were considered in order to increase the
probabilities of convergence and optimisation of the first registration step. Tab. 4.3
shows the 16 combinations (IDcomb) of the four SIFT parameters (r, n, s and
rod) explored for each sample. The table also presents the number (#) and the
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Tab. 4.2: Quantitative evaluation of all the samples in the dataset.
IDsample
Feature-based registration Intensity-based registration
IDcomb FREPA FREFB ∆FRE MIbefore MIafter ∆MI
INT1 3 5.6 6.2 0.6 1.666 1.743 0.077
INT2 1 8.2 10.4 2.2 1.249 1.410 0.161
INT3 8 6.0 6.5 0.5 1.300 1.701 0.400
INT4 9 3.6 10.8 7.2 1.413 1.377 -0.037
INT5 13 1.8 2.3 0.5 2.310 2.312 0.002
INT6 1 1.2 1.4 0.2 1.870 2.195 0.325
INT7 16 2.8 3.9 1.1 2.273 2.342 0.069
INT8 14 4.7 5.4 0.7 1.713 1.790 0.078
INT9 6 18.4 46.1 27.7 0.948 1.324 0.376
INT10 5 3.1 3.5 0.4 1.478 1.709 0.232
INT11 8 10.1 23.0 13.0 1.470 1.632 0.163
INT12 16 5.2 5.9 0.7 1.322 1.389 0.067
INT13 6 6.3 31.5 25.2 1.174 1.446 0.272
INT14 11 3.2 3.4 0.2 1.065 1.127 0.062
INT15 7 5.2 6.0 0.8 1.435 1.594 0.159
INT16 11 7.8 7.9 0.1 1.418 1.508 0.090
NOR1 8 11.8 15.5 3.7 1.748 1.832 0.085
NOR2 16 10.4 10.7 0.3 1.532 1.759 0.227
NOR3 1 6.5 14.6 8.1 1.549 1.470 -0.079
NOR4 7 4.1 9.6 5.5 1.767 1.856 0.089
NOR5 1 11.8 25.8 14.0 1.245 1.405 0.160
NOR6 13 2.0 2.3 0.3 1.711 1.748 0.037
NOR7 4 1.6 1.6 0.1 1.864 1.894 0.030
NOR8 8 4.1 7.5 3.3 1.575 1.731 0.157
NOR9 6 6.4 93.3 86.9 1.327 1.398 0.070
NOR10 4 3.2 3.3 0.1 1.249 1.289 0.040
NOR11 3 5.5 6.7 1.1 1.674 1.803 0.130
NOR12 1 7.3 9.2 1.9 1.357 1.465 0.109
NOR13 6 16.0 24.4 8.5 1.734 1.658 -0.075
NOR14 5 9.3 11.1 1.7 0.985 1.110 0.125
NOR15 3 6.5 9.0 2.5 1.073 1.243 0.170
NOR16 8 2.7 3.2 0.5 1.635 1.772 0.138
TUM1 8 4.8 5.1 0.3 1.511 1.622 0.110
TUM2 8 6.4 6.6 0.1 1.258 1.407 0.148
TUM3 8 7.7 15.3 7.6 1.073 1.334 0.261
TUM4 8 2.7 3.5 0.8 1.086 1.192 0.106
TUM5 15 5.4 7.6 2.2 1.097 1.166 0.069
TUM6 15 16.2 20.4 4.3 0.844 0.865 0.021
TUM7 15 3.4 3.8 0.3 1.133 1.293 0.159
TUM8 13 10.4 12.4 2.1 1.304 1.473 0.169
TUM9 3 5.1 5.9 0.8 1.367 1.501 0.134
TUM10 15 4.1 4.3 0.1 2.303 2.350 0.047
TUM11 7 7.5 7.8 0.3 1.295 1.542 0.247
TUM12 14 10.6 11.0 0.4 1.710 1.940 0.229
TUM13 - - - - 1.134 1.153 0.019
TUM14 1 6.6 10.0 3.5 1.437 1.576 0.139
TUM15 6 15.5 17.0 1.4 1.049 1.325 0.276
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percentage (%) of samples which each combination has chosen as optimal (in terms
of maximal CR) in the feature-based registration step. As can be seen, although
three combinations of parameters have not been selected as optimal, there is not a
clearly prevailing combination. This fact justifies the exploration of different SIFT
parameters in this dataset. The exact combination (IDcomb) of SIFT parameters
that each sample has chosen as optimal is shown in Tab. 4.2.
Tab. 4.3: Explored combinations, identified by a number (IDcomb), of the four SIFT
parameters (r, n, s and rod) with the number (#) and the percentage (%) of samples which




r n s rod
1 4 4 6 0.8 6 13.0
2 4 4 6 0.9 0 0.0
3 4 4 10 0.8 4 8.7
4 4 4 10 0.9 2 4.3
5 4 6 6 0.8 2 4.3
6 4 6 6 0.9 5 10.9
7 4 6 10 0.8 3 6.5
8 4 6 10 0.9 9 19.6
9 8 4 6 0.8 1 2.2
10 8 4 6 0.9 0 0.0
11 8 4 10 0.8 2 4.3
12 8 4 10 0.9 0 0.0
13 8 6 6 0.8 3 6.5
14 8 6 6 0.9 2 4.3
15 8 6 10 0.8 4 8.7
16 8 6 10 0.9 3 6.5
By using the manually selected landmarks, the fiducial registration error for the
Procrustes analysis FREPA considered as the gold standard registration, the proposed
feature-based registration FREFB and the differences between them (∆FRE =
FREFB−FREPA) were computed for each sample (see Tab.4.2). Fig.4.9 presents the
box plots [231] which summarise the distributions of these error metrics if the samples
are divided into the three pathological groups or if all samples are considered. In these
box plots, whiskers extend to the most extreme data point that is no more than 1.5
times the IQR from the edge of the box. All the values outside the whiskers range
are considered as outliers (red plus signs).
As can be seen in Fig. 4.9a, the FREPA values (blue box plots) are very similar
between pathological groups, being their medians around 6 pixels. Only one outlier
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Fig. 4.9: Evaluation of the feature-based registration step. Box plots for the Intermediate
(INT), Normal (NOR), Tumoral (TUM) and ALL samples groups representing (a) the
fiducial registration error for the Procrustes analysis FREPA gold standard registration
(blue), the proposed feature-based FREFB registration (green) and (b) their differences
(∆FRE = FREFB − FREPA). In both subfigures, the empty regions of the vertical axes
have been cropped to improve the visualisation.
exists for the intermediate group, although three samples (with FREPA values above
15 pixels) are considered as outliers in the group of all samples. A higher dispersion
exists in FREFB values (green box plots) although their distributions are also similar
between pathologies and their median values remain under 10 pixels for all the groups.
Three outliers are present in the intermediate group with values between 20 and 50
pixels and one extreme outlier with a FREFB value over 90 pixels exists in the normal
group.
In Fig. 4.9b, the distributions of the paired differences of errors (∆FRE) show
a bit higher dispersion in the normal group with a median of 2.2 pixels meanwhile
the rest of pathological groups have a median error difference under 1 pixel. If all
the samples are considered, the median of (∆FRE) is also under 1 pixel with a low
dispersion, excluding the 5 outlier samples with (∆FRE) values above 10 pixels. It
must be remarked that there was one tumoral sample (TUM13; see Tab. 4.2) where




In order to assess the improvement due to the non-rigid transformation provided
by the intensity-based registration, the reference image R was compared with the
initial target image T2 and with the final target image T3. To that end, the
mutual information before (MIbefore; computed between R and T2) and after (MIafter;
computed between R and T3) the last registration step as well as their difference
(∆MI = MIafter −MIbefore) were computed for each sample (see Tab. 4.2). Fig. 4.10
shows the box plots of the distributions of these MI values divided by pathological
groups and considering all the samples. The rules regarding the notches, whiskers
and outliers of these box plots are the same as in Fig. 4.9.


































Fig. 4.10: Evaluation of the intensity-based registration step. Box plots for the Intermediate
(INT), Normal (NOR), Tumoral (TUM) and ALL samples groups representing (a) the mutual
information before (MIbefore; computed between R and T2) the intensity-based registration
(blue), after (MIafter; computed between R and T3) the intensity-based registration (green)
and (b) their differences (∆MI = MIafter −MIbefore).
As observed in Fig. 4.10a, the distributions of MIafter are above their respective
distributions of MIbefore for all the groups. Although these tendencies suggest an
improvement in the alignment of the images, it is not possible to state confidently such
an improvement due to the partial overlap caused by the spread of the corresponding
distributions. The analysis of the paired differences ∆MI removes the within-sample
variability and reduces the source of uncertainty to the spread in these differences
[232]. The distributions of ∆MI (Fig. 4.10b) present predominant positive values
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(with the exception of one intermediate and two normal samples; see Tab. 4.2) with
medians around 0.1 bits in the three pathological groups and a median of 0.125 bits
in the group of all samples. The right-tailed Wilcoxon signed-rank test [227] returned
p-values under 0.001 for all the groups, supporting the alternative hypothesis that the
medians of all ∆MI distributions are greater than 0. This result suggests that there
is a statistically significant improvement in the alignment of the images.
4.4 Discussion
The main novelty of this work is the use of a representative grayscale image
extracted from the FTIR hyperspectral data cube which condenses the most relevant
information of the biological structures of the tissue. The preprocessing to extract
this grayscale image is crucial to get a spatial contrast similar to the grayscale
image obtained from the H&E image. This grayscale image provides higher spatial
information than the binary or the clustered images which were used as inputs
in other previous approaches that treated to solve similar multimodal registration
problems [205, 206]. This increase in local information is essential in this work in
order to tackle the additional problem of aligning different sections of tissue.
In the feature-based registration step a medium level of information at different
levels of resolution is explored by the SIFT algorithm to automatically detect relevant
landmarks. No optimal combination of SIFT parameters clearly prevailed in the
studied samples (Tab. 4.3), which justifies the use of different SIFT values and an
optimisation procedure in terms of CR. This fact also confirms the wide morphological
variability between samples, whose sections of tissue may not even be adjacent.
Regarding the differences in pathology, normal and intermediate samples have more
distinctive references inside the tissue due to the presence of glandular structures,
whilst tumoral tissue contains more heterogeneous structures as the severity of cancer
increases. As a consequence, the automatically detected inlier keypoints in the
tumoral samples are mainly located at the tissue borders, which may be a problem
if not enough border regions are captured in the image. Apart from that, similar
results were obtained for all the pathological groups in the comparison of the feature-
based registration step with a gold standard manual registration. Most of samples
obtained a difference in positioning error ∆FRE under 10 pixels and the median of the
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distribution of all samples was under 1 pixel. These differences may be considered as
quite satisfactory taking into account that the main purpose of the first registration
step is to provide a coarse initial alignment for the second registration step.
The final intensity-based registration step is essential to refine the initial coarse
alignment provided by the detected keypoints and to compensate for the spatial
unevenness between the different sections of tissue. This step is a complement of the
first registration step because it considers the images at the lowest level of information
given by their intensities. The values of the parameters used in this step were
empirically tuned in the studied dataset as a good global trade-off between achieving
a finer alignment and avoiding excessive local deformations. The statistical significant
increase of the mutual information shared between the registered images confirmed
the alignment improvement that had been already visually observed, independently
of the pathological state.
4.4.1 Advantages and limitations
Taking into account the previous considerations, the main advantages of the proposed
method may be divided in the following points:
 Simplification of the multimodal problem: the multimodal problem of finding
the correspondence between the three-valued H&E pixels and the hyper-valued
FTIR pixels is simplified by condensing their information in grayscale images.
It allows the use of registration methods in the grayscale domain, which have
been successfully and efficiently applied in other medical areas.
 Gain of spatial information: using grayscale images augments the spatial
information, compared to other related approaches recently published. In
particular, a simple binarisation is applied in [205], meanwhile previous
independent segmentations by clustering within each image are proposed
in [206]. It must be remarked that in those studies the same tissue section
was measured by FTIR microspectroscopic imaging and then stained to get
the H&E image. Therefore, relatively simple spatial transformations had to be
calculated; specially restricted in [206], where only translations and rotations
up to ±30 degrees were considered due to its computational complexity and
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probably to the uncertainty introduced by the pre-segmentation step. In this
problem, the gain in spatial information provided by the grayscale image is
crucial to compensate for the local spatial differences caused by employing
distinct tissue sections for H&E and FTIR images. In addition, the suggested
approach avoids pre-segmentation steps, which would increase the complexity
of the problem (segmentation is maybe the most challenging task in medical
image analysis) and may accumulate errors coming from the incorrect partition
of corresponding anatomical structures.
 Estimation of local deformations: the computation of non-rigid spatial
transformations by the intensity-based registration step is another improvement
compared to [207], where distinct tissue sections treated with different stains are
aligned only with rigid transformations. The computed non-rigid displacements
are decisive to improve the alignment of more distant sections and compensate
for the deformations due to the handling and cutting of the biopsies.
 Robustness against pathological variability : the methodology is versatile and
robust against distinct sources of variability, including different morphological
configurations depending on the pathological state. This robustness is increased
in the first registration step by considering different combinations of parameters
and maximising a similarity measure (CR).
On the other hand, the main limitations of the framework are:
 Presence of distinctive anatomical structures: the feature-based registration
step tries to find relevant keypoints normally present inside the tissue in normal
or intermediate pathological states, such as glandular structures. However,
the tissue heterogeneity increases with the pathological state and the distance
between tissue sections. Therefore, in those cases the presence of tissue borders
in the recorded images may be crucial to find an optimal spatial transformation.
 Global regularisation in non-rigid registration step: the smoothness of the
displacement field is equally defined in the whole image by the parameter
α. This characteristic may be problematic in samples with uneven local
deformations, for example, due to the presence of different pathological regions.
Therefore, there may be zones where under- or over-deformations may be
computed.
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 Possible unrealistic deformations: because the intensity-based registration
method only considers the low-level information of pixels’ intensities. A possible
solution would be to create a model of tissue deformation with higher levels of
information, which may require challenging tasks such as pre-segmenting inner
tissue structures (e.g. nuclei or glands) or estimating mechanical properties of
the biological material.
 Automatic parameter optimisation in non-rigid registration step: single values
for the parameter α and the related ηmax were fixed for all the samples as a
good global trade-off, but better results may be obtained by individually tuning
these parameters. However, the main challenge is to pick the optimal values
automatically without applying over-deformations. Opposing to the feature-
based registration step, where the best combination of parameters is chosen by
the maximisation of CR, there is no auxiliary reliable metric that may indicate
the optimal configuration for each sample.
4.5 Application
This multimodal registration framework was employed for a preliminary assessment
of the capabilities of FTIR spectra to discriminate normal and cancerous regions in
colorectal tissue samples. Some images and the quantitative results presented here
were kindly provided by collaborators from UoE and GHFT.
This preliminary binary classification of spectra tried to discriminate spectra that
were extracted from glandular regions containing epithelial cells. As was explained in
Sec. 1.1.3, those regions are responsible for the onset of the development of malignant
patterns and their spectra are likely to contain more differential features from the
diagnostic point of view. Nevertheless, the identification of those glandular regions in
the FTIR images is not trivial and two different approaches were explored, as sketched
in Fig. 4.11.
Pathologists are used to interpreting the patterns in the H&E stained images and
they are able to better delineate the glandular regions in those kinds of images (green
boundaries in Fig. 4.11). This first approach uses the developed registration method
to transfer the regions annotated by the pathologist in the H&E images to the FTIR
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space. Hence, a binary mask is obtained, which isolates the pixels (black pixels in
Fig. 4.11) whose spectra must be retained in each image for the later classification.
The main problem of this approach is that several errors are introduced, mainly due
to the use of distinct tissue sections for both imaging modalities.
The second approach to identify the glandular regions is a direct segmentation
based on unsupervised classification or clustering of individual FTIR spectra. An
example of the results obtained by K-means clustering can be seen in Fig. 4.11. As
observed, clustering groups pixels into different categories symbolised by different
colours. Pixels from clusters likely associated with glandular regions are finally
retained for the later classification. Although this alternative offers an objective
delineation, it has several drawbacks as the dependence of the number of groups
(very difficult to state for each sample) and the dependence on the natural tendency
of FTIR spectra from glandular regions to form isolated groups in the spectral feature
space.
Finally, the third approach merges the previous approaches and only the pixels
retained both by registration and clustering are used in the classification.
H&E REGISTRATION
FTIR CLUSTERING
Fig. 4.11: Sketch of the fusion of spatial information obtained by registration and clustering.
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The binary classification used PCA-LDA (Sec.5.2.8) to discriminate the individual
extracted pixels into 2 groups (Normal vs Cancer). In order to better assess the
generalisation capabilities of the discrimination framework, a Leave-one-map-out
cross-validation was performed [186]. That is, alternatively, the spectra belonging
to each tissue sample were considered as the test set, and the classification algorithms
were trained with the rest of spectra. The final assessment metrics were computed
with the predicted labels for those test sets. Sensitivity (Sn) and Specificity (Sp)





· 100, Sp(%) = TN
TN + FP
· 100 (4.10)
where TP are the True Positives (pixels from cancerous regions correctly classified),
FN are the False Negatives (pixels from cancerous regions incorrectly classified), TN
are the True Negatives (pixels from normal regions correctly classified) and FP are
the False Positives (pixels from normal regions incorrectly classified).
Tab. 4.4 presents the final quantitative results in terms of Sn and Sp together
with the total number of analysed spectra and tissue samples used for each approach
to extract the previous spatial information of the glandular regions. As can be
observed, clustering offered better Sn and Sp values than registration, but their
combination clearly outperformed the individual approaches. Further applications to
larger datasets of tissue samples are currently under development. Those classification
models will also try to discriminate intermediate states of pathology.
Tab. 4.4: Quantitative results of the preliminary discrimation of normal and cancerous








Registration 79% 83% 770K 25
Clustering 84% 86% 260K 26
Registration + Clustering 90% 93% 81K 24
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5.1 Introduction
This chapter will present the second main application of this thesis. It seeks to
contribute to the findings about the use of FTIR microspectroscopic imaging as a
tool to improve cancer diagnosis by means of cytopathological samples. The followed
methodology, which fuses techniques described in previous chapters with new methods
from the areas of machine learning and pattern recognition, will be detailed together
with the main reasoning behind each applied step. In addition, the final results will
be quantitatively assessed and thoroughly discussed.
A limiting factor for the use of FTIR spectroscopes in biomedical problems has
been the sensitivity of the systems, which is related to the relatively high acquisition
times needed to obtain measurements of sufficient quality. This problem is of greater
concern for single layers and/or individual cells, which contain less biological material
than tissues and provide lower signals. Therefore, to obtain spectra from cells with
signal-to-noise ratio comparable to tissues, the acquisition time is normally on the
order of two or even four times longer for cells than for tissue. Moreover, the
measurement of cells has normally been a very tedious task because they are frequently
spread out in the sample preparations. These facts have hampered the proper analysis
of cell spectra and prevented the systematic assessment of their discriminative power.
Recently, modern FTIR microspectroscopes have increased their acquisition speed
mainly thanks to the development of larger and more sensitive imaging sensors. The
present work constitutes a proof-of-concept to assess if a modern benchtop FTIR
microspectroscope, together with the existing protocols of sample preparation and
spectral analysis, are ready to provide a reliable diagnostic system using cytological
samples. In particular, the ability of FTIR spectra to differentiate between cells
from cultures of four different skin cell lines, including two melanoma cell lines with
malignant phenotypes, was studied.
5.1.1 Related work
Because of the aforementioned difficulties, the application of FTIR microspectroscopic
imaging to cytopathological problems is considerably less than the large number
of studies and significant advances accomplished in histopathology. Nevertheless,
several research groups around the world have pushed, and still push, forward with
its application and development.
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Until the advent of FTIR microscopes, cytological studies analysed average FTIR
spectra recorded from large samples of cell pellets, which lacked enough spatial
resolution to accurately distinguish cell subpopulations [233]. The first relevant
studies of cells by combining FTIR spectroscopes and optical microscopy were
performed with synchrotron sources around the beginning of this century [128,143]. In
fact, these kinds of facilities (Sec. 2.5.2) were used in pioneering studies that revealed
one of the main problems in FTIR cytology: Mie and Resonant Mie Scattering
(RMieS) [141,146,160]. Improvements in optical components and sensor sensitivities
extended the use of FTIR microspectrometers with thermal sources to laboratories.
In addition, the introduction of FPA sensors enabled faster measurements of cell
preparations [234].
The most relevant bibliography involving FTIR cell analyses can be found in recent
reviews [114, 235]. Regarding the discrimination of cells from the diagnostic point of
view, commonly referred to as Spectral Cytopathology (SCP), the most important
works using FTIR microscopy are mainly related to Diem’s collaborations [236–243].
All these studies are focused on smear cells directly extracted from different parts
of the patients rather than in cell cultures. They have covered different types
of cancer pathologies: urine [239], cervix [240] or upper respiratory and digestive
tract [241–243]. In most of them, cells were deposited on low-e slides and measured
in transflection. Due to the preparation of the extracted samples, cells were relatively
spread and isolated. A patented method called PapMap [234], which computes a
mean spectrum per isolated cell and discards clumped cells, is used in those studies.
As stated above, most existing studies related to cancer discrimination analyse
cells directly extracted from the patient. In principle, this is the ideal methodology
to develop decision support systems to assist the clinician in the diagnosis of
cytopathological samples. Nevertheless, one of the problems of using these kinds of
samples is the need for an explicit labelling by expert pathologists, which is considered
the ground truth, or gold standard. This process is very time-consuming for the
experts and is also subject to their interpretation. In addition, most of the extracted
cell samples contain debris and undesirable heterogeneities that may diminish the
quality and reliability of the cell datasets. These problems, added to the intrinsic
difficulties when recording FTIR spectra of cells, have resulted in most existing studies
being based on reduced datasets of spectra (e.g., less than 1000 cell spectra). As
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a consequence, their results are generally founded on just qualitative assessments
(e.g., by means of PCA scores plots) or quantitative classifications where no clear
separations of the training and test sets (e.g., by cross-validation) are stated. Hence,
their findings offer limited statistical significance and generalisation capabilities of the
models are very difficult to guarantee, especially given the high-dimensional nature
of FTIR spectra.
5.1.2 Objective
The main objective of this study is to assess the capabilities of FTIR spectra to
discriminate different skin cell lines, comprising two non-tumoral and two tumoral
types. These cell lines were cultured and fixed in a controlled environment before
being measured with a modern state-of-the-art commercial FTIR microspectrometer.
The selected cellular models are rather simple, stable and have significant differences
in tumorigenicity. Cultured cells belong to catalogued cell lines with approximately
constant characteristics within the same populations, which reduces the uncertainty
linked to the establishment of a reliable ground truth. In addition, cell cultures
provide higher spatial densities of cells, which increases the efficiency for recording
larger amounts of data. Therefore, these cultured cells should potentially constitute
a suitable standard model for the evaluation of the processing and classification of
FTIR cell spectra with higher levels of statistical significance than current related
studies.
Nevertheless, some technical problems and additional difficulties arise when
dealing with cell cultures. Some of these particularities introduce confounding
artifacts that may mislead the discrimination. The aim of this work is to apply
different data analysis methodologies that diminish those critical biases and promote
a discrimination based on the genuine biochemical information of the cell lines. Special
efforts will be made to evaluate the generalisation capabilities and robustness of
those methodologies against possible fluctuations in experimental conditions. This
variability, introduced both during sample preparation and spectral acquisition, will
also be considered during the discrimination analysis. Therefore, another goal of this
work is to identify the possible limitations of the current measurement and sample
preparation protocols.
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5.2 Materials and methods
5.2.1 Discrimination pipeline
Fig.5.1 shows the flow diagram with the main steps that were followed to discriminate
skin cell lines, including melanoma and non-melanoma cells, based on their FTIR
spectra. This process starts with the preparation of cultured samples of catalogued
skin cell lines and their measurement with a modern FTIR microspectrometer in order
to obtain the hyperspectral images. From these images, the pixels associated with
cells were separated from the non-cell pixels so that only useful spectra were retained
for subsequent steps.
FTIR spectra extracted from the retained pixels were individually preprocessed by
different techniques to normalise their values and remove unwanted variations which
may mislead the posterior quantitative analysis. A mean spectrum was computed
for each cell in order to reduce the complexity of the dataset and try to mitigate
remaining undesirable effects in the preprocessed spectra of individual pixels, such as
random noise. The anomalous or extreme values in the dataset of mean cell spectra
were filtered out to promote stability and reduce bias in the dimensionality reduction
and classification algorithms.
An exploratory analysis was performed in the resulting dataset in order to study
the main trends within the data. Finally, the kept mean cell spectra went through a
process of feature extraction and supervised classification where different alternatives
were explored, too. This final process of classification was subject to a methodology
called nested Cross-Validation (CV) consisting of two loops, which separates the
training and testing subsets of spectra in order to avoid over-fitting and give a reliable
measurement of the performance of the constructed classification algorithms. All of
these steps will be described in detail in the following sections.
5.2.2 Hyperspectral images
Cell culture and sample preparation
Tab. 5.1 summarises the cell lines used in this study (A-375, HaCaT, NIH-3T3,
SK-MEL-28). With the selection of these cell lines the two major cellular skin
























Fig. 5.1: Flow diagram of the main steps applied for the discrimination of skin cells.
constituents, keratinocytes and fibroblasts, together with two skin cancer cell types
are represented (Sec.1.1.6). These cell lines were obtained from CLS Cell Lines Service
GmbH (CLS) [244] and Leibniz Institute-German Collection of Microorganisms and
Cell Cultures (DSMZ) [245]. All cell lines were individually cultured in Dulbecco’s
Modified Eagle Medium (DMEM - high glucose, Sigma-Aldrich) supplemented with
10% Fetal Bovine Serum (FBS Good, PAN-Biotech) and 2 mM L-Glutamine (Lonza)
at 37 ◦C and 5% CO2. Cells were grown to near confluence within two to three days
(A-375, NIH-3T3) or five to seven days (HaCaT, SK-MEL-28) and then transferred
to new culture plates. All cell lines were regularly tested for mycoplasma infection by
Polymerase Chain Reaction (PCR).
Tab. 5.1: Information about the cell lines used in this study.
Name A-375 HaCaT NIH-3T3 SK-MEL-28
Species Homo sapiens Homo sapiens Mus musculus Homo sapiens
Origin Skin Skin Embryo Skin
Type Melanoma Keratinocytes Fibroblasts Melanoma
Provider CLS CLS DSMZ CLS
Reference 300110 300493 ACC 59 300337
Cells/well 1.5 · 105 2 · 105 1 · 105 1 · 105
Incubation time one day two days one day one day
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CaF2 windows (grade VUV, 12.5 × 12.5 mm in size and 1.5 mm thick) were
obtained from CRYSTAL GmbH [246]. Both sides of the windows were optically
polished. The windows were decontaminated and stored in pure alcohol before use.
Before seeding cells, CaF2 windows were placed in a 12-well plate, washed twice with
Phosphate Buffered Saline (PBS) and kept in cell media. Cells were counted and the
cell suspensions were dropped onto the windows and incubated at 37 ◦C and 5% CO2.
Densities (in cells/well) and incubation times are shown in Tab. 5.1.
Once the cells had built a confluent layer on the CaF2 window, they were washed
twice with PBS, fixed with 1% glutaraldehyde/PBS for 30 minutes and washed
again. The fixed samples were dehydrated by carrying out an ascending ethanol
series. Finally, the samples were air-dried and stored in order to perform posterior
measurements. More detailed information about the cell culture and the sample
preparation can be found in [247–249].
FTIR measurements
The measurements were performed with the micro-FTIR spectroscopic imaging
system described in Sec.2.5. Six frames per sample were taken and combined, covering
a horizontal and vertical area of around 2.1 × 1.4 mm2 that included the whole cell
culture. The measurements were carried out in transmission mode and absorption
spectra were acquired between 1000-3900 cm−1 with a wavenumber interval of 4 cm−1.
The images of the reference backgrounds (taken from regions of empty substrate)
and the images of the cell samples were created by co-adding 256 and 128 scans,
respectively.
Batches definition
Cells from each cell line were independently cultured and later seeded and fixed
separately in specific regions of a CaF2 window forming a cell sample. The separation
of these regions were delimited by silicone inserts or moulds with four rectangular
holes that were attached to the CaF2 window before cell seeding and were removed
after fixation. Fig. 5.2 shows a picture of one of these inserts attached to a square
CaF2 window.
Fig. 5.3 shows the representative grayscale images obtained from the FTIR
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Fig. 5.2: Photography of the inserts or moulds used to separate different cell cultures in
the same CaF2 window.
hyperspectral images of all the cell samples that were prepared and measured for
this study. As can be observed, three samples per cell line were measured giving a
total of twelve cell samples. These samples have been arranged in different batches
according to preparation and measurement criteria:
 The samples within Batch 1 were cultured at the same time and later seeded
and fixed in the same CaF2 window. They were also measured during the same
day in the FTIR microspectrometer.
 The samples within Batch 2 and Batch 3, with the exception of the samples of
HaCaT cell line, were cultured at the same time (around one year and a half later
than cells from Batch 1 ) and were also seeded and fixed in two separate CaF2
windows. HaCaT samples of Batch 2 and Batch 3 were later cultured (3 months
later) and seeded and fixed in a separate CaF2 window due to problems during
the preparation of that cell line in the original CaF2 windows of those batches.
Finally, all the samples from Batch 2 and Batch 3 (including HaCaT cells)
were measured during the same day in the FTIR microspectrometer, around
nine months after acquiring the images of Batch 1.
Both preparation and measurement factors introduce variations in the FTIR
spectra. Those variations will determine the strategies of the quantitative analysis
and will also have influence in the obtained results.
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Fig. 5.3: FTIR grayscale images of the measured samples of skin cultured cell lines. Images
from different cell lines are arranged by columns and from different batches by rows. The
red dotted line reminds that images of HaCaT cells from Batch 2 and Batch 3 were cultured
in a separate CaF2 window. Green scale bars represent 1 mm.
5.2.3 Spectra extraction
The first step in the analysis of the FTIR hyperspectral images is to separate pixels
containing cell structures from those containing only substrate. Those different
regions can be distinguished when a representative grayscale image is computed from
the FTIR data cube in a similar way that was described in Sec. 4.2.3. In this case,
the spectral window was cropped to the region 1610-1690 cm−1, which contains the
strongest peak of the spectrum (Amide I) and, therefore, the influence of noise in
the final image is reduced. The standard deviation (Eq. 4.2) of the cropped spectral
region was computed for each pixel and the range of values obtained in the whole
image was linearly transferred to the intensity grayscale range of 0-255, allowing 0.5%
of saturated pixels in both intensity endpoints to consider the impulsive noise and
dead pixels. Finally, the intensity range was inverted in order to mimic the intensity
pattern of the white light images (light in the substrate and dark in cells). This
methodology was used to create the images presented in Figs. 5.3 and 5.4a.
In these grayscale images, substrate pixels have the highest (lightest) grayscale
levels, nuclear regions have the lowest (darkest) ones and pixels mainly associated






















Fig. 5.4: Illustration of automatic binarisation by Otsu’s method. (a) FTIR grayscale
image. (b) Binary mask. (c) Histogram of the grayscale levels of image (a) and the automatic
thresholds computed by Otsu’s method. The threshold 2 (green vertical line) was used to
create the binary mask (b). Green scale bars of images (a) and (b) represent 500 µm.
with cytoplasm have intermediate grayscale levels. This behaviour is reflected in the
histogram of the grayscale images (Fig. 5.4c). Attending to the characteristics of
the histogram, the Otsu’s method [250] can be used to automatically compute two
thresholds that separate the three classes of pixels (nucleus, cytoplasm and substrate).
The highest threshold (threshold 2 in Fig.5.4c) can be used to compute a binary mask
that separates the regions mainly containing substrate from cell structures (Fig.5.4b).
These binary masks were computed individually for each cultured sample and the
spectra of cell structures (black pixels in Fig. 5.4b) were retained for next steps of the
discrimination pipeline.
5.2.4 Spectral preprocessing
As was explained in Sec. 3.2, spectral preprocessing is recognised as a key step in
quantitative analysis of FTIR spectra, especially for cytological studies. In order
to better understand the need of spectral preprocessing, Fig. 5.5 shows several
examples of raw spectra corresponding to pixels from different regions of the four
studied cell lines. Those pixels, whose effective size is 5.5 × 5.5 µm2, have been
overlaid on independent white light images of higher resolution aligned with the FTIR
hyperspectral images.
As can be observed, even spectra from nearby pixels in the same image can be
highly variable. Most of the gross variations are mainly determined by differences in
concentrations and optical path lengths (thickness), which commonly result in offsets
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and multiplicative factors. Nevertheless, more complex distortions can be observed
in some cases, showing the pattern distinctive of Mie and Resonant Mie Scattering
(RMieS) (e.g., complex baselines, lower ratio Amide I-Amide II peaks, derivative-like
depressions beyond the Amide I peak), which were thoroughly described in Secs. 2.6
and 3.2. By looking at the white light images, those complex spectra can be associated
with regions where the cells are more compact and rounded. Hence, they have
characteristics that produce Mie scattering phenomena.
This morphological heterogeneity, which gives rise to critical variations in the
FTIR spectra, can be related to different stages of the cell cycle, as was demonstrated
in previous studies [143, 251–253]. Those studies showed that cells in stages G2 and
close to mitotic phase M (Sec. 1.1.2) have more compact structures that increase the
presence of RMieS artifacts. They also demonstrated that FTIR spectra from cells of
the same cell type could be discriminated attending to their stage in the cell cycle. In
addition, some other cells may have entered into apoptosis, due to the high levels of
cell stress that can appear locally in the cell culture, acquiring compact and rounded
configurations too.
The main aim of spectral preprocessing is to normalise and standardise the spectra
so that they can be categorised based on biochemical properties, rather than unwanted
physical properties (thickness, concentrations, morphology, etc) that increase the
spectral variability and presumably can confound the discrimination. The raw spectra
together with four different preprocessing methods that were described in Sec.3.2 have
been considered in order to study their possible influence in the discrimination of cell
lines:
 Raw : the spectra were not further preprocessed.
 Min-Max : Min-Max normalisation.
 SNV : Standard Normal Variate [180].
 DiffSG1 : 1st order differentiation by Savitzky-Golay (SG) filter (2nd order
polynomial and 19 fitting points) and vector normalisation.
 RMieS-EMSC : Resonant Mie Scattering-Extended Multiplicative Signal Cor-
rection algorithm after 20 iterations. As was shown in Sec. 3.2.1, 20 iterations
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is a conservative number that generally gives a stable correction. Neverthe-
less, it took 4 weeks to individually preprocess all the initial extracted spectra
(∼480000) in the computer platform that was described in Sec. 4.2.8, which si-
multaneously ran the current version of the RMieS-EMSC algorithm in 4 parallel
MATLAB sessions.
Traditionally, the first three preprocessing methods (Min-Max, SNV and DiffSG1)
have been mainly applied in FTIR spectroscopic measurements of tissues, although
they have been also employed for cell spectra [177]. Nevertheless, since the
characterisation of RMieS artifacts and the publication of RMieS-EMSC algorithm,
it has generally become the default preprocessing method in cytological studies.
In all cases, the spectral range was cropped to the fingerprint region (1000-
1800 cm−1). This restriction was applied to the raw spectra and before preprocessing
except for the case of RMieS-EMSC, whose spectra were cropped after preprocessing
so that the RMieS baselines could be modelled and corrected more accurately with
the information of higher wavenumbers (Sec. 3.2.1).
5.2.5 Mean cell spectra
The vast majority of cytological studies based on FTIR hyperspectral images compute
a mean or average spectrum per cell in order to reduce complexity and increase the
robustness of later analyses. These mean spectra are computed after (instead of
before) preprocessing the raw spectra of individual pixels independently in order to
compensate for uneven spectral distortions due to the heterogeneous spatial properties
of cells [252].
This approach is in line with object-based or object-oriented classification
approaches, which are very popular in the analysis of hyperspectral images in
remote sensing [254]. Object-based approaches incorporate a certain level of spatial
information that generally improves the performance of pixel-wise or pixel-by-pixel
classification.
In order to compute mean cell spectra, it is essential to delimit the regions of pixels
belonging to each individual cell. The binarisation method described in Sec. 5.2.3
follows a similar philosophy to the so-called PapMap method [234], which was
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designed to identify isolated cells from smears preparations and discard clumped
cells. Nevertheless, unlike smears of cells, which are normally scattered and isolated,
cultured cells tend to grow into clusters due to spatial constrictions. Therefore,
segmentation methods [255,256] more advanced than a simple binarisation are needed
to separate the regions which belong to single cells. The segmentation of cells was
performed with a methodology similar to the one proposed by Filik et al. [257], which
applies the marker-controlled watershed transformation.
Watershed transformation
The watershed transformation is one of the most used techniques of mathematical
morphology [255, 258, 259] and also one of the most used methods to segment cells
and nuclei in different microscopy modalities [260,261]. It was firstly defined in [262]
and the most efficient algorithmic implementation based on hierarchical queues was
found in [263].
The watershed transformation considers a grayscale image as a topographical
surface whose height is determined by the grayscale intensity level of each pixel and
which is composed of different local maxima and minima. Fig. 5.6a shows the main
elements of this analogy. The local minima of the image are surrounded by lighter
pixels that form catchment basins. The watershed transformation supposes that a hole
exists at each local minimum and that the surface is flooded from these holes Fig.5.6b.
As the water level increases, the catchment basins get filled and the water tries to be
transferred between them. In order to prevent that merging, a kind of dams are built
at each contact point. When the water level reaches the global maximum height, the
union of all constructed dams constitute the watershed lines, which indicate the limits
of the catchment basins.
In order to illustrate this segmentation method, Fig. 5.7 shows an example where
the input grayscale image (Fig. 5.7a) can be considered as a topographical surface
(Fig. 5.7b). The watershed transformation segments the input image in different
connected objects limited by the watershed lines (Fig. 5.7c). The number of final
segmented objects (four in the considered example) is defined by the number of
catchment basins existing in the input image, which in turn is determined by the
number of connected local minima.














Fig. 5.6: Analogy of the watershed transformation. (a) Topographical patterns of a
grayscale image. (b) Construction of the watersheds by flooding. Adapted from [264].
(a) (b) (c)
Fig. 5.7: Example of segmentation with the watershed transformation. (a) Input
grayscale image. (b) Representation of the grayscale image as a topographical surface.
(c) Final segmented image with the watershed lines in red, delimiting four independent
regions. Reproduced from [265] with permission by courtesy of Serge Beucher (Center of
Mathematical Morphology).
Marker-controlled watershed
One of the major problems of the watershed transformation is over-segmentation.
As described before, each local minimum of the input image will give rise to a
segmented region. Apart from being sensitive to local irregularities and minima
due to noise, the final segmentation may produce excessive undesired divisions. The
marker-controlled watershed, firstly defined in [258], is the major enhancement of
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the watershed transformation and tries to prevent the over-segmentation problem by
introducing the notion of markers of the objects to be segmented. Each marker is a
set of connected pixels that defines a specific region in the image. The modification
consists of imposing the marker regions as global minima in the input image. During
the flooding of this modified image, the water springs up only from these new global
minima and the constructed dams enclose the modified catchment basins. Thus, a
segmented region arises from each selected marker.
As an example, Fig. 5.8a shows the same image that was segmented in Fig. 5.7
with three regions of connected pixels selected as markers in red. When comparing
the final segmented image (Fig. 5.8b) with the result of the regular watershed
transformation (Fig. 5.7c), it can be observed that the vertical watershed line that
divided the two central objects has disappeared. It can also be checked that the
number of final segmented objects in the marker-controlled watershed is determined
by the number of defined markers (three in this example).
(a) (b)
Fig. 5.8: Example of the marker-controlled watershed. (a) Input grayscale image with three
regions of connected pixels selected as markers in red. (b) Final segmented image with the
watershed lines in red. Reproduced from [265] with permission by courtesy of Serge Beucher
(Center of Mathematical Morphology).
In many situations, the aim of the segmentation task is to isolate specific objects in
the images. In those cases, the concept of foreground and background markers arises,
which are regions defined inside and outside the objects of interest, respectively. The
methodology to find or define these two types of markers may be different, but all of
them finally act as global minima in the modified input image to segment.
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Often, the objects of interest have relatively uniform intensities and their borders,
identified as regions of high local contrast, become local maxima in the gradient
image. In those cases, the gradient image is used as the input image of the watershed
transformation and the final watershed lines tend to match the borders of the uniform
objects. However, the use of the gradient image is not mandatory and the selection
of the input image will depend on the specific problem. The same reasoning applies
to the markers, whose definition is also problem-dependent.
Cell segmentation
As described above, three elements must be defined to segment cells with the marker-
controlled watershed, which in this case are:
 Input image: the FTIR grayscale image that was described in Sec. 5.2.3.
 Outer markers: the binary mask of substrate, also described in Sec. 5.2.3, after
being processed by morphological erosion with a disk of radius 1 as structuring
element [255,259].
 Inner markers: the regional minima of the FTIR grayscale image outside the
binary mask of substrate, which are mainly associated with the nuclear regions
that have higher absorbance than their neighbourhood.
A cropped image per cell line has been selected to illustrate the elements and
results of the cell segmentation in Fig. 5.9. The described segmentation method
gave good overall results for the four studied cell lines, which have different growth
behaviour. HaCaT cells presented the major difficulties because they tend to form a
layer with very close cells, which are not well resolved in some regions at the measured
spatial resolution (effective pixel size of 5.5 × 5.5 µm2). Finally, regions with less
than 5 and more than 100 pixels were rejected in order to correct over- and under-
segmentation respectively.
5.2.6 Outliers removal
Outliers can seriously bias and deteriorate the performance of the learning framework.
The correct way of proceeding with outliers is attempting to determine and address
their causes in order to detect possible failures in the followed methodologies [174].





Fig. 5.9: Illustration of cell segmentation. An example for each cell line is shown
by rows: (a) A-375, (b) HaCaT, (c) NIH-3T3 and (d) SK-MEL-28. Column 1: FTIR
representative grayscale image. Column 2: White light image aligned with the FTIR
image. Column 3: Markers of the marker-controlled watershed segmentation overlaid on
the white light image: inner markers coloured in green and outer markers coloured in red.
Column 4: Final segmentation mask overlaid on the white light images: isolated cellular
regions are defined by different pseudo-colours. Green scale bars represent 200 µm.
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In this problem, there are many sources that may cause anomalous samples, starting
from the cell culture preparation, the acquisition of spectra and finally in the previous
steps of the classification pipeline (e.g., spectral artifacts introduced or not corrected
during preprocessing). Due to the complexity of the problem, the limited technological
maturity of FTIR microspectroscopic imaging and the lack of standardised and
universally-recognised analysing protocols, it is reasonable to remove all possible
perturbations that may be caused by outliers and leave the (difficult) task of analysing
outliers for future studies.
The whole dataset of mean spectra per segmented cell region was studied to detect
outliers. For this task, the preprocessing option RMieS-EMSC was taken as a reference
to define those cell regions whose mean spectra are anomalous. This process was
performed by using PCA decomposition (retaining the first PCs that accounted for
99% of total variance) and Mahalanobis distance in the same way that was described
in Sec. 3.3.1. The cell regions with mean spectra preprocessed by RMieS-EMSC and
detected as outliers were discarded in all the preprocessing alternatives described
in Sec. 5.2.4 in order to keep the same set of cells for the final analysis.
5.2.7 Feature extraction
Feature extraction techniques aim to reduce the number of variables included in the
classification model. It is essential to reduce the complexity and increase the stability
of discrimination models. The problem of high dimensionality in hyperspectral images
is well-known in the field of remote sensing [266,267], commonly receiving the name of
Hughes phenomenon [268]. In summary, this phenomenon states that as the number
of dimensions increases, the effectiveness of the classifier decreases. The main reason is
that the number of parameters involved in the classification model increases with the
number of dimensions and, for a fixed sample size, the uncertainty in the estimation
of those parameters become wider [266]. PCA and PLS (Sec. 3.3) were the methods
used to reduce the dimensionality of FTIR spectra and try to prevent this problem.
5.2.8 Supervised classification
Supervised classification is the task of pattern recognition [184, 185] or machine
learning [186] whose goal is to create models capable of predicting or inferring the
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labels, classes or groups of the samples from a dataset, taking as inputs a set of
measured features. These models must be constructed or trained with a set of samples
whose labels or classes are known. In this problem, the features are the scores of the
components retained in the feature extraction step. These scores are used to predict
the label, i.e., the cell line, of each sample or cell. As there are four different cell lines,
this study can be categorised as a multiclass classification problem. Two main aspects
must be defined in the supervised classification step, namely the specific classification
algorithm and the measurement used to assess its performance.
Classification algorithms
Three classification algorithms or techniques, very popular in the chemometrics
field [182, 183], have been explored: Linear Discriminant Analysis (LDA), Quadratic
Discriminant Analysis (QDA) and Partial Least Squares Discriminant Analysis (PLS-
DA). The main difference is in the definition of the class boundary; hence, these three
alternatives have been considered in order to diminish their possible influence in the
final discrimination.
Linear discriminant analysis
LDA assumes an underlying multivariate Gaussian distribution for each class or
group, which is mainly defined by a mean vector and a covariance matrix. Those
two parameters, estimated with the training samples, are used to create discriminant
rules based on posterior probabilities [186]. Hence, a new object or sample will be
assigned to that class with the largest posterior probability based on the values of its
features [182]. The feature space is divided into different regions separated by decision
boundaries, which correspond to those feature values where the posterior probabilities
of distinct classes are equal.
In the special case of LDA, all the classes are considered to have the same
covariance matrix. As a consequence of this assumption or simplification, the
boundaries between classes created in the feature space are linear. That is, the specific
regions of the feature space assigned to each cell line are separated by hyperplanes.
PCA will be used as the method for dimensionality reduction in the feature
extraction step and the scores of the retained PCs will be the features used by LDA.
This combination will be denoted by PCA-LDA.
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Quadratic discriminant analysis
QDA follows the same methodology of LDA, but allows each class to have its own
covariance matrix. Therefore, QDA can potentially represent classes with different
variance or spread better than LDA. The main consequence is that decision boundaries
are no longer linear but quadratic. This increment in complexity increases the risk of
over-fitting but in some problems, as in biological applications, this additional level
of sophistication may provide better results [183]. This classifier will also be used in
conjunction with PCA and their combination will be referred to as PCA-QDA.
Partial least squares discriminant analysis
PLS-DA [197,269] is a technique extensively used in chemometrics, which directly
employs the latent variables computed by PLS (Sec. 3.3.2) to discriminate different
classes. Following the reasoning and notation that was described in Sec. 3.3.2, once
the PLS model is built, it can be used to predict the values of the response variable
y of new samples, which in principle is a continuous variable. In particular, the
independent variables X and the response variables y can be related by the following
expression [183]:
y = X · b + f = T · qT + f (5.1)
where b is a regression coefficient vector of dimensions J×1. This vector can be used
to predict the response vector ŷ of new samples from their measurements matrix or
independent variables X̂ by:
ŷ = X̂ · b (5.2)
The estimation of b can be obtained through the pseudo-inverse of X (denoted
X+) as follows:
b = X+ · y = W · qT (5.3)
where W is the matrix whose columns contains the weight vectors of the PLS
components (Sec. 3.3.2).
In PLS-DA, the response or dependent variable y of the training samples only
contains discrete values that codify different classes or labels. In particular, the
implementation based on PLS1 only allows to discriminate two classes, which are
normally coded as +1 and -1 in y. Therefore, PLS-DA based on PLS1 is a pure two-
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class or binary classifier and its extension to multiclass problems is less straightforward
than in LDA and QDA. Here, the one-versus-all strategy was adopted, which consists
of creating as many binary classifiers as the existing classes (4 in this case). During the
training of each classifier, alternatively, the samples belonging to one of the classes are
considered as the positive class (coded by +1) and the samples of the rest of classes are
grouped together to form the negative class (coded by -1). When a new test sample
arrives, a specific continuous value of the response variable ŷ will be computed for
each classifier by using Eq. 5.2. The predicted label is finally assigned to that class
which was considered as positive in the classifier that provided the highest predicted
value ŷ. The continuous nature of the ŷ variable allows to perform this judgement of
superiority between binary classifiers.
Classification boundaries
The described classification algorithms produce different decision or classification
boundaries by using the features of the training dataset. In order to illustrate these
differences, Fig.5.10 shows the areas assigned to each cell line and their limits created
with the dataset of 300 skin cell spectra that was presented in Fig. 3.6 and Fig. 3.15,
both for raw spectra and spectra corrected by RMieS-EMSC. In these examples, the
inputs or independent variables have been simplified to only two features (the two
first PCs) so that the boundaries can be easily visualised.
As can be checked in the figures, both LDA and PLS-DA create linear boundaries
(straight lines in the input space) meanwhile QDA generates more complex limits
with quadratic nature (e.g., elliptic, parabolic or hyperbolic curves). The boundaries
created by LDA and PLS-DA are very similar in these simplified cases, but their
differences increase when a higher number of PC is retained. In those input spaces
of higher dimensions (e.g., more than 3), the linear boundaries created by LDA and
PLS-DA become hyperplanes and the quadratic boundaries of QDA generalise to
quadric hypersurfaces.
Assessment metric
Another important component in classification is the metric for its evaluation. As the
problem in hand is a multiclass problem, a suitable assessment metric is the overall
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PC1 (89.6%)


































































































Fig. 5.10: Example of boundaries computed by different classification algorithms when
retaining the two first PCs in the dataset of 300 skin cell spectra that was presented in
Fig. 3.6 and Fig. 3.15, both for raw spectra (upper row) and spectra corrected by RMieS-
EMSC (bottom row). (a),(d) LDA. (b),(e) QDA. (c),(f) PLS-DA.
accuracy [266,270], which condenses the global classification performance of all classes.
As will be presented later (Tab.5.2), a small imbalance exists between the four classes
of the dataset, reaching almost a 3:1 ratio in some cases (e.g., NIH-3T3/HaCaT in
Batch 2, see Tab. 5.2). To avoid favouring the larger classes [271, 272], the Balanced
Accuracy (BA) was used instead of the overall accuracy to select the optimal models
and to assess the final multiclass classifications. BA is the mean of the accuracies for









where Nc is the number of classes (4 in this case) and cij is the number of spectra of
class i classified as class j. Hence, cii is the number of cell spectra correctly classified
for the class i.
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5.2.9 Nested cross-validation
One of the main concerns in classification is to obtain a reliable measure of the
performance of the developed models. In order to avoid, or at least diminish, over-
fitting and assess generalization ability of the classifier, the test and training sets
of spectra must be very well defined and separated during the whole process of
training, optimisation and assessment of the learning framework [183,186]. This task
was accomplished by applying a hierarchical Cross-Validation (CV) approach, called
nested CV, which consists of two loops: an outer loop for assessing the constructed
classification models and an inner loop for training and optimising those learning
models. Following this structure, two cross-validation alternatives were applied with
the aim of checking the dependency of the discrimination capabilities of FTIR spectra
on sample preparation and measurement conditions.
Outer loop: model assessment
In classification problems it is relatively easy to obtain high classification success
rates even starting with random data [183]. This phenomenon, normally referred to
as over-fitting, makes possible to get very good or even perfect discrimination on the
dataset used to train the classification models, but generally offers poor prediction
capabilities for new unseen samples [273]. In order to prevent this, in the outer loop a
group of mean cell spectra called test set is separated from the rest of the dataset and
does not take part during the construction of the learning models performed in the
inner loop. Once the models are finished, the spectra from the test set act as unseen
samples and they are used to assess the models constructed in the inner loop. This
technique tries to give an estimate of the generalisation capabilities of those models.
Inner loop: model selection
The remaining samples not considered as test set in the outer loop are normally
referred to as training set. The classification models have a series of parameters
which must be tuned with that training set. These parameters can be divided into
those tuned with the statistics of the samples, e.g., the specific weight given to a
variable, and those whose values must be explicitly imposed by the expert, which
are sometimes called hyperparameters. As the hyperparameters also influence the
performance of the learning model, the selection of their values must be optimised.
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In this case, the only hyperparameter is the number of components K retained
during the feature extraction step, which determines the complexity of the model.
In order to optimise its value and, again, reduce the risk of over-fitting, the original
training set is alternatively subdivided into two subsets inside the inner loop of CV.
The first subset of samples, normally called validation set [183,186], plays the role of
independent set, which assesses the performance of the classification models trained
with the samples of the second subset. In this process, all the samples are considered
once inside a validation set and a global measure of performance in terms of BA can
be computed for each value of K. As an illustration, the left plot of Fig.5.11 presents
two curves with the evolution of BA with K for different validation sets.
NumberKofKComponents





























Fig. 5.11: Sketch of the optimisation of the number of retained components K. The left
plot presents two curves (yellow and blue) with the evolution of the Balanced Accuracy (BA)
with K for different validation sets. The right plot presents the same curves after applying
the transformation to the normalised space where the distances to the ideal performance
point are computed. In both plots, the ideal performance point and the selected optimal
points for each curve have been symbolised as shown in the legends.
One straightforward way to optimise K would be to take the value corresponding
to the maximum of those computed curves. However, in cases like the curves presented
in Fig. 5.11, taking the maximum value would näıvely increase the complexity of the
model. The Hughes phenomenon (Sec.5.2.7), together with the fact that the presence
of noise increases with the number of retained components (Sec. 3.3), recommend
to keep the value of K as low as possible. Therefore, an optimisation procedure
was developed to try to find automatically a compromise solution between the
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maximisation of BA and the minimisation of K. The key concept of this procedure
is that the ideal point, for a given maximum performance, would be the point
(Kmin,BAmax). Therefore, the optimal point inside the computed curve would be
the closest one to that ideal point. As the variables of the two original axes (K,BA)
have different nature, they must be normalised in order to give them a fair weight.
Mathematically, the coordinates (ξ, η) of this referenced and normalised space are









As can be seen in the right plot of Fig. 5.11, the performance curves are
distorted in the normalised space and the ideal performance point becomes the point
(ξideal, ηideal) = (0, 1). In this new normalised space, the optimal number of retained
components Kopt is finally computed as the value of the curve that minimises the
distance to the ideal point dopt. That is:






(ξ − ξideal)2 + (η − ηideal)2 (5.7)
The optimal points for each curve of Fig. 5.11 are symbolised by asterisks. In the
final applications, the values of minimum (Kmin) and maximum (Kmax) number of
retained components were respectively fixed to 1 and 25. The final step in the inner
loop consists of constructing the classification models by using the computed Kopt
values and the whole original training set. Those optimised models are taken to the
outer loop to assess their generalisation performance with the isolated test set.
Cross-validation alternatives
Once the CV method has been chosen, it is important to decide how the test, training
and validation sets will be created from the whole dataset of mean cell spectra
that were retained after the removal of outliers. The prediction capabilities of the
classification models are determined by the similarities between the spectra from the
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test sets and the training sets. In order to assess those similarities, two approaches
were followed to separate the mean cell spectra of each kind of set:
 One-Batch-Out CV: consecutively, the spectra extracted from the images of
one batch (Fig. 5.3) are considered as the test set in the outer loop and the
classification algorithms are trained with the spectra of the other batches in
the inner loop. The process is repeated so that each batch is considered once
as the test set. The results for each test batch are combined to provide the
final performance measurement (a single value of BA). The idea behind this
approach is to assess the uniformity of cell lines between batches and to check
if there may be some critical factors for correct discrimination (e.g., the sample
preparation procedure or the measurement conditions).
 In-Batch CV: as shown in Fig. 5.12 for Batch 1, each image is split in 5 vertical
stripes with an equal number of segmented cells. Each vertical stripe of the same
colour is considered as the test set and the remaining stripes form the training
set. This is repeated until all stripes have been in the test set once. The main
reason to group cells in vertical stripes, instead of randomly choosing them
for the test sets, is to try to construct synthetic subimages where the spatial
variability within the same cell culture is also assessed. When this process is
finished for one batch, it is repeated for the remaining batches independently.
The results for each test stripe and batch are finally combined to provide the final
performance measurement (a single value of BA). The aim of this approach is
to assess the discrimination between cell lines inside each batch and to compare
the performance with the One-Batch-Out CV approach.
A-375 HaCaT NIH-3T3 SK-MEL-28
Batch 1
Fig. 5.12: Sketch of the In-Batch CV approach. Each image is split in 5 vertical stripes
with an equal number of segmented cells; CV is performed independently within each batch
by alternately considering one of the stripes from each cell line as the test set and the rest
of stripes as the training set. Green scale bars represent 1 mm.
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5.3 Results
5.3.1 Exploratory data analysis
Before presenting the final classification results, it is useful and even advisable to
perform an exploratory analysis of the data in search for trends or patterns that may
justify the outputs of the classification. This analysis is centred on the inputs of the
final classification module, i.e., the mean cell spectra after outliers removal (Fig. 5.1).
This task consists of visualising the main outputs of descriptive statistics and PCA.
Descriptive statistics
Morphological information
The information about the final number of segmented cell regions and their
corresponding number of pixels retained after outliers removal for each cell line and
batch are presented in Tab. 5.2. A total of 22700 cells were retained for the final
analysis. As can be observed, the number of cells varies between cell cultures.
Tab. 5.2: Information about the retained cells after outliers removal. Number of segmented
cellular regions (first number) and number of pixels inside them (second number) for each
cell line (columns) and batch (rows). The last row and column present the corresponding
total marginal values.
A-375 HaCaT NIH-3T3 SK-MEL-28 Total
Batch 1 2247 / 35473 1638 / 41525 1750 / 31524 2495 / 34610 8130 / 143132
Batch 2 2438 / 31314 966 / 23367 2656 / 45348 1931 / 35875 7991 / 135904
Batch 3 1867 / 27906 875 / 20609 2318 / 45377 1519 / 32022 6579 / 125914
Total 6552 / 94693 3479 / 85501 6724 / 122249 5945 / 102507 22700 / 404950
The information of the total number of retained cells and pixels can be
complemented by the histograms of pixels per cell shown in Fig. 5.13. The majority
of cells cover less than 20 pixels but there are slight differences between samples and
cell lines. As already pointed out (e.g., see Figs. 1.13 and 5.9), HaCaT cells tend to
form more homogeneous monolayers and adopt flatter configurations than the other
cell lines, which is reflected in more uniform histograms. On the contrary, malignant
cell lines (A-375 and SK-MEL-28) and in a less extent NIH-3T3 cells normally grow
in a more proliferative and disordered way. As a result, those cell lines present higher
proportions of smaller cells, which also tend to be more rounded and compact and,
hence, more liable to produce scattering artifacts.
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Fig. 5.13: Histograms of pixels per cell in the final retained cells of each sample.
Spectral information
The mean and the standard deviation (std) of the retained mean cell spectra were
computed for each hyperspectral image as measurements of central tendency and
dispersion. Fig. 5.14 displays these values for the raw spectra without preprocessing
in the form of shaded error bars for each cell culture or hyperspectral image. In
addition, the mean spectrum of each cell line has been represented in order to disclose
the differences between batches for each cell line. In these plots, the gross variations
(offsets, maximum absorbance, etc.) of raw spectra that have been extensively
described in Secs. 3.2 and 5.2.4 become evident. This variability between mean cell
spectra within the same hyperspectral image and also between batches can seriously
hamper the prediction capabilities of the learning models.
Spectral preprocessing techniques aim to reduce the unwanted variability of raw
measurements by standardising or normalising the spectra. As an illustration of the
effects of spectral preprocessing, Fig. 5.15 shows the equivalent shaded error bars
of the mean cell spectra preprocessed by the RMieS-EMSC alternative. The most
distinguishing effect of this preprocessing alternative is the drastic reduction of the
standard deviation of spectra, i.e., differences between spectra become much more



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































188 Chapter 5. Discrimination of skin cancer cells
subtle. Depending on the preprocessing alternative this variability will be mainly
caused by different sources and, in the case of RMieS-EMSC (the most complex
alternative), the main source is supposed to be the biochemistry of the cells. If
the drawn preprocessed spectra are closer studied, those subtle differences can be
identified. As an example, in A-375 and SK-MEL-28 cell lines of Batch 2 high
frequency variations in the range 1300-1800 cm−1 are more relevant than in the other
batches, which may suggest a higher content of water vapour artifacts.
For brevity, the shaded error bars of the rest of alternatives are not shown but
in exchange the mean spectra for each cell line and preprocessing alternative are
presented in Fig. 5.16. As can be observed, the differences between cell lines change
depending on the preprocessing. In fact, the order of presentation of the preprocessing
alternatives corresponds with the level of differences observed. This order also
agrees with the level of transformation that individual spectra experiment during
the corresponding preprocessing. In this sense, Min-Max alternative broadly removes
the offsets and applies a basic normalisation. Therefore, with this preprocessing the
differences observed between cell lines are likely due to Mie scattering artifacts and, by
extension, to cell morphology as evidenced by the uneven ratios of Amide I-Amide II
peaks and remaining baselines. Either way, it must be demonstrated if the reduction
of undesirable artifacts with the most complex preprocessing alternatives is necessary
and effective enough to discriminate, or improve the discrimination of, cell lines.
Principal component analysis
As was described in Sec. 3.3.1, the capabilities of PCA for dimensionality reduction
can be used to visualise the intrinsic structures of hyperspectral datasets. Because
PCA is an unsupervised method (no information of the cell class is used), their
plots provide useful details about the proximity or similarity between spectra and
the possible natural groups that they may form. Following this line, PCA can be
used to extract preliminary information from the different datasets which each cross-
validation alternative (Sec. 5.2.9) will have to deal with.
In the case of One-Batch-Out CV, it is interesting to explore the whole dataset
of mean cell spectra in order to study if there are relevant differences between the
batches. The most important plots after applying PCA to the whole dataset of
retained mean cell spectra are shown in Fig. 5.17. Again, RMieS-EMSC has been
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Fig. 5.16: Mean spectra of the mean cell spectra retained after outliers removal for each
cell line and preprocessing alternative.
chosen as the reference preprocessing because it is the most advanced alternative.
In Fig.5.17a, 100 mean cell spectra from each cell line and batch have been randomly
selected to construct the score plots of the 2 first PCs. In that plot, points from the
same cell line have been drawn with the same colour and same symbols have been
used to identify points from each batch. As can be observed, some subgroups of
the same cell lines seem to appear mainly from non-tumoral HaCaT and NIH-3T3,
which spread less than melanoma cell lines A-375 and SK-MEL-28. Despite those
local subgroups, a global separation between cell lines is not so evident.
In Fig. 5.17b the points belonging to each cell line have been isolated in distinct
subplots in order to better distinguish differences between batches within each cell
line. In those subplots, batches have been denoted by the same symbols used in
Fig.5.17b but assigned different colours. As can be seen, spectra from Batch 1 clearly
tend to cluster separately from the rest of batches in all cell lines. However, points
from Batch 2 and 3, with the exception of NIH-3T3, are much more overlapping. If
these subplots are compared with Fig. 5.17a, now spectra from Batch 1 can be better
identified in the lower part of the graphs. In that batch, NIH-3T3 spectra seem more
isolated than the other cell lines. In addition, HaCaT cells from Batches 2 and 3 can







































































































































Fig. 5.17: Principal component analysis of the whole dataset of retained mean cell spectra
preprocessed by RMieS-EMSC. (a) Score plots of the two first PCs with the corresponding
percentage of explained variance in parentheses where 100 mean cell spectra for each cell
line (depicted with different colours) and batch (depicted with different symbols) have been
randomly chosen from the whole dataset. (b) Same score plots than in (a) showing only the
randomly selected spectra of each cell line; symbols used to denote the batch are the same
as in figure (a) but colours have been changed to better identify differences between batches.
(c) Loadings of the 2 first PCs with the corresponding percentage of explained variance in
parentheses. (d) Evolution of the cumulative explained variance for the first 25 PCs.
be better distinguished in the right central region more or less mixed with NIH-3T3
spectra. Finally, spectra from melanoma cell lines A-375 and SK-MEL-28 of Batches 2
and 3 are much more tangled in the upper-central region of the chart.
Fig. 5.17c displays the corresponding loading vectors of the 2 first PCs. As
observed, the highest weights of the first PC (PC1), which explains 40.9% of the total
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variance, are located around the Amide I peak (∼1600-1700 cm−1, with maximum at
1653 cm−1) and Amide II peak (∼1500-1600 cm−1, with maximum at 1543 cm−1).
Other stronger weights occur around 1070 cm−1 and 1240 cm−1. The second PC
(PC2) explains 15.4% of the total variance and it gives important clues about the
presence of two spectral artifacts (Sec. 2.6). The first artifact is Resonant Mie
Scattering, which causes shifts in the maxima’s position of the strongest absorption
peaks and may be responsible for the difference in the position of the maximum
weight (1660 cm−1) with respect to PC1. The second artifact is likely water vapour,
which may be responsible for the high-frequency fluctuations throughout the range
1300-1800 cm−1.
Finally, Fig. 5.17d shows the evolution of cumulative explained variance with the
number of retained PCs. As can be observed, the first 5 PCs account for 80% of the
total variance and 15 PCs must be retained to explain a 95% percentage.
In the case of In-Batch CV, the similarities between cell lines within each batch
may be inferred from the described study of the whole dataset. However, it may
be more convenient to analyse each batch independently in order to reduce the
interferences of other batches during the computation of the main directions of
variation. Fig. 5.18 shows the most relevant plots when applying PCA to the subsets
of retained mean cell spectra preprocessed by RMieS-EMSC from each batch.
The score plots of the 2 first PCs of each batch (first column of Fig. 5.18)
reveal congruent information with the study of the whole dataset about the relative
dispersion of each cell line: HaCaT and NIH-3T3 tend to form more compact
subgroups, meanwhile A-375 and SK-MEL-28 are relatively more spread. Concerning
the separation between cell lines, slight differences can be observed within each batch:
in Batch 1, NIH-3T3 seems to be the most isolated cell line followed by HaCaT, which
has partial overlaps with the other cell lines; in Batch 2, HaCaT and SK-MEL-28
spectra seem well separated but there is a significant overlap between A-375 and
NIH-3T3; in Batch 3, HaCaT and NIH-3T3 seem to overlap only partially with the
rest of cell lines, meanwhile A-375 and SK-MEL-28 spectra appear more mixed, as in
Batch 1.
The loading vectors of the 2 first PCs (second column of Fig. 5.18) again highlight
the problems of RMieS, which may be responsible for the shifts in the maximum
weights around the Amide I peak, and water vapour. In particular, fluctuations due
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Fig. 5.18: Principal component analysis of the subsets of retained mean cell spectra from
each batch (rows) preprocessed by RMieS-EMSC. First column: Score plots of the two first
PCs, with the corresponding percentage of explained variance in parentheses, where 200
mean cell spectra for each cell line (depicted with different colours) have been randomly
chosen from the corresponding batch’s subset. Second column: Loadings of the 2 first PCs
with the corresponding percentage of explained variance in parentheses. Third column:
Evolution of the cumulative explained variance for the first 25 PCs.
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to water vapour seem stronger in Batch 2, clearly distorting the maximum weights.
Finally, the plots of the cumulative explained variance with the number of retained
PCs (third column of Fig. 5.18) inform that, although in Batch 1 the first PC is less
relevant than in the rest of batches, more than 80% and 95% of the total variance
can be explained by respectively retaining 5 and 15 PCs in all batches.
5.3.2 Classification results
The preliminary descriptive information of the most relevant trends are based on two
principal components and must be contrasted with objectively-assessed classification
models that consider the whole dataset of cells and a larger number of components.
Fig. 5.19 shows graphically the final classification results in terms of Balanced
Accuracy (BA) for the combinations of explored preprocessing options (Sec. 5.2.4),
classification algorithms (Sec.5.2.8) and cross-validation alternatives (Sec.5.2.9). Each
final BA was computed by combining the predicted labels of the corresponding test
sets of mean cell spectra.
At first glance, there is an evident difference between the ranges of BA values
obtained by the two CV approaches. Meanwhile in One-Batch-Out CV BA values
range from around 0.35 to approximately 0.6 (combination RMieS-EMSC and PCA-
QDA), in In-Batch CV all the combinations provide a final BA between 0.85 and
0.95 (combination RMieS-EMSC and PLS-DA). Regarding preprocessing, there is no
clearly prevailing option and the final performance also depends on the employed
classification algorithm. Although the maximum BA values in both CV alternatives
have been reached by a combination including RMieS-EMSC.
If now we focus on the best combinations of each CV alternative, further details
may be obtained about the underlying reasons to get those final BA values. The aim
is to gain deeper information about why the misclassification may occur even in the
best scenario.
Firstly, it is worth studying the optimisation curves of the number of retained
components, computed with the corresponding validation sets as was described in
Sec.5.2.9. Figs. 5.20 and 5.21 show the optimisation curves for the best combinations
of One-Batch-Out CV and In-Batch CV, respectively. In One-Batch-Out CV, a
remarkably higher performance (around double BA) is reached when the Batch 1
is left out as test set and algorithms are trained and validated only with the spectra





















































Fig. 5.19: Classification results in terms of Balanced Accuracy for the different
preprocessing options (grouped by rows), classification algorithms (colours) and cross-
validation alternatives: (a) One-Batch-Out CV and (b) In-Batch CV.
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from Batch 2 and 3 than when one of those batches is left out and the other one forms
the initial training set with Batch 1. This fact confirms that there are more similarities
between spectra from Batch 2 and 3 than with those from Batch 1, which is in line
with the preliminary studies by PCA (Fig.5.17). On the other hand, the optimisation
curves of In-Batch CV, individually constructed for each batch by leaving out vertical
stripes of cells in the hyperspectral images, present much more similar characteristics
between them. Even so, Batch 2 provides a slightly lower performance than the other
batches but in all cases BA is above 0.9. This suggests a high degree of similarity
between the spectra from the same hyperspectral image and, hence, from the same
cell line, as well as relevant differences with other cell lines within the same batch.



























Fig. 5.20: Optimisation curves for the best combination (RMieS-EMSC and PCA-QDA)
of One-Batch-Out CV.
Finally, again for the best combinations (highest BA) of each CV alternative, the
predicted cell labels in the test sets were joined to create pseudo-colour images by
using the colour code shown in Fig. 5.22. Figs. 5.23 and 5.24 respectively present
those images for One-Batch-Out CV and In-Batch CV with the same distribution
of batches (rows) and cell lines (columns) as in Fig. 5.3. Note that cells within each
image should be coloured with the colour specified outside each column for a correct
classification. These images provide more detailed information about the position of
the misclassified spectra.
When analysing Fig.5.23, some observations can be stated about the classification
performed by the best combination of One-Batch-Out CV :







































































































Fig. 5.21: Optimisation curves for the best combination (RMieS-EMSC and PLS-DA) of
In-Batch CV.
A-375 HaCaT NIH-3T3 SK-MEL-28
Fig. 5.22: Colour code for the predicted labels of cells in the images of qualitative results.
 Batch 1 : it presents the highest rate of misclassification. A significant amount
of malignant A-375 cells are incorrectly labelled as the benign NIH-3T3. The
worst case is the non-tumoral HaCaT cell line, whose cells are mostly identified
as the tumoral SK-MEL-28. A small number of NIH-3T3 cells are confounded
with cancerous A-375 cells. Lastly, almost half of SK-MEL-28 cells are wrongly
classified as A-375.
 Batch 2 : the malignant A-375 cell line of this batch is another case with extreme
misclassification, again with the benign NIH-3T3. However, the rest of cell lines
are very well categorised.
 Batch 3 : A-375 cells are also mistaken with NIH-3T3 but in a lower degree
than in Batch 2. The rest of cell lines present high rates of correct classification,
although some cells from NIH-3T3 and SK-MEL-28 are mainly confused with
the same cell types as in Batch 1.
Finally, the images of the best combination of In-Batch CV (Fig. 5.24) confirm
the good general classification of most cells. The only remarkable inaccuracies are
mainly located in the malignant A-375 and the benign NIH-3T3 cell lines of Batch 2,









































































































































































In principle, the excellent classification results obtained in the In-Batch CV suggest
a high potential of FTIR spectra to discriminate the skin cell lines, at least inside
each batch. Nevertheless, those high rates of success are obtained independently
of the preprocessing technique and even for the raw spectra. This fact warns that
the results of the In-Batch CV may be too optimistic and some level of over-fitting
may be playing a critical role. Those suspicions are supported by the less favourable
results obtained in the One-Batch-Out CV alternative, which better assesses the
generalisation capabilities of the discrimination framework.
Indeed, a deeper study of the most optimistic discriminative option reveals that
critical differences exist, especially between cells from Batch 1 and the other batches.
These findings are also supported by the unsupervised PCA score plots of the
exploratory analyses. Taking into account that cells from Batch 1 were prepared
and measured at time points different from Batch 2 and 3 (Sec. 5.2.2) and, although
similar sample preparation and measurement protocols were followed for all batches,
they are likely to introduce confounding factors in FTIR spectra which are critical for
the correct discrimination of cell lines. Fortunately, when the experimental conditions
are more comparable, as in Batch 2 and 3, the extrapolation of the discrimination
capabilities is more satisfactory.
These findings put into doubt the actual potential of FTIR spectra to detect
subtle biochemical changes between pathological phenotypes and raises the question
of whether the discrimination of cells is critically biased by the experimental factors.
These factors are mixed with the rest of physicochemical information in the final
hyperspectral images and discovering the exact sources of these perturbations is not
easy. Despite this, the exploratory analysis of preprocessed spectra has revealed the
undesirable presence of water vapour effects even in the loadings of first PCs. These
water vapour fluctuations, which highly depend on the environmental conditions
during the spectral acquisition, could not be avoided even when purging the sample
area with dry air. Moreover, those interferences, whose relative importance is higher
in spectra with lower absorbance, increase their impact in the global dataset due to
the spectral normalisation.
The exploratory analyses also offered interesting information about the efficiency
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and consequences of the RMieS-EMSC algorithm, which is currently the most
advanced preprocessing method available practical with a implementation. In this
study, 20 iterations of the algorithm were used, which took around 4 weeks to
process the whole dataset of extracted individual spectra (around 400 thousand in
total). However, shifts in the most relevant weights of the PCA loadings around the
Amide I peak suggest a suboptimal correction of Resonant Mie Scattering artifacts.
These artifacts, associated with morphological differences, are accentuated by cell
culture conditions, where cells have sustained nutrients, support and enough space
to proliferate, favouring the presence of mitotic stages. Differences in growing and
proliferation properties between cell lines are responsible for uneven sizes and shapes,
with tumoral cell lines more prone to being smaller and more compact. Therefore, Mie
and Resonant Mie Scattering artifacts may have also played determinant confounding
roles in the discrimination of cell lines. For example, this factor may be responsible
for the misidentification of A-375 cells as NIH-3T3.
Clinically, the confusion of cancerous cells as normal (e.g., A-375 cells classified
as NIH-3T3) is critical from a diagnostic point of view and a hypothetical decision
support system would fail in the detection of the correct pathology for samples in a
different batch, which is the likely clinical scenario. On the other hand, the designation
of normal cells as cancerous (e.g., HaCaT in Batch 2 classified as SK-MEL-28) would
give rise to over-diagnosis, over-treatment and waste of resources. Hence, the transfer
of the current technologies and methodologies to clinical practice is not recommended
at this point in time.
Chapter 6
Conclusions
An extensive review of the current literature concerning the application of FTIR
spectroscopy for cancer diagnosis has been accomplished throughout the development
of this thesis. The most relevant references have been properly cited along this
final manuscript. The most important biomedical notions have been synthesised and
considered during the whole technical process.
Thorough reviews and understanding of the current knowledge of FTIR
technology, ranging from the instrumentation to the involved physicochemical factors,
have been also carried out. Special attention has been given to the possible spectral
artifacts introduced in the different experimental steps. These artifacts are mixed with
the biochemical information of the biological samples and can potentially mislead their
later analysis. Huge efforts have been made to reduce the presence of those artifacts
both during the acquisition of spectra and during their computational processing.
The most advanced existing methodologies for the correct handling, processing and
analysis of hyperspectral images and signals have been also identified and adapted to
the specific problems and real applications tackled in this thesis. The most relevant
contributions of this thesis to the global knowledge in the spectroscopic and clinical
fields have been condensed into two different applications.
In the first main application, a multimodal registration framework for the
automatic alignment of FTIR spectroscopic and H&E stained images from different
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histological sections has been presented. This methodology was used to register 47
colon samples from three different pathological groups (16 normal, 16 intermediate
and 15 tumoral) with good overall qualitative and quantitative results. The proposed
method exploits the information of concentration and thickness contained in the
absorbance FTIR spectra to generate a grayscale image with a contrast similar to the
one obtained from the H&E image. Thus, the morphological structures are highlighted
and can be used as a reference for the alignment of the two multimodal images. This
approach does not need a prior segmentation step that may introduce errors and
reduce the spatial information content.
This automatic method can be easily extrapolated to other kinds of pathologies,
such as prostate or breast cancer, where the inner part of the tissue contains relevant
morphological structures. Moreover, it can also be applied to more heterogeneous
tissues if their borders are also captured in the image. The values of the parameters
used in the two steps of the registration framework may be tuned depending on
the intrinsic morphological variability of the tissue. In particular, the required
deformations computed in the second registration step should be higher as the distance
of the sections of tissue to register increases.
The proposed method can improve the accuracy to combine the spatial information
extracted from both the traditional H&E stained images and the emerging FTIR
spectroscopy, even if different sections of tissue are used. These combinations can
result in richer diagnostic algorithms which may consider complementary aspects of
the pathological tissue, following the same philosophy as other approaches that fuse
different medical imaging modalities.
In the second main application of this thesis, the potential application of the
current state-of-the-art FTIR technology to cytopathological diagnosis has been
assessed. A dataset of approximately 22700 cultured cells, derived from two tumoral
and two non-tumoral skin cell lines, has been analysed to evaluate the discrimination
capabilities of current FTIR technology in cytopathological problems. This number
of analysed cells is relatively high when compared with existing studies. The
analysed cells were distributed across three different batches, which were prepared
and measured at different time points by following similar protocols to maximise
uniformity between batches. However, these controlled protocols are limited by
current technological and procedural restrictions, e.g., the lack of an isolation chamber
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for the measured samples, or the need of a particular growing and preparation protocol
for each cell line. Therefore, external perturbations were inevitably introduced both
during sample preparation and spectral acquisition.
Different methodologies and approaches have been explored to process FTIR
hyperspectral images and correctly analyse cell spectra throughout the whole
discrimination pipeline. Excellent discrimination results are obtained when the
algorithms are trained and tested with cell spectra from the same batch. However,
those results are not confirmed when cells from different batches are mixed to
construct the algorithms and they are finally applied to a different batch. This
disappointing fact questions the real generalisation capabilities of the discriminative
properties of FTIR spectra, which seems to be critically influenced by the differential
factors between batches, such as the sample preparation protocol or the measurement
conditions (e.g., different water vapour content).
Experimental design of future studies should assess if the optimistic results ob-
served between cell lines of the same batches are really driven by genuine biochemical
differences rather than artificial perturbations introduced by sample preparation and
measurement protocols. In any case, the high rates or misclassification for some
cell lines in different batches warn about the need of a better standardisation of the
aforementioned protocols, together with the specific analysis methodologies. This is
fundamental to develop and establish a reliable diagnostic technology of cancerous
cells based on FTIR microspectroscopy in the near future.
Further development of standardisation protocols is needed, which will also have
to incorporate and adapt to the existing routine procedures of anatomical pathology
laboratories. Additional improvements can be introduced in the different steps of
the proposed discrimination pipeline apart from the experimental improvements.
Regarding spectral analysis, it is expected that the most relevant factors may
be the preprocessing and the supervised classification framework. In the case of
preprocessing, more complex techniques for the removal of interferences such as water
vapour should be explored in case that measurements could not be performed in
isolated environments. In addition, new advances in algorithms for the correction
of RMieS, with higher computing speed, more stability and robustness against
perturbations (e.g., again water vapour), should be incorporated.
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Finally, the biomedical relevance and the extrapolation of the results obtained with
cultured cells are limited because they are grown in artificial conditions. Therefore,
the development of a reliable decision support system will necessarily have to use FTIR
spectra of cells extracted from the patient, with a reference ground truth provided by
pathologists, such as in histopathological studies. This is a question that may not
be answered in the short term, at least until more urgent technical problems are
addressed and more standardised protocols for sample preparation, measurement and
analysis are developed and widely used.
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F. Peñaranda, and J. Schnekenburger, “Potential of mid IR spectroscopy in
the rapid label free identification of skin malignancies,” in Proc. SPIE, vol.
9703, 2016, pp. 970 307–1–970 307–8.
[249] ——, “Performance of mid infrared spectroscopy in skin cancer cell type
identification,” in Proc. SPIE, vol. 10060, 2017, pp. 1 006 006–1–1 006 006–10.
[250] N. Otsu, “A threshold selection method from gray-level histograms,” IEEE
Transactions on Systems, Man, and Cybernetics, vol. 9, no. 1, pp. 62–66, Jan
1979.
References 231
[251] C. Hughes, M. D. Brown, F. J. Ball, G. Monjardez, N. W. Clarke, K. R. Flower,
and P. Gardner, “Highlighting a need to distinguish cell cycle signatures from
cellular responses to chemotherapeutics in SR-FTIR spectroscopy,” Analyst,
vol. 137, pp. 5736–5742, 2012.
[252] M. Jimenez-Hernandez, C. Hughes, P. Bassan, F. Ball, M. D. Brown, N. W.
Clarke, and P. Gardner, “Exploring the spectroscopic differences of Caki-2 cells
progressing through the cell cycle while proliferating in vitro,” Analyst, vol. 138,
pp. 3957–3966, 2013.
[253] D. R. Whelan, K. R. Bambery, L. Puskar, D. McNaughton, and B. R. Wood,
“Synchrotron Fourier transform infrared (FTIR) analysis of single living cells
progressing through the cell cycle,” Analyst, vol. 138, pp. 3891–3899, 2013.
[254] T. Blaschke, M. Kelly, and H. Merschdorf, “Object-Based Image Analysis:
Evolution, History, State of the Art, and Future Vision,” in Remotely Sensed
Data Characterization, Classification, and Accuracies, ser. Remote Sensing
Handbook. CRC Press, 2015, pp. 277–294.
[255] R. C. Gonzalez and R. E. Woods, Digital Image Processing (3rd Edition).
Pearson, 2007.
[256] J. C. Russ, The Image processing handbook, 7th ed. CRC Press LLC, 2016.
[257] J. Filik, A. V. Rutter, J. Sule-Suso, and G. Cinque, “Morphological analysis
of vibrational hyperspectral imaging data,” Analyst, vol. 137, pp. 5723–5729,
2012.
[258] F. Meyer and S. Beucher, “Morphological segmentation,” Journal of Visual
Communication and Image Representation, vol. 1, no. 1, pp. 21–46, 1990.
[259] P. Soille, Morphological Image Analysis. Springer Nature, 2004.
[260] E. Meijering, “Cell segmentation: 50 years down the road [life sciences],” IEEE
Signal Processing Magazine, vol. 29, no. 5, pp. 140–145, Sept 2012.
[261] H. Irshad, A. Veillard, L. Roux, and D. Racoceanu, “Methods for nuclei
detection, segmentation, and classification in digital histopathology: A review-
current status and future potential,” IEEE Reviews in Biomedical Engineering,
vol. 7, pp. 97–114, 2014.
232 References
[262] S. Beucher and C. Lantuejoul, “Use of Watersheds in Contour Detection,”
in International Workshop on Image Processing: Real-time Edge and Motion
Detection/Estimation, Rennes, France., Sep. 1979.
[263] F. Meyer, “Un algorithme optimal de ligne de partage des eaux,” Actes du,
vol. 2, pp. 847–859, 1991.
[264] J. Serra, “Courses on Mathematical Morphology,” Center of Mathematical Mor-
phology, http://cmm.ensmp.fr/∼serra/cours/, 2000, [Last access: 25/07/2017].
[265] S. Beucher, “Image Segmentation and Mathematical Morphology,” Center of
Mathematical Morphology, http://cmm.ensmp.fr/∼beucher/wtshed.html, 2010,
[Last access: 25/07/2017].
[266] P. Mather and B. Tso, Classification Methods for Remotely Sensed Data, 2nd ed.
CRC Press, 2009.
[267] J. Li and A. Plaza, “Hyperspectral Image Processing: Methods and Ap-
proaches,” in Remotely Sensed Data Characterization, Classification, and Ac-
curacies, ser. Remote Sensing Handbook. CRC Press, 2015, pp. 247–258.
[268] G. Hughes, “On the mean accuracy of statistical pattern recognizers,” IEEE
Transactions on Information Theory, vol. 14, no. 1, pp. 55–63, 1968.
[269] R. G. Brereton and G. R. Lloyd, “Partial least squares discriminant analysis:
taking the magic away,” Journal of Chemometrics, vol. 28, no. 4, pp. 213–225,
2014, cEM-13-0209.R1.
[270] R. G. Congalton and K. Green, Assessing the Accuracy of Remotely Sensed
Data, 2nd ed. CRC Press, 2008.
[271] H. He and E. A. Garcia, “Learning from Imbalanced Data,” IEEE Transactions
on Knowledge and Data Engineering, vol. 21, no. 9, pp. 1263–1284, 2009.
[272] S. Wang and X. Yao, “Multiclass Imbalance Problems: Analysis and Potential
Solutions,” IEEE Transactions on Systems, Man, and Cybernetics, Part B
(Cybernetics), vol. 42, no. 4, pp. 1119–1130, 2012.
References 233
[273] T. Fearn, “Discriminant Analysis,” in Handbook of Vibrational Spectroscopy,
1st ed., J. M. Chalmers and P. R. Griffiths, Eds. John Wiley & Sons, Ltd,
2002.
